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SUMMARY
T h e  p r e s e n t  w o r k  i n v e s t i g a t e s  t h e  v a l u e  of p u l s a t i l e  
a d m i n i s t r a t i o n  of L H - R H  to h y p o g o n a d a l  m a l e s .  In 
p a r t i c u l a r ,  t h e  v a l u e  of p u l s a t i l e  L H - R H  i n f u s i o n s  in t h e  
d i f f e r e n t i a t i o n  of c o n s t i t u t i o n a l  d e l a y  of p u b e r t y ,  s h o r t  
s t a t u r e  a n d  h y p o g o n a d o t r o p h  ic h y p o g o n a d i s m  is a s s e s s e d .  
B o t h  t h e  e a r l y  e n d o c r i n e  e f f e c t s  a n d  t h e  e f f e c t  of 
p r o l o n g e d  i n f u s i o n s  on i n d u c t i o n  of f e r t i l i t y  a r e  
s t u d i e d .  In a d d i t i o n ,  t h e  e f f e c t s  of h u m a n  c h o r i o n i c  
g o n a d o t r o p h i n  (HCG) on t h e  p u b e r t a l  d e v e l o p m e n t  of b o y s  
p r e s e n t i n g  w i t h  d e l a y e d  s e x u a l  d e v e l o p m e n t  a r e  e v a l u a t e d .  
Prior- r e l e v a n t  r e s e a r c h  a n d  w o r k  p u b l i s h e d  d u r i n g  t h e  
c o u r s e  of t h e  p r e s e n t  s t u d y  a r e  r e v i e w e d .
N o c t u r n a l  s u r g e s  in s e r u m  g o n a d o t r o p h i n  a n d  
t e s t o s t e r o n e  c o n c e n t r a t i o n s  in p u b e r t a l  b o y s  a r e  
c o n f i r m e d .  F o l l o w i n g  s i x  d a y s  of p u l s a t i l e  L H - R H  
i n f u s i o n s  at p u l s e  d o s e s  r a n g i n g  f r o m  2 . 5  to 1 5 u g / p u l s e  
s u b c u t a n e o u s  1 y at 9 0  in i n i n t e r v a l s ,  t h e  n a t u r a l l y  
o c c u r i n g  d i u r n a l  h o r m o n e  r h y t h m s  a r e  p e r t u b e d .  E x o g e n o u s  
a d m i n i s t r a t i o n  of L H - R H  s t i m u l a t e s  g o n a d o t r o p h i n  
s e c r e t i o n  a b o v e  p r e - i n f u s i o n  c o n c e n t r a t i o n s  o n l y  at t i m e s  
of t h e  d a y  w h e n  e n d o g e n o u s  s e c r e t i o n  is at a m i n i m u m .  At 
t i m e s  of n i g h t - t i m e  h o r m o n e  s u r g e s  t h e  e f f e c t  of 
e x o g e n o u s  L H - R H  a d m i n i s t r a t i o n  is v a r i a b l e ;  t h e  n e t  
e f f e c t  on a g r o u p  of p u b e r t a l  b o y s  wa s  to l e a v e  n o c t u r n a l  
LH c o n c e n t r a t i o n s  u n a l t e r e d .
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D e s p i t e  th e  a l t e r a t i o n  in g o n a d o t r o p h i n  f l u c t u a t i o n s  
t h r o u g h o u t  t h e  d a y  a n d  n i g h t  c a u s e d  by  L H - R H  
a d m i n i s t r a t i o n  s e r u m  t e s t o s t e r o n e  c o n c e n t r a t i o n  c o n t i n u e d  
to s h o w  m a r k e d  d i u r n a l  v a r i a t i o n  w i t h  p o s t - i n f u s i o n  
c o n c e n t r a t i o n s  s t i m u l a t e d  a b o v e  p r e - i n f u s i o n  l e v e l s  
t h r o u g h o u t  t h e  24 h o u r  p e r i o d s .
T h e  d o s a g e  of L H - R H  p e r  p u l s e  o v e r  t h e  r a n g e  2 . 5  to 
1 5 u g / p u l s e  d i d  n o t  a p p e a r  to s i g n i f i c a n t l y  a l t e r  t h e  
g o n a d o t r o p h i n  r e s p o n s e  to L H - R H ,  g i v e n  o v e r  6 d a y  
p e r  i o d s .
M e a n  g o n a d o t r o p h i n  c o n c e n t r a t i o n s  m e a s u r e d  by 
s a m p l i n g  b l o o d  e v e r y  15 m i n u t e s ,  o v e r  3 h o u r  p e r i o d s  in 
t h e  a f t e r n o o n  w h e n  e n d o g e n o u s  s e c r e t i o n  is low, s h o w e d  a 
l i n e a r  r e l a t i o n s h i p  b e t w e e n  p r e -  a n d  p o s t - i n f u s i o n  
c o n c e n t r a t i o n s .  P a t i e n t s  w i t h  c o n s t i t u t i o n a l  d e l a y  of 
p u b e r t y  a n d  b o y s  w i t h  s h o r t  s t a t u r e  s h o w e d  s i m i l a r  
i n c r e m e n t s  in g o n a d o t r o p h i n s  f o l l o w i n g  p u l s a t i l e  L H - R H  
a d m i n i s t r a t i o n .  H o w e v e r ,  m a l e s  w i t h  h y p o g o n a d o t r o p h i c  
h y p o g o n a d i s m  s h o w e d  q u a n t i t a t i v e l y  g r e a t e r  i n c r e m e n t s  
w h e n  c o m p a r e d  w i t h  t h e  o t h e r  t w o  g r o u p s .
T h e  g o n a d o t r o p h i n  r e s p o n s e s  to s t a n d a r d  b o l u s  
i n j e c t i o n s  ( l O O u g  I.V . )  of L H - R H  f a i l e d  to d i f f e r e n t i a t e  
b e t w e e n  t h e  b o y s  w i t h  d e l a y e d  p u b e r t y  a n d  s h o r t  s t a t u r e  
a n d  t h e  p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .  
F o l l o w i n g  p u l s a t i l e  i n f u s i o n s  of L H - R H  to p a t i e n t s  w i t h  
s h o r t  s t a t u r e  a n d  d e l a y e d  p u b e r t y ,  t h e r e  w e r e  no 
s i g n i f i c a n t  d i f f e r e n c e s  in b a s a l  or p e a k  LH
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c o n c e n t r a t i o n s ,  or i n c r e m e n t s  in LH d u r i n g  L H - R H  b o l u s  
t e s t s .  P a t i e n t s  w i t h  h y p o g o n a d o t r o p h  ic h y p o g o n a d i s m ,  on 
t h e  o t h e r  h a n d ,  h a d  s i g n i f i c a n t l y  e l e v a t e d  b a s a l  a n d  p e a k  
LH c o n c e n t r a t i o n s  to t h e  b o l u s  t e s t s .  I n c r e m e n t s  in LH in 
t h e  p o s t - i n f u s i o n  b o l u s  t e s t s ,  h o w e v e r  r e m a i n e d  u n c h a n g e d  
f r o m  t h e  b a s a l  v a l u e s .
P e a k  F S H  c o n c e n t r a t i o n s  t e n d e d  to fall in the  
p o s t - i n f u s i o n  b o l u s  L H - R H  t e s t s  c o m p a r e d  to p r e - t h e r a p y  
t e s t s  in t h e  s h o r t  s t a t u r e  a n d  d e l a y e d  p u b e r t y  g r o u p s .
B a s a l  a n d  p e a k  F S H  c o n c e n t r a t i o n s  r o s e  in t h e
h y p o g o n a d o t r o p h i c  m a l e s  in t h e  p o s t - i n f u s i o n  b o l u s  t e s t s .  
H o w e v e r ,  o v e r l a p  b e t w e e n  t h e  g r o u p s  p r e v e n t e d  t h i s  t e s t  
f r o m  a d e q u a t e l y  d i s c r i m i n a t i n g  b e t w e e n  t h e  g r o u p s .
I n c r e m e n t s  in s e r u m  t e s t o s t e r o n e  f o l l o w i n g  6 d a y s  of 
p u l s a t i l e  L H - R H  a d m i n i s t r a t i o n  w e r e  not d i f f e r e n t  b e t w e e n  
t h e  t h r e e  p a t i e n t  g r o u p s ;  d e l a y e d  p u b e r t y ,  s h o r t  s t a t u r e  
a n d  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .  T h e  s t i m u l a t e d
t e s t o s t e r o n e  c o n c e n t r a t i o n  s h o w e d  a r e l a t i o n s h i p  to th e  
b a s a l  t e s t o s t e r o n e  a n d  the p a t i e n t ’s b o n e  age. L i t t l e  or
no i n c r e m e n t  in t e s t o s t e r o n e  o c c u r r e d  w i t h  p u l s a t i l e
L H - R H  i n f u s i o n s  if t h e  b a s a l  t e s t o s t e r o n e  wa s
u n d e t e c t a b l e  or t h e  p a t i e n t ’s b o n e  a g e  w a s  l e s s  t h a n  12 
y e a r s .
T h e  p r e s e n t  w o r k  h a s  c o n f i r m e d  t h a t  t h e  p r o l a c t i n  
r e s p o n s e  to T R H  (2 0 0 u g  I . V . ) w a s  u n a b l e  to d i f f e r e n t i a t e  
b e t w e e n  p a t i e n t s  w i t h  p u b e r t a l  d e l a y  or p e r m a n e n t
h y p o g o n a d o t r o p h  ic h y p o g o n a d i s m .  F o l l o w i n g  p u l s a t i l e  L H - R H
2b
i n f u s i o n s  t h e r e  w e r e  no s i g n i f i c a n t  d i f f e r e n c e s  in the  
b a s a l ,  p e a k  or i n c r e m e n t a l  p r o l a c t i n  r e s p o n s e s  to T R H  in 
e i t h e r  g r o u p  of p a t i e n t s  d e s p i t e  i n c r e a s e s  in b o t h  s e r u m  
LH a n d  t e s t o s t e r o n e  in b o t h  g r o u p s . T h e r e  is t h e r e f o r e  no 
o b v i o u s  r e l a t i o n s h i p  b e t w e e n  e x o g e n o u s  L H - R H
c o n c e n t r a t i o n s  a n d  t h e  p r o l a c t i n  r e s p o n s e  to TRH.
T h e  p r e s e n t  w o r k  c o n f i r m s  th e  a b i l i t y  of p r o l o n g e d  
p u l s a t i l e  i n f u s i o n  of L H - R H  to i n d u c e  t h e  e n d o c r i n e  
c h a n g e s  of p u b e r t y .  H o w e v e r ,  d i f f i c u l t i e s  w i t h  p a t i e n t  
c o m p l i a n c e , i n a d e q u a t e  t e s t i c u l a r  f u n c t i o n  or
s e n s i t i z a t i o n  to the L H - R H  p r e p a r a t i o n ,  p i 'evented  
s u c c e s s f u l  s p e r m  p r o d u c t i o n  in m o s t  p a t i e n t s  w i t h  
h y p o t h a l a m i c  h y p o g o n a d i s m .  S t a n d a r d  b o l u s  L H - R H  t e s t s  a n d  
H C G  s t i m u l a t i o n  t e s t s  a r e  p o o r  p r e d i c t o r s  of p i t u i t a r y  
a n d  t e s t i c u l a r  r e s p o n s e  to t h i s  t r e a t m e n t .
P r o l o n g e d  p u l s a t i l e  i n f u s i o n  of L H - R H  at i n c r e a s i n g  
p u l s e  d o s e s  f a i l e d  to s t i m u l a t e  g o n a d o t r o p h i n  s e c r e t i o n  
in o n e  p a t i e n t  w i t h  c o n g e n i t a l  a d r e n a l  h y p o p l a s i a .  T h i s  
r e s u l t  w o u l d  s u g g e s t  t h a t  t h e  h y p o g o n a d o t r o p h i c  
h y p o g o n a d i s m  in t h i s  c o n d i t i o n  is of p i t u i t a r y  r a t h e r  
t h a n  h y p o t h a l a m i c  o r i g i n .
H u m a n  c h o r i o n i c  g o n a d o t r o p h i n  w a s  s h o w n  to be a 
p o t e n t  s t i m u l a t o r  of g r o w t h  a n d  s e x u a l  d e v e l o p m e n t  in 
p u b e r t a l  m a l e s .  G e n i t a l  d e v e l o p m e n t  w a s  a c c e l e r a t e d  
p a r t i c u l a r l y  in b o y s  at g e n i t a l  s t a g e s  1 a n d  2, w h e n  
c o m p a r e d  w i t h  m a t c h e d  c o n t r o l s .  It w a s  d i f f i c u l t ,  h o w e v e r  
to d e m o n s t r a t e  a n y  s i g n i f i c a n t  H C G  e f f e c t  on t e s t i c u l a r
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s i z e  w h e n  c o m p a r e d  w i t h  u n t r e a t e d  c o n t r o l s .
P a t i e n t s  w i t h  h e i g h t  v e l o c i t i e s  of 7 c m  / y e a r  or' less 
s h o w e d  s i g n i f i c a n t l y  a c c e l e r a t e d  g r o w t h  d u r i n g  H C G  
t h e r a p y .  H e i g h t  v e l o c i t i e s  fell in m o s t  p a t i e n t s  
f o l l o w i n g  w i t h d r a w a l  of HCG. P a t i e n t s  g r o w i n g  i n i t i a l l y  
at g r e a t e r  t h a n  7 c m / y e a r  h a d  m o r e  v a r i a b l e  r e s p o n s e s  to 
H C G  t h e r a p y .  P r e - p u b e r t a l  p a t i e n t s  s h o w e d  t h e  g r e a t e s t  
a c c e l e r a t i o n  in h e i g h t  v e l o c i t y  w h e n  c o m p a r e d  w i t h  
u n t r e a t e d  p a t i e n t s  at the s a m e  g e n i t a l  s t a g e .
O n l y  o n e  of 8 t r e a t e d  p a t i e n t s  f o l l o w e d  to a d u l t h o o d ,  
a c h i e v e d  a f i n a l  h e i g h t  g r e a t e r  t h a n  p r e d i c t e d  p r i o r  to 
i n s t i g a t i o n  of H C G  t r e a t m e n t .  O n l y  o n e  of 11 p a t i e n t s  
w i t h  i n i t i a l  s k e l e t a l  a g e s  l e s s  t h a n  1 1 . 5  y e a r s  s h o w e d  an 
i n c r e a s e d ,  f i n a l  e x p e c t e d  h e i g h t  a f t e r  t h e r a p y .  On th e  
o t h e r  h a n d ,  t h e r e  w a s  no s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n  
the p r e - t r e a t m e n t ,  p r e d i c t e d  a d u l t  h e i g h t s  a n d  either' t h e  
p o s t - t h e r a p y  p r e d i c t e d  a d u l t  h e i g h t  or f i n a l  h e i g h t  
o u t c o m e  in p a t i e n t s  w i t h  i n i t i a l  b o n e  a g e s  g r e a t e r  t h a n
11.5 years.
In c o n c l u s i o n  t h e r e f o r e ,  p u l s a t i l e  L H - R H  i n f u s i o n s  to 
p a t i e n t s  w i t h  p u b e r t a l  d e l a y  c a n  a l l o w  s u c c e s s f u l  
i d e n t i f i c a t i o n  of p a t i e n t s  w i t h  p e r m a n e n t
h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .  H o w e v e r ,  r e s p o n s e s  to 
t h i s  t h e r a p y  a r e  h e t e r g e n e o u s  a n d  d e p e n d e n t  u p o n  t h e 
d e g r e e  of e n d o g e n o u s  L H - R H  r e l e a s e .  P r o l o n g e d  i n f u s i o n s  
for i n d u c t i o n  of f e r t i l i t y  r e q u i r e  h i g h  p a t i e n t  
m o t i v a t i o n  a n d  a r e  o f t e n  u n s u c c e s s f u l .  H C G  t h e r a p y  for
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i n d u c t i o n  of p u b e r t y  is m o s t  e f f e c t i v e  for p r e - p u b e r t a l  
p a t i e n t s  a n d  p a t i e n t s  at s t a g e  2 p u b e r t y .  It c a n  be
a s s o c i a t e d  in e v e n t u a l  s t u n t i n g  of g r o w t h  if g i v e n  to 
p a t i e n t s  w i t h  b o n e  a g e s  l e s s  t h a n  1 1.5 y e a r s .
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CHA PTER 1
LIT ER ATUR E REVIEW
1.1) THE PHYSIOL OGY OF LH-RH SECRE TION AND ITS
THE RAPEUTIC USE
The h y pot ha la mo-hy po physeal  portal system of blood 
vessels was first desc ribed in 1930 (Popa and Fielding) 
but it was not until 17 years later that the 
physiological significa nce of this system was a ppr ec iated 
by Green and Harris (1947). They proposed that the
multitude of nerve fibres, ter mina ti ng in the vicinity of 
ca pil lary loops of the median eminence of the
hypothalamus, liberated sub stances which were tr ansporte d 
by these vessels to the anterior pituitary gland and 
s ti mul ate d hormone release.
In 1967 Schally et al demons tr ated that the human 
hyp oth alamus con taine d factors which releas ed 
g ona dotroph ins from animal pitui tary glands and in 1969 
Kastin et al d e m o n st rated that extracts of porcine 
hypothalami released gonad ot rophins  from the pituitary 
gland in man. In the same year Root et al (1969) 
de mo nstr at ed  that ovine hypo thalamic extract relea sed LH 
in two infants with lethal chromosomal anomalies and
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multiple congenital ab no rmalities and in one child with 
cerebral dysfunction of unknown aetiology.
In 1971 the decapept ide structure of luteinizing 
h o r m o n e -r el easing  hormone was char ac terised  by Schally, 
Nair and Redding (1971b) and later confirm ed  by 
synthesis (Schally, Kastin and Arimura, 1972). In these 
first studies its biological activity was d emon st rated 
both in animals and in man. It also became clear that the 
one hormone could release both LH and FSH (Schally et al, 
1971a) and despite a cons idera bl e amount of work since, 
there is still no con clusi ve evidence for separate LH and 
FSH relea sing hormones.
The av ai lab ility of LH-RH has allo wed its 
administrat ion to become an e stablis he d method for 
assessment of pituitary gonadotroph secreto ry reserve in 
normal and abnormal clinical states (Job et al, 1972; 
Hashimoto et al, 1972; Roth et al, 1972; Espiner and 
Donald, 1973; Mortimer et al, 1973a). The value of single 
LH-RH injections in the assessment of hypogonadal states 
will be discussed  below.
Early attempts to use LH-RH for the tre atment of male 
and female infertility has been reviewed by Mortimer, 
Besser and McNeilly, (1975). Initially pro mi sing results 
using high dose twice daily intramuscular injections of 
LH-RH were reported (Mortimer et al, 1974).H o w e v e r , 
Davies et al (1977) s ubseque nt ly dem o n s t r a t e d  reduced 
gonadotrophin  response to LH-RH after chronic
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admin ist ration to impotent men. Brook and Dombey (1979) 
dem onstr at ed  an initial response to twice daily LH-RH in 
4 patients with hy pogon ad otrophi c hypo gonadis m who were 
treated for more than one year. Rabin and McNeil (1981) 
also showed only a transient rise in serum testost ero ne 
in 2 of 4 males with isolated gon adotrophin deficienc y 
treated with high dose (lmg, twice or thrice daily) LH-RH 
given subcutan eou s 1y .
These early attempts at treatment of
hyp og onad ot ro phic h y p o g onad is m with LH-RH replacement 
used u n p h y s i o 1o g i c a 1 amounts of hormone given 
infrequently. Because of the short half-life of exogenous 
synthetic LH-RH in serum (3.6 to 8 mins CArimura et al, 
1974; Jeffcoate, Green wo od  and Holland, 1974; Pimstone et 
al, 1977, Barron, Millar and Searle, 1982]) potent long 
acting analogues of LH-RH were devel op ed (Coy et al, 
1976; Schally, Kastin and Coy, 1976). Initia 1 studies 
using such analogues in both animals and humans again 
dem onstr at ed  the ability of these hormones to cause only 
transient rises in go nadotr op hi ns and testosterone.
The explanation for this initial stimulation followed 
by inhibition of gon adot rophi n release using the 
protocols described above had to await a better 
und ersta nd in g of the basic physiology. Although it was 
known that serum LH levels exhibit ed  episodic 
fl uctuations (Nankin and Troen, 1971; Yen et al, 1972; 
Santen and Bardin, 1973; Boyar et al, 1978) the
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phy sio logical signif icance of this was not apprec iated 
until the work of Knobil and his colleagues who carried 
out a series of pion eering experiments on the Rhesus 
monkey.
Dierschke et al (1970) first showed that plasma LH 
co nce ntra ti on s o s c i lla te d with a fre quency of 
app ro xi mately  1 hour in 13 ova ri ectomis ed  and 7 intact 
female Rhesus monkeys. The osci llati ons showed a rapid 
rise of serum LH followed by a decay curve, thus 
su gg esti ng  a pulsatile release of the gonadot rophin from 
the pituitary gland. Plant et al (1978) were able to 
obliterate endogenous gon ad otrop hin secretion in the 
female Rhesus monkey with bilateral r a di of requenc y 
lesions in the region of the arcuate nucleus. Using this 
technique, Belchetz et al (1978) were able to study the 
effects of LH-RH infusions on the Rhesus monkey without 
endogenous LH-RH secretion. They showed that only when 
the infusion was given as an intermittent deliver y was 
gon ado trophin secretion st imulated and maintained. 
Continu ous  infusion resulted in return of gonadotro phin  
concentrati ons to basal levels whereupon further 
intermittent infusion cause d a second stimulation. Wildt 
et al (1981) were later able to show in the same animal 
model that alteration of the infusion pulse frequency and 
amplitude critica lly influenced the gonadotroph response 
to LH-RH. When LH-RH was infused at a frequ ency of 1 
pulse per hour (thus simu lating the natural pe riodicity
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in the female rhesus monkey ) physiological serum 
co nc en tra tions of LH and FSH were achieved. When the 
frequency of admin ist ratio n was increased to 2, 3 or 5
pulses per hour, serum LH and FSH declined. A decrease in 
the frequency to 3 hourly caused a variable reduction in 
serum LH but a rise in FSH. A decrease in pulse amplitude 
result ed in a decline in both LH and FSH, while an 
increase in amplitude caused a drop in FSH only.
Recently similar studies have been report ed in human 
males with isolated gon adotrophi n deficiency. Gross, 
Matsumoto and Bremner, (1987) have shown that as the 
frequency of LH-RH adm in istration was decre ased from 
every 1 to 2 to 3 hours serum FSH levels pr og ressively 
increased while serum LH con cen trat io ns did not differ 
s i g n i f i c a n t 1y . Spratt et al (1987a), on the other hand, 
dem ons trat ed  that as the frequency of LH-RH stimulation 
increased, mean serum LH conce ntr ation s rose. Assuming 
that each dose of LH-RH causes an equal increase in 
gonado tro phin secretion, Spratt argued that do ubling the 
frequency of LH-RH admi ni stration should cause a doubli ng 
of gon adotrophin concentrations. Therefore, an increase 
in serum gonadot rophins of less than 100% after a 
doubli ng of LH-RH frequency should reflect a dimini shed 
gonadotroph respo nsive ness to LH-RH. Thus, while mean LH 
rose with pulse frequency, this LH rise was less than 
expect ed for the increased LH-RH dosage. The amplitude of 
each LH pulse also fell as frequency increased.
Spratt and colleagues, found no change in mean FSH 
concentrations, although FSH corrected  for LH-RH dosage 
fell to a greater degree than corrected LH. These two 
studies differed in several respects. The former study 
looked at patients 4 days after alterations in infusion 
frequences, while the latter group studied acute changes 
immediately following increases in the frequency of 
pulsatile LH-RH administration.
It has become clear therefore, that stimulation of 
the pituitary go nadotrophs requires administrat ion of 
LH-RH in a pulsatile manner mimic king the normal 
physiology; continuou s exposure to LH-RH or its analogues 
results in d o w n - r e g u 1 ation of the pituitary gonadotrophs. 
The mechanisms of go nad otroph d o w n - r e g u 1 ation are not the 
subject of this text and have been ade quately  reviewed 
elsewhere. (Clayton, 1987)
1. 2) NORMAL AND DELAYED SEXUAL  DEVE LOPMENT
1.2.1) General Concepts
The onset of pub erty is a consequence of a complex 
sequence of m a t u r a t i o n a 1 changes that are incompletely 
und ers tood (Grumbach et al 1974; Grumbach 1975; Odell and 
Swerdloff, 1976). It is recognised that the 
hyp oth alaraic-pituitary-gonada1 system operates in fetal 
life and infancy (Kaplan, Grumbach and Aubert, 1976) but 
is suppres sed to a low level of activity in childhood.
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This inhibitory stage is characte ri sed by low 
gonadotrophin secretion, increased sens iti vity to the
negative feedback effects of sex stero ids ,low pit uitary 
responsivenes s to LH-RH and only a slight increase in
gonadotrophin secretion in functional and surgical 
castrates (Kelch, Kaplan and Grumbach, 1973; Kelch et al, 
1975; Conte et al, 1980).
The timing of pubertal onset and its course are
strongly influenced by genetic factors and are modified 
by a variety of environmental factors such as nutrition, 
social deprivation and chronic disease. This has been 
adeq uat ely reviewed els ewhere (Grumbach et al, 1974; 
Gr umbach 1975).
Frisch and Revelle (1970) have suggested that, in
healthy girls, there is a ’critical w e i g h t ’ which must be
reached before menarche can be achieved. However Johnston
and colleagues, (1975) in a caref ully argued critique of 
the work of Frisch and Revelle have exposed the errors in 
their hypothesis which is based upon population means. 
The large degree of v ari ab ility in g i r l s ’ weights at 
menarche argues against the critical weight theory. 
Nevertheless, the pos si bi lity remains that some component 
of body com position can provide a metabolic signal to the 
CNS for the timing of puberty.
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1.2.2) The Endocrine Changes of Puberty
Pre-pubertal children appear to release
gonadotrophi ns in a pulsatile manner although the 
amplitude of the pulses is small and difficult to detect. 
Reiter, Root and Ducket, (1976) showed low amplitude LH 
pulses in 4 of 16 pre-pubertal children and Penny, 
Olambi won no and Frasier, (1977) noted episodic LH 
secretion during the day (0800 - 1300hrs) in 3 sexually 
immature children between 9 and 11 years of age. More 
recently, Jakacki et al (1982) using a sensitive LH 
assay, documented pul satile secretion of LH in 8 of 15 
pre-pubertal children with bone ages less than 10 years.
In 1972 Boyar and co ll eague s discovered a striking 
nocturnal rise in gon adot rophi ns  which occurs in boys and 
girls beginning in late pre-puberty. As adolescent s reach 
the later stages of puberty, daytime LH secretory  
episodes increase in amplitude, but are still less than 
during sleep. Finally the adult pattern with LH pulses of 
similar amplitude throughout the 24 hours, is achieved. 
The pre-pubertal, nocturnal surge in gonad otrop hi ns 
probably represents an ampl ifi catio n of the pre-exi sting 
pattern of gonadotrophin secretion; several authors have 
reported significant ele vation of urinary go nadotroph in 
co ncentrati ons at night-time in pre-pubertal patients 
(Kulin and Reiter, 1976; Beck and Wuttle, 1980; Jakacki 
et a 1, 1982 ) .
In 1932, Hohlweg and Junkman , desc ri bing experi men ts 
in the rat, advanced the concept of a change at puberty 
in sensitiv ity to circ ulatin g sex steroids of a ’CNS 
S e x u a 1z e n t r u m 1 that reg ulates gonado trophin  secretion. 
There is now a substantial body of data in experimental 
animals and the human to support the hypothesis that the 
hy pothalamic go nad o t r o p h i n - r e g u l a t i n g  mechanism of the 
pre-pubertal individual is more sensitive to the negative 
feedback effects of ci rc u l a t i n g  androgens and oestrogen s 
than that of the adult (Donovan and van der Werff ten 
Bosch, 1965; Cri tchlow and Bar-Sela, 1967; Ramirez, 1973; 
Davidson, 1974). This concept of the ’re set tin g of the 
g o n a d o s t a t ’ is generally accept ed as a critical 
oc currence in the initiation of puberty. The escape of 
the CNS regulatory centre from feedback inhibition by the 
sex steroids allows the hypoth alamus to secrete 
increasingly larger amp litude pulses of LH-RH thus 
st im ul ati ng gon adotrophi n release and subseque ntly 
maturation of the hypot halami c-gona da l axis progresses. 
The mechanisms initiating this phenomenon and influencing 
the timing of pubertal onset are unknown.
1.2.3) Delayed puberty
Host boys presenti ng with delayed puberty have simple 
(constitutional) delay, and will undergo the normal 
process of sexual maturation after a variable period. A
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much smaller number who present with delayed puberty will 
have permanent hy pogonado trophic hypogonadism. One form 
of this condition is K a l l m a n n ’s syndrome, in which 
hypo go nadism is as so ciated with anosmia and various
congenital abno rma litie s (Kallmann, Sch oen fi eld and 
Barrera, 1944). Although the association between
hypo go nadism and anosmia was known acc ording to De 
Horsier (1954), since the mid nineteenth century,
Kallmann et al, were the first to review the literature 
of these cases and a genet ica lly determined hyp othalamic 
defect was postulated. In 1971, Naftolin, Harris and 
Bobrow, dem ons trate d low gonadotrophin levels in these 
pat i e n t s .
1 • 3) THE USE OF ACUTE A D M I N I STRATIO N OF L H - RH IN ATTEMPTS 
TO DI FF ERENTIATE SIMPLE DELAYED PUBERTY FROM 
HY PP GO NADOTR OP HIC HY POG ONADI SM
1.3.1) The standard bolus LH-RH test
A difficult problem in clinical practice is to 
distinguish p r o s p e c t i v e 1y between h y p og onadotr op hic  
h y p o g onad is m and constitutional delay in puberty. 
Initially it was hoped that go nadotroph in levels 
following LH-RH bolus adm inist ra tion might di fferentiat e 
the two conditions. However, several workers (Hashimoto 
et al, 1972; Roth et al, 1972; Espiner and Donald, 1973;
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Mortimer et al, 1973a) have shown that patients with 
h y p og onado tr op hic hyp og onadism  can have normal, minimal 
or sub-optimal gon ado trophin responses to single bolus 
injections of LH-RH. Subsequently, Bell et al (1973) 
concl ude d that there was too much h e tero ge neity of 
response in the patients with hyp og onadot ro phic  
hypogonad is m to allow such diff erentiati on to be made.
In 1978 de Lang, Snoep and Doorenbos suggested that 
four hour infusions of 200 ug of LH-RH could identify 
patients with h y p ogona do trophic  hypo go nadism  since LH 
values following infusion were lower com pared to subjects 
with constitutional delaye d puberty. However, the authors 
did not quote individual values and the large standards 
deviations  of res ponses suggest that the test would not 
be sensitive or specific enough to be of any clinical 
value. Furthermore, the n o n - p h y s i o 1o g i c a 1 nature of this 
mode of administr ation is now recognised. The following 
year, Razdan et al (1979) demonstr at ed that 4 hour LH-RH 
infusions produced greater LH reactions than a 
conventi ona l bolus test in boys with delayed puberty but 
not hypogonadal males. However the hypogonadal group 
included patients with known pit uitary lesions and this 
result is therefore not unexpected. More recentl y Kelch, 
Hop uoo d and Marshall, (1980) found standard go na dotro phin 
re lea si ng hormone tests of no value in the 
di ffe rent ia ti on of obese children with co nstitut ional 
de layed puberty and h y p ogon ad otrophi c h y pog on adism in a
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well design ed five year study examining gon adotrophin 
releasing hormone responses throughout this period of 
time.
1.3.2) The effect of supplementary LH-RH on the 
standard LH-RH bolus test
Hashimoto et al, (1975) investigated the effect of 
daily intramuscular injections of LH-RH (400ug for 5 
days) on standard bolus LH-RH tests in 13 patients with 
pi tui tary and suprasel lar lesions. A fall in response in 
the second test occurred in 3 patients with pituitary 
tumours and in one patient with a suprasellar lesion who 
had a normal initial LH-RH test. The only patients to 
show an augmented  response in the second test were the 
two remai ning patients with suprasellar lesions. It may 
well be that this regimen resulted in d o w n - r e g u 1 ation of 
the gonadotrophs, part icularl y in patients showing 
evidence of some per sis ti ng gonadotroph function.
Dickerman, Prager-Lewin and Laron, (1976)
investigated the effect on a standard LH-RH test after 5 
daily intramuscular injections of LH-RH (lOOug) in 
patients with h y p og onadotr op hic hyp ogon adism or pituitary 
deficiencies. However, the authors divided the patients 
into 3 groups depen ding on the degree of au gme nta tion of 
the LH response and it is therefore impossible to know 
whether there were any dif ferences between the two
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cl i n i c a 1 g r o u p s .
Wentz and Andersen (1980), investigated the effect of 
giving 3 I.V. boluses of LH-RH at 2 hourly intervals to 
females with primary and secondary amen orrhoe a of 
hypothalam ic origin and found no augment ation of LH 
release. Similar results were found for patients with 
pi tui tary defects. Snyder and colleagues (1979) were able 
to nor malise the LH response to a bolus LH-RH test in 5 
patients with hy pothalam ic hypo gonadism fol lowing daily 
infusions of 500ug LH-RH for 7 days. In view of the 
n o n - p h y s i o 1o g i c a 1 nature of this therapy and the 
inability of continuous infusions to stimulate 
g on ad otr ophin release in the animal model, these results 
are surprising.
The major fault with all the above studies is the 
no n-physio logical mode of LH-RH administr at ion which is 
likely to have caused variable degrees of pitu itary
gonad otr oph stimulation or d o w n - r e g u 1ation dep en ding on 
the exact protocol used. It is not surprising therefore 
that the studies give variable results.
1.3.3) The effects of more prolonged, repeated
adm ini st ration  of LH-RH
Reitano, Ca mi nos-T or re s and Snyder, (1975) found 
increased LH and FSH release in response to 50ug
intravenous injections of LH-RH given 4 hourly for 7 days
to 6 patients with hy pogona do trophic  hypogonadism. This 
study d emon st ra ted that pitui tary gona dot rophs must be 
primed by prior exposure to LH-RH before they are capable 
of res po nd ing to LH-RH in a normal adult fashion. The 
study however used pharmacologic al doses of LH-RH given 
at a n o n - p h y s i o 1o g i c a 1 frequency.
Jacobson and coll eagues (1979) adm in istered  LH-RH at 
nig ht- time to 2 males with K a l l m a n n ’s syndrome using a 
portable infusion pump in an attempt to simulate normal 
physiology. LH-RH was infused over one minute every 64 
minutes for 10 suc cessi ve nights. Both patients showed 
s ig ni ficant ly  elevated serum FSH con centrat io ns during 
LH-RH infusions on the last night com pared with the first 
night. Go nadotrop hin responses to an intravenous infusion 
of LH-RH (0.55ug/min for 3 hours) were also increased at 
the end of the pulsatile therapy, although one patient 
showed a predo min ant FSH rise and the other, a biphasic 
LH response. The high FSH levels achiev ed  by the 
pulsatile infusion may reflect the one hour pulse 
frequency used or a primar y testicular failure with lack 
of feedback inhibition of FSH. No details of testicular 
size are however given.
Valk et al, (1980) st ud ied  4 males and 2 females with 
isolated gon adotrop hi n def ic iency  given LH-RH 
(0.025ug/kg) intra venously every 2 hours for 5 days. LH 
c o ncen tr ations and incremental responses to LH-RH boluses 
(2.5ug/kg) rose throughou t the study in all patients. The
males showed increasing and the females de cr easin g 
incremental FSH responses to LH-RH and the authors 
conc lu ded that this reflected the di ffere nces normally 
seen in maturing  boys and girls. However, alternative 
explanatio ns  for this difference in FSH response can be 
m a d e .
Several recent studies have used pulsatile infusions 
of LH-RH in an attempt to dis tinguish between patients 
with constitutional delay of puberty and permanent 
hy p o g o n adotro ph ic hypo g o n a d i s m  (Sippell, Hermanu ssen and 
Partsch, 1984; Barkan et al 1985; Partsch, Her manussen 
and Sippell, 1985; Wagner et al, 1986;) Sippell et al 
(1984) gave LH-RH over 36 hours intravenously at a dose 
of 5ug every 90 mins to 18 hypogonadal patients. Their 
patients were divided into 4 groups; K a l l m a n n ’s syndrome 
(4 patients), idiopathic h y pop it uitaris m (6 patients), 
isolated hypog on ad otrop hi c hypogonad is m (3 patients), and 
cons tit utional  dela yed puberty (5 patients). They 
d em o n s t r a t e d  a sig nificant rise in serum FSH in the 
patients with K a l l m a n n ’s syndrome and idiopathic 
h y po pituit ar is m but not in the patients with isolated 
h y p o g o n adotr op hi c h y p o g on adism and only in 3 of 5 
patients with delayed puberty. The difference between the 
patients with K a l l m a n n ’s syndrome and hyp og ona d o t r o p h i c 
h y p o g on adism is diffi cul t to explain, since the latter 
group had higher serum testost erone and might therefore 
have been more adeq uately  primed. The small number of
patients in each group is also d i s c o ncerti ng  since 
hy p ogo na dotroph ic  hypogon ad ism is a het erogeneou s
condition and differen ces between the groups might
reflect different degrees of hypogonadism within each 
group. A further study by the same workers (Partsch et 
al, 1985) is open to similar criticism. Using the same 
protocol, they reported a predominant LH response to
short-ter m pulsatile LH-RH ac companied  by a rise in serum 
testoste ro ne in a group of 9 patients with constitutional 
del ayed puberty whereas an FSH response without LH or 
tes tos tero ne  occurred  in 8 patients with
h y p og on ad otrop hi c hypogonadism. This latter pattern in
boys is typical of the early normal pubertal response 
while the former is more like that seen in the later
stages of normal puberty. The former group cont ained  4 
patients with testicular volumes of 9mls or greater and 
it is likely that the dif fe rences between the groups is a 
result of the relative maturity of the boys with delayed 
pu berty who were studied.
Variation in response to pulsatile LH-RH 
ad min istr at io n in patients with different degrees of
h y p o go na dism was further confir me d by Barkan et al (1985) 
who divided their patients into partial or complete 
h y p og onado tr op hic h y po gonadi sm  depending on the presence 
or absence of secre tory LH pulses during 24 hr hormone 
profiles. They showed a predominent LH response only in 
the patients with partial hyp og on adotro ph ic hypogonadism.
This study did not include any patients with
const itu tional delay of puberty for comparison.
Wagner et al (1985) concluded that they were unable 
to distinguish between temporary and permanent 
hypothalami c hyp ogona di sm by means of the FSH/LH ratio 
following pulsatile LH-RH infusions. Their groups were 
also defined by the presence or absence of nocturnal LH 
secretory  pulses. Their results however show a much
greater FSH increment in the patients with absent 
nocturnal pulses, a feature which might reflect a less 
advanced state of mat uration of the reproductiv e system 
in these patients. Since their groups were de fi ned in 
terms of the initial 24 hour LH sec retory profiles and 
since they compared po st -infusion co nc en tratio ns  during 
two 4 hour periods with these pre-infu sion results their 
data is strongly biased: It is clearly easier to achieve
significant rises in serum LH and FSH in the group which
had no night-t ime  hormone rises. Since the follow up
period of the study was only 90 days the cla ssifica ti on  
of the groups into tem porary and permanent h y pog on adism 
may be inaccurate.
1.4) PROLO NGED PU LSATILE  LH-RH INFUSIONS FOR THE 
INDUCTION OF FERT ILI TY
As early as 1979, small, portable infusion pumps were 
used for deli ve ring LH-RH in a pulsatile manner (Jacobson
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et al, 1979). Using such technology, chronic pulsatile 
LH-RH infusions have been used to induce all the changes 
of puberty in men with hypothalamic hypogonadism, 
including sper matogenes is (Hoffman and Crowley, 1982; 
Skarin et al, 1982; Morris et al, 1984; Santoro, Filicori 
and Crowly, 1986;)
Hoffman and Crowley (1982) reported the response to 
pr olonged pulsatile LH-RH therapy in 6 males with 
hyp og onad ot ro phic hypogonadism. All patients showed rises 
in serum go nad otrophi ns by 2 weeks but in only 4 patients 
did testosteron e achieve adult concentra tions and only 3 
patients demonstr at ed maturation of sp ermatogene sis after 
4 to 43 weeks of treatment. Post treatment sperm counts 
were as low as 2.3 million/ml and only one patient 
successf ul ly  fathered a child. Failure to normalise serum 
testostero ne may have been due to inadequate doses of 
LH-RH, since a subsequent report by the same group 
(Santoro et al, 1986) dem onst ra ted normal testosterone 
co nce ntra ti on s in all 13 patients studied, if the LH-RH 
pulses were increased in some patients to a maximum of 
2 0 0 n g / k g .
Morris et al (1984) reported normali sation of 
test ost erone in 3 of 10 patients with hypog on adotrop hi c 
hypogonadism. All 3 patients achieved fertility although 
sperm counts were as low as 1.5 m i 11 ion/ml and paternity 
was not tested. These 3 patients had all pre vio usly been 
uns ucces sf ul ly treated with the more conventional therapy
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of HCG and H M G .
Five patients in the series of Morris showed a 
de cli ning hormone response to LH-RH during a y e a r ’s 
treatment despite increasing the pulse dosage from 2.5 to 
20ug. This desens itisa ti on may indicate that pulse dosage 
or frequency should be speci fically  tailored to the 
patient. Stanhope and colleagues (1985a) have described a 
similar arrest in clinical induction of puberty in a 
16.9yr old female with hy po gonadotroh pic hypogonadism,
following 3 months of pulsatile LH-RH therapy at a dose 
of 15ug/pulse. They attempt to explain the decreased 
pituitary responsi veness of this patient as resulting 
from d o w n - r e g u 1 ation of LH-RH receptors or depletion of 
gonadotro phin stores or both. They have no evidence 
however for such mech anisms and after such a pro longed 
perio d of treatment, development of antibodies to LH-RH 
would also be an al ternative  mechanism.
Morris et al (1984) desc ribed  a local skin reaction 
in one patient in their series. Subsequent skin testing 
con fi rm ed sensitis ation to the LH-RH solution. Santoro et 
al (1986) dem onstr at ed antibod ies to LH-RH in 1 of 13 
males who failed to respond to pulsatile therapy. 
Si mil arly we have been able to show skin sen sitiv it y in 
one of six patients who recieved prolonged LH-RH therapy.
The only indication of sensit isa tion in this patient
during treatment was a progressive decline in
go na dot rop hin response. If an allergic reaction to the
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LH-RH solution was responsible for the decline in LH
response in some or all of the 5 patients de scribed by
Morris et al and the single patient described by Stanhope 
et al (1987), then the incidence of this comp lication may
be as high as 8 in 68 (11%) when all the above series are
taken into consideration.
Stanhope et al, (1984, 1987) have attempted to
simulate normal pubertal development by induction of 
puberty using 2-4g LH-RH pulses every 90 minutes at 
night time only, until mid-puberty. When testicular 
volumes reached 8mls treatment was altered to pulsatile 
administrat ion throughout 24hrs. Despite this 
physiological approach, puberty was accelerated 2-3fold 
compared with the normal rate of pubertal changes 
(Marshall and Tanner, 1970). The relative merits of this 
regimen, therefore remain to be established.
The end point in the study of Stanhope et al (1987) 
was induction of puberty and not fertility. However the 
results of this study are relevent to the dicussion on 
hormonal responses to prolonged pulsatile LH-RH 
administration. Seventeen patients with either delayed 
puberty or hyp og on adotr op hic hypogona dism were studied. 
Puberty was su ccessfull y induced in 11. Of the rem aining 
6 patients, 3 (18%) were non-compliant, 1 patient with 
K a l l m a n n ’s syndrome showed ’absent testicular r e s p o n s e ’ 
and 2 patients had probable pituitary defects. Poor 
compliance and pre sumab ly (although not clearly stated)
absent testoste rone production limited the value of this 
t r e a t m e n t .
The relative merits of LH-RH therapy over more 
conventional treatment remain to be established. The 
response in the 3 patients of Morris following failure of 
HCG and HMG is encouraging. Donald et al (1983) reported 
a case resistant to HCG but responsive to pulsatile 
LH-RH. A 30 year old patient with hy pogonad otrophic  
hypo go nadism failed to demonstrate a testosterone 
response to 10 months of HCG therapy (1500 units twice 
weekly) and remained azoospermic. LH-RH given for 6 
months as 6, daily I.V. boluses ( 5ug per injection) 
resulted in increased testicular volume and the 
dev elopment of spermatazoa. After changing  to hourly 
3-min infusions of 2.7ug given s u b c u t a n e o u s 1y , the 
p a t i e n t ’s serum testostero ne became normal and sperm 
count reached 11 million/ml. The reason for failure of 
testicular response to HCG in this patient is not clear.
Finkel, Phillips and Snyder, (1985) in a caref ull y 
executed study of conventional therapy (HCG alone or with 
HMG) showed that in patients who developed hypog on ad ism  
after puberty, fertility was achieved with HCG alone. 
Five of 7 patients with pre-pubertal hyp ogona di sm  
responded to combined  therapy while only 1 of 7 patients 
responded to HCG and HMG if there was a history of 
pre-pubertal h ypog on adism and cryptorchisra. It is clearly 
important, therefore, when ass essing response to LH-RH
therapy that such factors are taken into consideration. 
No history of testicular descent was given on any of the 
patients in the series of Morris et al (1984), Santoro et 
al(1986) or Stanhope et al (1987).
1.5) FAMILIAL CYTOME GALIC AD RENOCORTI CAL HYPOPLASIA
This condition was first rec ognised by Sikl in 1948
and later the histological features were described 
(Kerenyi, 1961). These consist of adrenal cortices with 
absent zonal dif ferenti ation and the presence therein of 
large vacuola ted  cells resembl ing those seen in the 
normal fetal adrenal gland. A family with 2 affected
brothers was first describe d in 1959 by Mitchell and
Rhaney and in 1968, the X-linked inheritance of the 
condition was demon st ra ted (Dacou and Di George, 1968).
In 1975, Prader, Zachmann and Illig descr ibed a boy 
with congenital adrenal hypo plasia who failed to show
signs of puberty by age 16 years and at age 18 years was 
shown to have hyp og onadot ro phic hypogonadism. During 
1977, 3 more cases of this association were reported 
(Black, Brook and Cox, 1977; Golden, Lippe and Kaplan, 
1977; Kelly, Joplin and Pearson, 1977)
Kruse, Sippell and Schnakenb ur g (1984) recently
reviewed the response to bolus LH-RH tests in 14 
pr ev iously reported cases and included results for 2 
patients of their own. In 15 of the 16 cases there were
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absent or markedly impaired increments of both LH and 
FSH. The single case with normal peak LH and FSH 
increments was reported by Petersen et al (1982) and 
followed only until the age of 14 years at which time he 
remained prepubertal and had a bone age delay of 2.5 
years. It is therefore not known whether this patient 
s p o n t a n e o u s 1y entered puberty or not. Black et al (1977) 
and Richards et al (1978) each reported minimally 
improved gon adotrophin responses to a bolus LH-RH test 
following intermittent LH-RH stimulation for up to a 
week. Richards et al were led to conclude from these
findings that the hypog on ad ism in their patient was due 
to LH-RH deficiency. Similarly, Kelch et al (1984) have 
suggested on the basis of similar findings that the 
hypogona di sm  of this condition is of hypothalamic  origin. 
However, Hay, Smail and Forsyth, (1981) reported the
responses to LH-RH tests in 3 patients in whom the tests 
were repeated several months apart, and variations in the 
magnitude of responses were similar to those reported by 
Black et al and Richards et al sug gesting that the 
improvements in gonadot rophin increments which they 
obser ved  may have occured by chance.
Kruse et al (1984) reported the gonad otrophin 
response in two patients with presumed congenital adrenal 
hy poplasi a following low dose pulsatile LH-RH infusions 
for 26 hours. They report ed a rise in serum LH and FSH in 
1 patient and serum FSH alone in the second patient.
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However their data is unconvincing. The changes in 
gonadotrophin concent rations were small and pulsatile 
infusions were commenc ed shortly after standard LH-RH 
tests had been undertaken. The gonadotrophin 
concentratio ns were elevated  at the start of the infusion 
periods compared with the results prior to the LH-RH 
bolus tests and when this is taken into consid erati on it 
is unlikely that there was any change in LH 
co ncentr ations during the infusions and FSH levels only 
rose minimally. There was also no significant improvement 
in response to a second bolus LH-RH test following the 
period of pulsatile infusion indicating a lack of ability 
to prime the gonadotroph in these patients.
More recently, Kikuchi et al (1987) have reported 
failure to induce puberty in another case of congenital 
adrenal hypoplasia, following 13 weeks of pulsatile LH-RH 
therapy. They dem onst rated a minimal increase in serum 
FSH alone while serum LH remained unchanged and 
test ost erone remained undetectable. There was a small 
improvement of the FSH response to a standard LH-RH bolus 
by day 21 of the infusion, although the response remained 
subnormal and there was no further improvement.
The data of Kikuchi et al would therefore favour a 
pi tuitary basis for the hypogonad ism and this is of 
interest in view of the report of Harsden and Zakhour 
(1978) showing similar cytomegalic changes in the 
pitui tar y of a patient with cytomegalic adrenal
h y p o p 1 as i a .
1.6) HUMAN CHORIONIC G O N A D OT RO PHIN THERAPY FOR INDUCTION
OF PUBERTY
In 1904, Halban obs erved that the genital organs of 
newborn infants of both sexes showed evidence of
hypertrophy. He sp eculated that this temporary 
d eve lopment  of the genitali a was due to the action of a 
then unknown secretion of the placenta. In 1932, Engle 
d e m o ns tr ated that an extract of urine from pregnant women 
was able to increase the size of the testes in immature 
rats and monkeys. The urinary extract was therefore
similar in effect to anterior pituitary gland extract
which was also shown to cause growth of testicular
interstitial cells and tubules. The following year, 
Goldman and Stern (1933), d emonst ra ted the effectiv en ess 
of anterior p i t u i t a r y - 1 ike gon ado trophic  hormone on the 
un desce nd ed  testes of two adolescent boys.
Later, Sexton (1934) showed the ability of this 
urinary extract to sti mulate testicular develop ment in 
patients with c ryptor ch is m and hypogonadal states. In a 
series of papers between 1935 and 1942, Dorff co nfirmed 
the ability of extracts from pregnant urine to stimulate 
te sticular growth along with the development of secondary 
sexual ch ar ac te risti cs  in groups of boys with 
hy po gona di sm  ( 1 9 35 a, 1 9 3 5 b , 1936, 1937, 1938,1940,1942)
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The studies of Dorff and others were carried out in 
heterog en eous groups of children at a time when it was 
not yet possible to confirm endocrine pathology  by
measu rem ent of serum hormone concentrations. It is
therefore likely that many of the children with
h ypogo na di sm were su ffering  from a number of different
hormone problems such as h y poth yr oidism and 
h y p o p i tu it ar ism as well as primary hypogonadism. This is 
of particular importance when the data on growth (Dorff 
1940, 1942) are discussed, since the presence of other
endoc rin e pathology is likely to have influenced the
results of HCG treatment.
In 1940, Dorff de scribed  growth data in 9 boys aged 
between 3.25 and 8 years who were treated with a variety 
of HCG prep ara tions for periods ranging from 5 to 25
months. Four patients who were obese also receiv ed 
des si cate d thyroid. In most cases there was an increase 
in height velocity a c c o mp an ied by more rapid advancem ent 
of skeletal age than chronological age. However,
unc er ta inty about the u nd er lying diagnoses, the possible 
effect of thyroid hormone on growth, and the inability at 
the time to ac curately assess skeletal age makes the 
findings difficult to interpret.
A further paper by Dorff in 1942 descr ibes growth in 
4 boys aged 3.25 to 21 years who received HCG for varying 
periods for cr y p t o r c h i d i s m  (2 boys), hypog o n a d i s m  and 
short stature. Again acceleration in growth was
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dem on st rated during treatment. However, in 2 cases 
accelerat ed  growth co ntinued for many years after 
treatment stopped and it is therefore dif ficult to 
believe that this co nti nue d rate of height gain was due 
to the HCG. Skeletal age data are given on only one 
patient and it is difficult to assess the accuracy  of 
such information.
Reiss et al (1965), de scr ibed the growth promo ting 
action of HCG in 24 men tally and phys ica lly ret arded boys 
aged 7.5 to 13.5 years. Since this is the only other work 
de scrib in g growth during  HCG treatment, it demands some 
attent ion .
HCG was given in doses between 400 and 2500 IU daily 
for 2 to 7 months. Growth rates were c onsi de rably 
increased during the tre atment periods and in the 
ma jor ity of cases height velocities exceeded that seen 
during a normal pubertal growth spurt. Growth rates 
immediately after treatment was stopped were rec ord ed in 
most patients although data on periods of longer than one 
month were available on only 9 patients. All patients 
showed reduced growth fol lowing therapy although 8 of 9 
patients were growing faster after treatment than before 
therapy was begun.
Follow up data, 3 to 5 years after treatment was 
available on 17 patients. Twelve of the patients showed a 
height percentile idhich was higher than the pre-treat me nt 
range. No information, however was available on skeletal
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maturity or final height outcome.
Similarly, no data was given re ga rding the
a nd ro genisi ng  effects of this therapy or the 
e nd oc rinolo gy  of the patients. It is notable that 5
patients received thy roid replacement therapy in the 
follow up period and this is likely to have affect ed 
growth in patients who were hypothyroid.
In 1941, McCullagh and Rossmiller reported the effect 
of m e t h y 1 testostero ne on growth and metabolism. However 
concern arose over reports that large doses of this 
androge nic  compound sti mul ated osseous maturation 
di spr o p o r t i o n a t e l y  to linear growth. (Talbot and Sobel, 
1947; Deamer, 1948; Sobel et al, 1956). Despite these 
reports, other drugs which might have improved
a n a b o 1 i c •androgenic ratios were sought and many 
derivati ves of testostero ne were produced. This has been 
adequatel y reviewed else where  (Hopwood and Kelch, 1976). 
While it is outwith the scope of this text to review in 
detail the literature on anabolic steroids it is 
important to compare the effects of these agents with the 
data on HCG therapy. For this reason tables 1 - 3  list 
information on the larger clinical trials in patients 
with delayed puberty, of the three most widely used of 
these compounds, i.e. m e t h y 1 t e s t o s t e r o n e , f 1uoxymest er one 
and oxandrolone.
It is immediately clear from these tables that many 
studies co ntained  small numbers of patients, of whom some
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had short stature and some delayed pubertal development. 
There is a wide range of age groups treated in the 
different studies. In addition, the doses and the 
treatment duration of the anabolic agents used, varied 
cons id er ably between studies and often within studies. 
The lengths of periods following cessation of treatments 
has often been short and therefore inadequate for 
as ses sing effects on future growth. It is not surprisi ng  
therefore that there is a general lack of consensus 
re gar ding the relative effects of these agents on height 
growth and skeletal maturation.
Furthermore, few papers include adequate control 
data. This is of particular importance when the age group 
studied is likely to enter spo ntaneous puberty during the 
period of treatment. For example, Stanhope, Bommen and 
Brook, (1985b) have sugg es ted that a 3 month course of 
f 1uox yme sterone was suf ficient to accelerate growth which 
was maintain ed after treatment was stopped. However, the 
mean testicular volume of their patients, at the end of 
the treatment period was 9.9 mis su gg est ing that perhaps 
half the patients studied had entered a spontane ous 
growth spurt during this period. This would also explain 
the cont inuing rapid growth after treatment was stopped. 
Without the inclusion of a control group, it is therefore 
impossible to de monstrate a therapeutic effect in this 
study. On the other hand, Lenko, Haenpaa and P erhe en tupa 
(1982), in a much larger study, using control patients
b7
was clearly able to demonstr ate an acc eleration in growth 
velocity in the treated group.
Some authors compare change in bone age with change 
in height age after therapy. Height age is the
chronological age at which the particular height measured 
would lie on the 50th percentile. Height age, however 
disrega rds  the ind ividuality of height potential (half 
the population never reaches so-called adult height i.e. 
177cm for males) and the variabilit y of growth during the 
pubertal years ; thus co ncl usions based on height age 
changes may be highly misleading.
Similarly, prediction of adult height using the 
tables of Bayley and Pinneau (1952), is beset by
problems. These tables are less accurate if bone age
retardation is greater than 2 years, as is the case in 
many patients undergoing anabolic steroid treatment. This 
might lead to a tenden cy to either over- or 
under-estim ate final adult heights compared with later 
predictions during treatment, when bone age delay is 
likely to be smaller.
Several limited co nclusio ns can therefore be made 
from the previous work with anabolic steroids. It is 
likely that high doses of anabolic steroids used for long 
periods adver sel y affect final height outcome. Reilly and 
Gordan (1961) have shown that the effect of 
f 1uo xymeste rone on epiphyseal maturation is dose related 
but growth acceleration is not. In a very large,
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controlled  study, Foss (1965) showed that patients 
treated with m e t h y 1 testostero ne for periods between 2 and 
14 months at doses less than 30mg daily achieved expect ed 
final heights- However patients treated c o n t i nuo us ly with 
either implants, oral testoste ron e or frequent injections 
of testoste ron e esters showed a significant reduction in 
final height compar ed with initial predictions.
The age of the patient and in particular, the 
skeletal age at the time of therapy may also be 
important. Zangeneh and Steiner (1967) found
d i s pr oport io na te bone accelera tion in children between 
0.9 and 8.1 years trea ted with oxandrolone. This did not 
occur in older children. Similarly, Jackson et al (1973) 
found the greatest reduction in predicted adult height in 
patients with the earliest bone ages who receiv ed 
ox an dro lon e therapy. However Limbeck et al (1971) using 
height age de ter mi nations  did not detect a 
dispropo rt ionate skeletal maturation in patients with 
bone ages less than 10 years.
1.7) AIMS OF THE PRESENT STUDY
The present study set out to investigate the value of 
pulsatile LH-RH infusions in the investigation of delayed  
pubertal states and to assess HCG as a ther apeutic agent 
for the treatment of constitutional delayed puberty. In 
view of the lack of consensus in the literature re garding
the short-t erm hormonal responses to pulsatile LH-RH 
administration in different groups of hypogonadal 
patients, an attempt has been made to take account of the 
effects of LH-RH dosage, timing of studies and, most 
importantly, the h et erogen ei ty of the clinical conditions 
studied.
An attempt has also been made to assess both the 
immediate and long-term effects of HCG therapy, on the 
growth of a typical group of patients pr esenting to an 
end ocrine clinic with dela yed puberty.
During the course of this work other papers have been 
publi she d which are relevant to the present thesis. These 
p ub licatio ns are discussed in the relevant chapters of 
this thesis along with the a u t h o r ’s own data.
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CHAPTER 2
E XP ER IMENTA L SECTION
2.1) SUBJEC TS AND METHODS
2.1.1) Ac quisition of patients
The Glasgow Royal Infirmary offers an
endoc rin ologica l service to the West of Scotland and, in 
particular, the eastern area of Glasgow. Patients in this 
study were usually referred by their General 
Practitioner. O c c a s ion al ly patients were referred by the 
school Medical Officer or by other hospital specialists. 
All patients in this study were male and referred  for 
investigation of pubertal delay or shortness of stature. 
Some adults with hy po go nadot ro phic h y p o g on adism were 
ref er red by consultant end ocr in ologis ts  from other 
hospitals in Glasgow and Falkirk.
2.1.2) Initial prese nta tion and clinical examin ation
The patients were initially seen at the Endocrine Clinic 
at the Royal Infirmary, Glasgow and a full clinical 
history was recorded in the presence of one or both 
parents. A full medical exa mination including mea surement 
of standing height (method of Tanner and Whitehouse,
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1975) was undertaken. Genital and pubic hair development 
were assesse d on a five point scale devi sed by Tanner 
(1962). The scale is descri be d below:
Boys : genital de vel opment : (G)
Stage 1 Pre-adolescent. Testes, scrotum and penis
are of about the same size and proportion 
as in early childhood.
Stage 2 Enl argement of scrotum and testes. Skin of
scrotum reddens and changes in texture.
Little or no enlargement of penis at this
s t a g e .
Stage 3 Enlargement of penis, which occurs at first
mainly in length. Further growth of testes 
and scrotum.
Stage 4 Increased size of penis with growth in
breadth and development of glans. Testes 
and scrotum larger; scrotal skin darker.
Stage 5 Ge nitalia adult in size and shape.
Pubic hair : (P )
Stage 1 Pre adolescent. The vellus over the pubes
is not futher developed than that over the 
abdominal wall, i.e. no pubic hair.
Stage 2 Sparse growth of long, slightly pig mented
downy hair, straight or slightly curled, 
chiefly at the base of the penis.
Stage 3 Con siderab ly  darker and coarser and more
curled. The hair spreads over the junction 
of the pubes.
Stage 4 Hair now adult in type, but area covered is
still cons id erably smaller than in the 
adult. No spread to the medial surface of 
thighs.
Stage 5 Adult in quality and type with dist rib ution
of the horizontal (or clas ica lly 
'feminine') pattern. Spread to medial 
surface of not up linea alba or elsewhere 
above the base of the inverse triangle 
(spread up linea alba occurs late and is 
rated 6).
Testicular volume ( T . V . ) was measured using a Prader 
orch ido meter (Prader, 1966). All me asurement s of height, 
weight and genital developmen t were made by one observer.
2. 1.3) Assessment of bone age
In all patients, bone age was assessed routine ly  by 
G r e u 1i c h - P y 1e (1959) hand standards. Those patients who 
were included in the study of HCG therapy had skeletal 
age estimated in a retrosp ec tive manner, by one observer,
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using both the G r e u 1i c h - P y 1e atlas and also the TW2 
method of Tanner et al (1975). Estimates of final heights 
were made using the method of Bayley and Pinneau (1952) 
revised for use with the Greulich-Pyl e atlas and also the 
method of Tanner et al (1975) using the TW2 bone ages.
2.1.4) Interpretation of clinical measurements
The height standard deviation score was determin ed  
ac cor ding to the formula X-x/Sx where X is the p a t i e n t ’s 
standing height, x the mean height at that age and Sx is 
the standard deviation for height at that age. The last 
two measure ments were obt ai ned from data accordi ng  to 
Tanner, Whitehouse and Takaishi, (1966). The p a t i e n t s ’ 
heights and weights were plotted on the growth charts of 
Tanner and Whitehouse (1975). Height age was defi ned as 
the age at which a particular height would lie on the 
50th centile accordi ng to the above charts. The degree of 
sexual maturation was det erm ined from the percentile 
charts for testicular volume and genital and pubic hair 
development according to Tanner and Whitehouse (1976); 
data also from Marshall and Tanner (1970) and Zachmann et 
al ( 1974 ) .
2. 1.5) Selection of patients for study
Subjects of chr onological age of 14 years or older
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were assessed if height was below the third percentile 
and if genital staging and or testicular volumes were 
below the third percentile. In addition, subjects of 
chronological age 12.5 to 14 years who were pre-pubertal 
(i.e. G1 PI T.V. < 4 ml) were studied if height was below 
the third percentile and if there was a bone age deficit 
compared to chronological age of at least 2 years.
For the main pul satile LH-RH studies compar ing 
patients with permanent hypogon ad ot rophic  hypogona di sm 
with patients with delayed puberty (chapters 5 - 7) the
boys were divided into two groups; those with no signs of 
puberty beyond Tanner stage 2 by the age of 14 years or 
greater were defined as 'delayed puberty'. The remainder 
of the boys whose height was below the third percentile 
and whose puberty was dela yed but whose pubertal staging  
was still above the 3rd percentile acc or di ng to Tanner 
were def ined as 'short s t a t u r e ’.
Hypog on adotrop hi c hyp ogon ad ism was diagnos ed  by 
absence of pubertal changes during follow-up to 
chronological age 21 years. In addition, the finding of 
low basal serum gona dot rophi n levels relative to the low 
serum testosterone  was required for diagnosis.
Thirty five patients were included in the study 
comparing gonadotrop hin responses to pulsa tile LH-RH 
infusions (chapter 5). The p a t i e n t s ’ diagnoses are listed 
in table 4 below. Further clinical details of these 
patients are given in the relevant chapter and details on
6b
patients who underwent other studies are also given in 
the approprate chapters.
Table 4
THE FINAL DIA GN OS IS IN 35 PATIENTS UNDE RGOING 
PU LSA TILE LH-RH THERAPY
Simple Delayed Puberty 9
Short Stature 14
Idiopathic H y p og onadotr op hic Hyp ogonad is m 7
K a l l m a n n ’s Syndrome 4
Anorchia 1
Adult patients with idiopathic h y p o g o n ado tr ophic 
hypogonadis m who ex pre sse d a desire for fertility were 
offered therapy initially by pulsatile infusion of LH-RH.
2.2) CLINIC AL INVESTIGATIONS.
2.2.1 ) Initial end ocrine assessment
All subjects underwent a combined anterior pitui tary  
function test. In addition serum adrenal and testicular 
androgens, dih yd ro e p i a n d r o s t e r o n e  ( DHA )
di h y d r o e p ian dr osteron e sulphate (D H A S ) and test osteron e 
were estimated. Chro mosome analysis was undertaken in 
every pat i e n t .
2.2.2) Hormone es timations
All hormone estima tions were performed in the 
Endocrine Section of the Department of Clinical 
Biochemistry, Royal Infirmary, Glasgow. All hormones were 
measured by r a d i o i m munoas sa y techniques and a summary of 
these methods is given in Table 5. The assay methods 
remained constant throughout the study.
2.2.3) Anterior pituita ry function test
(Mortimer et al, 1973b)
Following an overnight fast in hospital 0.2 units/kg 
body weight of soluble insulin, lOOug gona do trophin
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releasing hormone and 200ug thyrotropin rel ea si ng hormone 
were sim ult an eo usly administe re d intravenously through an 
indwelling cannula inserted 15 minutes prior to the test. 
Blood was withdrawn for plasma glucose and hormone 
analysis at the times shown with a cross below.
T i m e G 1 uc Cor t h G H P R L L H F S H T S H T e s  to
(m i n s )
0 + + + + + + + +
15 + + +
30 + + + + + +
45 + + +
60 + + + + + +
90 + + +
120 + + +
The test was only con si dered  as sa tis facto ry for growth 
hormone reserve when the plasma glucose fell to a value 
of 2.2 mmol/1 or less.
2.2.4) Chromosome Analysis
Chromo som e analysis was performed on samples of 
venous blood by Professor Ferguson-Smith of the Institute 
of Genetics, Royal Hospital for Sick Children, Yorkhill, 
Glasgow.
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2.2.5) Semen Analysis
Semen analysis was carried out by the staff of the 
Department of Pathology at the Royal Infirmary, Glasgow.
2.2.6) LH-RH Infusion Study Protocols
The basic protocol for patients undergoing pulsatile 
LH-RH infusion studies is described below. Variations 
upon this basic protocol were made for some studies and 
the details of these alterations are described in the 
Patients and Methods section of the relevant chapter.
During the afternoon of the admission day, blood was 
sampled via an indwelling venous catheter, at 15 minute 
intervals over a period of 3 hours for subsequent 
measu rem ent of plasma LH and FSH. The following morning 
after an overnight fast, pituitary function was assessed 
as desc ribed above. Serum testosterone was measured at 
this time and a note made of the exact time of sampling. 
Thereafter sub cutaneous pulsatile LH-RH therapy was 
comm enc ed using an infusion pump (Graseby Medical, type 
MS 27) with delivery of gon ad otr o p h i n - r e l e a s i n g  hormone 
(LH-RH) pulses every 90 minutes at a dose of 
2 4 0 n g / k g / p u 1se in most studies. The needle was inserted 
into the subcutaneous tissue of the abdominal wall and 
the site changed daily.
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Following 6 days treatment with LH-RH further venous 
blood sampling every 15 minutes for 3 hours was
undertaken at the same time of day as the preinfusion
study, for estimation of LH and FSH. Blood was drawn for
measurement of serum tes tosterone at exactly the same 
time of day as the pretre atment sample. All samples from 
each patient were kept frozen at -20 degrees C and 
assayed in one batch to eliminate inter-assay error.
2.3) PATIENT FOLLOW-UP
2.3.1) Routine post- adm ission review
All patients attended the out-patient clinic 6 weeks 
after hospital dis charge and if there had been no
clinical or endocrine abnorm ality detected, patients were 
offered specific therapy to induce sec ondary sexual 
development. After full discussion, patients were able to 
choose between treatment or regular follow-up in the 
absence of specific therapy.
Patients who receiv ed HCG therapy were re-eval uated 
at 3 monthly intervals during the first year. Clinical 
exa mination included reassessment of sexual devel opment 
and measurement of testicular volume, standing height and 
weight.
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2.3.2) Retrospective studies and patient recall
Ca se-notes for all patients who had attended the 
Endocrine Clinic for investigation of short stature or 
delayed puberty between the years 1979 - 1987 were
reviewed. All patients who fell into the selection 
categories described in the previous section and who had 
had careful serial measur ements at 3 monthly intervals, 
of height and sexual maturation by one of two observers 
(D.G. or H.N.C.) were selected. Attempts were made to 
recall all selected patients in order to determine 
present height and bone age.
Fifty males who sub sequ ently underwent 6 m o n t h ’s 
therapy with Human Cho rionic Gon adotrophin (HCG) were 
reviewed. A further 30 males who declined therapy act as 
a control group.
2.3.3) Hale infertility study.
Adult males with either idiopathic hyp og on adotro ph ic 
h yp ogonadi sm or Kallmann's syndrome who expr essed a wish 
for fertility were offered treatment, initially by 
pulsatile LH-RH infusion. Those patients receivi ng sex 
hormone replacement therapy had all treatment stopped at 
least 6 weeks prior to the study period. LH-RH was 
a dm inister ed s u b c u t a n e o u s 1y in pulses every 90 minutes by
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pulsatile syringe driver (Graseby, M S 2 7 ). Doses of LH-RH 
varied acc ording to hormonal responses. Serum LH and FSH 
were measured every 15 minutes for 3 hours before 
starting LH-RH therapy. Each week thereafter blood was 
withdrawn every 15 minutes, over a 1 hour period for 
further measurement of serum LH and FSH. Serum 
testost ero ne was measured weekly. Where possible, semen 
samples were obtained by masturbation from patients 
before treatment and at monthly intervals thereafter.
Treatment was stopped after varying periods of time 
due to; allack of patient compliance with treatment 
blpatient unwilling to continue with therapy c )impaired 
or absent hormonal response dlfailure to obtain a 
significant rise in sperm numbers or inability to become 
fertile. Some patients were subsequently offered therapy 
with human chorionic gonadotrophin and human menopausal 
gon ado trophin (Pergonal).
2.4) STA TISTI CA L ANALYSIS
Comparison between groups has been performed by 
standard non-parametric testing. The Wilcoxon paired and 
unpaired tests and the K r u s k a 1- W a 1 1 is test were used as 
appropriate. Relat ionships between groups were cor related  
using the Spearsman rank order test.
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CHAPTER 3
24 HOUR HORMONE PRO FI LE S DURING PULSATILE LH-RH
INFUSIONS.
3.1) INTRODUCTION
Several recent studies have examined the effects of 
prolonged, pulsatile LH-RH infusions on pituitary 
go nad otroph response in pre-pubertal and pubertal males 
(Valk et al, 1980; Barkan et al, 1985; Delema rre-van de 
Waal et al, 1985; Partsch et al, 1985; Wagner et al, 
1986). However results are con trad ictor y and comparison  
between studies is con fo un ded by the variety of LH-RH 
infusion protocols used by the different workers. With 
the exception of the study of Wagner and colleag ues 
(1986), no account has been taken of the time of day at 
which the study was undertaken.
It is known from the work of Boyar et al (1972) that 
boys in early puberty exhibit nocturnal surges in LH and 
testosteron e secretion. The nocturnal LH peaks increase 
in amplitude as puberty pro gresses and eventually, in 
late puberty, LH pulses become easily detectable 
throughout the day. The effect of ’r o u n d - t h e - c l o c k ’ 
pulsatile LH-RH ad mi nistration  on the natural, diurnal 
variation in LH secretion has never been investigated. 
When as sessing the effects of LH-RH infusions it may be
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important to take account of the changing baseline of LH 
and testosterone secretion throughout the day. For these 
reasons a pilot study was carried out in 12 pubertal 
patients to assess the effect of dosage and time of day 
on the response to pulsatile LH-RH administration.
3.2) PATIENTS AND METHODS
Clinical details of the patients undergoi ng this 
study are shown in table 6. All patients were of short 
stature and the 24hour hormone profiles included hourly 
growth hormone meas ure ments (growth hormone data is not 
given). Mea surement of serum thyroxine,
t r i - i o d o t h y r o n i n e , TSH and the two 24hour hormone 
profiles replaced the combin ed anterior pituitary 
function tests as the method of assessing the pit uitary 
in these patients.
All patients underwent the basic protocol for LH-RH 
pulsatile infusion over 6 days, as described  in the 
Experimental Section. Tw enty- four hour hormone profiles 
were carried out immediately prior to, and at the end of 
the pulsatile infusions in the first 6 patients studied. 
A shorter study period, between the hours of 21.00 and
06.00 the following morning, was utilised in the 
remaining 6 patients. During the study times, blood was 
withdrawn every 20 minutes for estimation of serum LH and 
FSH. Every hour, on the hour, additional blood was drawn
PROTOCOL
Day I Days 2 - 6 Day 7
Serum Sampling every LH -R H  Infusion Serum sampling every
20 mins for LH/FSH and 20 mins for LH /FS H  and
hourly for testosterone/ hourly for testosterone/
growth hormone growth hormone
. . . . . .  p
0 4 11 i*  Z4 nrs w ^ ■ z4 nrs or ■ ■ ■ ►
between 21.00 and 06.00 hrs between 21.00 and 06.00 hrs
Figure 1 
Study protocol.
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for mea surement of serum testosterone and growth hormone. 
The study protocol is shown in diagramatic form in figure 
1.
LH-RH doses of 2.5, 7.5 and 15 ug/pulse were used in 
the first 6 patients, whilst patients 7 to 12 all 
received pulses of 7.5ug LH-RH.
3.3) RESULTS
The results of the pulsatile infusions of LH-RH on 
serum LH and test ost erone conce ntratio ns during 24hour 
periods are shown on figures 2 - 3 .  All patients showed 
the characteristic, pubertal night-time surges of LH and 
testosterone in the pr e- treatment profiles. Patient b), 
who was at genital stage 3 (table 6) also clearly showed 
LH pulses during the day-time.
Analysis of the LH profiles during the final 24 hours 
of pulsatile infusion revealed several interesting 
features: Firstly, despite the continuous nature of the 
infusion (i.e. pulses were given throughout the 24 hours) 
LH co nce ntrat ions in blood con tinued to show a night-time 
rise although in most cases this was less marked than 
prior to therapy. Only patient e) showed sti mulation of 
serum LH conc en trations above pre-tr eatment levels 
throughout the 24 hour period. The remaining patients 
showed either broadly unchanged or reduced serum LH 
during the n i g h t .Stimulation of LH secretion occu red only
24 Hour 
Profiles
Patient a)
b)
c)
d)
e)
f)
Profiles
Between
21.00 and
06.00 hours
Patient g)
h)
i) 
j) 
k) 
1)
Genital Testicular Chronological Bone Age
Staging Volumes (mis) Age (yrs) (yrs)
G1P1 6/6 15.2 12.6
G3P3 10/10 14.7 13.5
G1P1 3/3 15.1 11.2
G2P2 6/6 14.6 11.6
G2P2 8/10 17.8 14.0
G1P1 5/5 15.8 11.0
G2P2 8/8 17.8 14.0
G1P1 4/3 14.6 11.5
G1P2 5/5 18.1 13.5
G2P2 6/6 14.9 11.5
G1P1 3/3 15.0 11.2
G1P1 6/6 14.9 11.0
TABLE 6
Clinical details of patients undergoing 
hormone profiles prior to and during LH-RH infusions
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Figure 2
24-hour LH profiles in 6 patients prior to, 
and during pulsatile LH-RH infusions at doses 
of 2.5, 7.5 and 15ug/pulse. Pubertal staging 
data for each patient is given in the text.
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Figure 3
24-hour testosterone profiles in 6 patients 
prior to, and during pulsatile LH-RH infusions 
at doses of 2.5, 7.5 and 15ug/pulse.
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during the day at times when pre-infusion concentr ations  
were at a nadir. No significant LH stimulation at any 
time is evident in patient b) who had pulses of LH 
secretion during the day and night prior to LH-RH 
infusion.
It is difficult to see any significant effect of 
pulse dosage on LH concentrations. Whilst the patient 
showing the greatest stimulation had the highest dose 
regimen, patient f) who also received 15ug pulses showed 
marked reduction in LH secretion at night-time.
Despite the ’flatten ing out* of the LH curves during 
pulsatile LH-RH infusions, most patients continu ed to 
dem ons trate marked diurnal variation in serum 
testosterone during the treatment period. Patient c) who 
had very low or undetect able serum test ost erone 
co nce ntra ti on s in the pre-infusion profile failed to show 
any significant stimulation during the study. Patient 
a) showed elevated testoste rone concentrat ions only 
between 16.00 and 24.00 hours. Patient b) who was already 
well establishe d in puberty, had lower serum testos terone 
at almost all time points, during the second profile.
Similar results were obtain ed for the 6 patients who 
underwent the shorter study periods. All 6 patients 
showed elevated serum LH concentration s co mpa red with 
pre-inf usi on results between 21.00 and 24.00 hours. 
However, after midnight, the stimulation of LH release 
was more variable (figure 4). Serum testosterone
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Figure 4
Serum LH profiles between 2 1.00 and 08.00 
hours in 6 patients prior to, and during 
puls ati le LH-FH infusions at a dose of
7.5ug/pulse. Pubertai staging 
patient is given in the text.
data for each
Pre L II-R H  infusion
20 “I
15-
o
B
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Clock Time
During L H -R II  infusion
C/5
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Clock Time
F i g u r e  5
Serum t e s t o s t e r o n e  p r o f i l e s  between 2 2 . 0 0  and 
0 6 . 0 0  hours in 5 p a t i e n t s  p r i o r  t o ,  and d u r i n g  
p u l s a t i l e  LH-RH i n f u s i o n s  a t  a dose o f  
7 . 5 u g / p u l s e .
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concentration s on the other hand, were elevated in the 5 
patients for which results were available, throughout the 
study periods (figure 5).
When the data from all 12 patients are taken together 
for the period 21.00 to 06.00 hours on the following day, 
it can be clearly shown that at all time points between
21.00 and 24.00 hours LH secretion is signi ficantly  
enhanced by exogenous LH-RH pulses (figure 6). However, 
between midnight and 6.00a.m. serum LH levels were not 
signifi ca ntly different during LH-RH infusions. In 
contrast, serum test ost erone concent rations were 
significan tl y elevated by pulsatile LH-RH administration  
at all times except 3.00 a.m. (figure 7). The 
testosterone increment was however greater before 
midn i g h t .
3.4) DISCUSSION
The results of this study suggest that gonadotrophin 
secretion is enhanced by exogenous pulses of LH-RH, only 
at times of relative quiescence in endogenous LH-RH 
release. Wildt and colleag ues (1981) have demonst ra ted in 
the Rhesus monkey, that the pituitary gonadotroph 
response to exogenous LH-RH pulses is cri tic ally  
dependent upon the frequency of the pulses. When the 
pituitary of the monkey was exposed to LH-RH pulses of 
increased frequency, serum LH and FSH con cen tr ations
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fell.
In the present study, patients were exposed to both 
endogen ous  and exogenous LH-RH pulses, par tic ularl y at 
night-time when endogenous secretion was maximal. The 
variable response to the pulsatile infusions at night may 
depend upon the interaction between endogenou s and 
exogenous pulses. For example, if exogenous pulses happen 
to coincide with endogen ous  pulses then one might expect 
enhanced release of LH. On the other hand, if endogenous 
and exogenous pulses were asyncronous this would have 
exposed the pituitary gonado trophs to an increased rate 
of pulses resulting in d o w n - r e g u l a t i o n .
The serum testosterone  concentra tio ns were stimulate d 
by LH-RH infusions throughout the day and night, even in 
patients who had reduced LH levels at night-time. This 
result would suggest that testosterone production in 
early puberty is dependent upon not only the serum 
concentration of LH but also upon the duration of 
exposure to luteinizing hormone during the day.
The results of the present study would be consistent 
with the findings of Wagner et al (1986) who studied 10 
boys with delayed puberty. Twenty-four hour gonadotrophin 
profiles in their patients identified 5 boys with 
nocturnal elevation of LH and 5 patients with absence of 
such elevations. All patients underwent pulsatile 
infusions of LH-RH (2 5 n g / k g / p u 1s e , i.v. every 90 mins for 
10 days). On day 5, two 4-hour sampling periods between
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the hours 8.00 - 12.00 and 20.00 - 24.00 were carried
out. After 10 days of pulsatile therapy a post-treatment 
24 hour sampling period was started to include the last 2 
to 3 pump pulses.
Only the patients with nocturnal pulses showed 
further spontaneous pubertal development over the rather 
short follow up period of only 90 days. The authors were 
able to demonstrate rises in serum LH only in the group 
lacking nocturnal LH pulses. All patients however showed 
rises in serum test ost erone during treatment.
The sampling periods on day 5 of the infusion 
coin cid ed with the times of spontaneous gonado trophin 
rises and falls and therefore at times when we also were 
unable to show consist ent LH increments in our patients 
with delayed puberty. W a g n e r ’s group did not sample 
during treatment, in the afternoon, when natural LH 
secretion would be at ’baseline* and when stimulation 
above pre-t reatment levels can be demonstrated.
It is also significant to note that Wagner and 
co lleagues were unable to demonstrate the pre-ther apy 
nocturnal LH elevation in the post-treatment profiles, 
sug ges ting that there treatment had inhibited this 
phenomenon even after the infusion had been stopped.
Stanhope et al (1987) have suggested that induction 
of puberty with pulsatile LH-RH infusions is best carried 
out when the infusions are given at night-t ime thus 
simulating normal pubertal endocrinology. However, this
method may be quite inappropriate for patients with 
constitutional delayed puberty since nocturnal 
administr ati on of LH-RH may result in dec reased 
gonado tro phin secretion due to mechanisms described 
above. It may be more appropriate to administer LH-RH 
during the afternoon and evening when stimulation of LH 
secretion can occur and possibly result in increased 
testost ero ne throughout 24 hours.
CHAPTER 4
T HE EFFECTS OF LH-RH PULSE DOSAGE ON RESPONSE TO 
PULSATILE LH-RH INFUSIONS
4.1) INTRODUCTION
In view of the variable response to pulsatile LH-RH
infusions, during the night and morning, it was decided
to undertake further investigations of pulsatile LH-RH
administr ati on during 3 hour periods in the afternoons.
At this time endogenous LH-RH secretion is at its lowest 
and unlikely to interfere with the response to endogenous 
LH-RH administration. A 3 hour study period was choosen 
to ensure that hormone measuremen ts would include the 
response to 2 LH-RH pulses.
Previous studies have used a variety of LH-RH pulse 
doses given by both the intravenous and sub cutaneous 
routes. (Sippell et al, 1984; Barkan et al, 
1985;D e 1emarre-van de Waal et al, 1985; Partsch et al, 
1985; Wagner et al, 1986). The effects of the different 
dosages used, on gonadotrophin response are unknown.
Spratt and colleagues (1986) have investigated the 
dose response to LH-RH administ ered at physiological 
conc ent rations  to patients with hypogon adotrophi c 
hypogonadism. However, their study looked at the 
go nadotrophin response to a single pulse. The response to
r e p e a t e d  p u l s e s  at d i f f e r e n t  d o s e s  h a s  n e v e r  b e e n  
studied.
4.2) P A T I E N T S  A N D  M E T H O D S
T w e n t y  t w o  b o y s  u n d e r w e n t  p u l s a t i l e  i n f u s i o n s  of 
L H - R H  a c c o r d i n g  to t h e  p r o t o c o l  d e s c r i b e d  in t h e  
E x p e r i m e n t a l  S e c t i o n .  P u l s e  d o s e s  of 2.5, 7 . 5  a n d  1 5ug
w e r e  a d m i n i s t e r e d  to 7 , 9  a n d  6 p a t i e n t s  r e s p e c t i v e l y .  
T h e s e  d o s e s  w e r e  c h o s e n  in o r d e r  to c o v e r  t h e  l i k e l y  
d o s a g e  r a n g e  w h i c h  w o u l d  be u s e d  in f u t u r e  s t u d i e s  of 
y o u n g  b o y s  a n d  a d o l e s c e n t  m a l e s .  C l i n i c a l  d e t a i l s  of the  
p a t i e n t s  u n d e r g o i n g  t h i s  s t u d y  a r e  s h o w n  in t a b l e  7. 
T h e r e  w e r e  no s i g n i f i c a n t  d i f f e r e n c e s  in t e s t i c u l a r
v o l u m e s ,  c h r o n o l o g i c a l  or b o n e  a g e s  of th e  p a t i e n t s  in 
t h e  d i f f e r e n t  d o s a g e  g r o u p s .
4 . 3 )  R E S U L T S
F i g u r e s  8 a n d  9 s h o w ,  r e s p e c t i v e l y  t h e  s e r u m  LH a n d  
F S H  r e s p o n s e s  to p u l s a t i l e  L H - R H  i n f u s i o n s  in t h e  3
g r o u p s  of b o y s  t r e a t e d  w i t h  different. d o s e s  of L H - R H .
R e s u l t s  a r e  e x p r e s s e d  as m e a n  c o n c e n t r a t i o n s  of 
g o n a d o t r o p h i n s  m e a s u r e d  o v e r  t h e  3 h o u r  s t u d y  p e r i o d s .
It is c l e a r  f r o m  f i g u r e s  8 a n d  9 t h a t  p o s t - i n f u s i o n  
g o n a d o t r o p h i n  c o n c e n t r a t i o n s  a r e  d e p e n d e n t  u p o n  the
p r e - t r e a t m e n t  l e v e l s .  T h e  g r e a t e s t  i n c r e m e n t s  in L H  a n d
Pulse dosage No of Genital Testicular Chronological Bone Age 
group Patients Stages Volumes Age (yrs) (yrs)
G1 G2 G3 (mis)
2.5 ug/pulse n = 7 3 3 1 5.5 14.7 12.6
(2-10) (13.3-16.9) (10.5-13.5)
7.5 ug/pulse n = 9 4 4 1 5.5 15.0 12.0
(2-12) (14-17.7) (10.5-13.5)
15 ug/pulse n = 6 3 3 0 4.0 14.9 12.3
(2-9) (13.4-17.9) (10.0-14.0)
TABLE 7
Clinical details of the patient groups receiving 
different LH-RH pulse doses
When a patient had testes of differing sizes, a mean of the testicular
volumes was used.
Results expressed as median (range).
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F S H  d o s e - r e s p o n s e  c u r v e  for p u l s a t i l e  
i n f u s i o n s  of L H - 5 H  o v e r  6 days. Mean s e r u m  F S H  
c o n c e n t r a t i o n s  w e r e  c a l c u l a t e d  f rom s a m p l e s  
t a k e n  e v e r y  15 m i n s  o v e r  3 - h o u r  p e r i o d s .  L H - 5 H  
d o s e s  of 2.5, 7 . 5  a n d  1 5 u g / p u l s e  were used.
F S H  o c c u r e d  in t h e  p a t i e n t s  w i t h  the h i g h e s t  p r e - i n f u s i o n  
c o n c e n t r a t i o n s .
T h e r e  w e r e  no s i g n i f i c a n t  d i f f e r e n c e s  in p r e - t h e r a p y  
or p o s t - t h e r a p y  g o n a d o t r o p h i n  c o n c e n t r a t i o n s  b e t w e e n  the 
d o s a g e  g r o u p s .  S i m i l a r l y ,  g o n a d o t r o p h i n  i n c r e m e n t s  w e r e  
n o t  s i g n i f i c a n t l y  d i f f e r e n t .  H o w e v e r ,  th e  s m a l l  n u m b e r  of 
p a t i e n t s  in e a c h  g r o u p  p r e v e n t e d  f u r t h e r  s t a t i s t i c a l  
a n a l y s i s  of t h e  r e s u l t s .
4 . 4 )  D I S C U S S I O N
T h i s  s t u d y  f a i l e d  to s h o w  a r e l a t i o n s h i p  b e t w e e n  t h e 
c o n c e n t r a t i o n  of g o n a d o t r o p h i n s  in s e r u m  f o l l o w i n g  6 d a y s  
of p u l s a t i l e  L H - R H  i n f u s i o n  a n d  t h e  L H - R H  p u l s e  d o s e .  
H o w e v e r ,  b e c a u s e  of t h e  s m a l l  n u m b e r s  of p a t i e n t s  in e a c h  
g r o u p ,  s m a l l  d i f f e r e n c e s  in r e s p o n s e  to d o s a g e  a l t e r a t i o n  
c o u l d  n o t  be i d e n t i f i e d .
S p r a t t  et al ( 1 9 8 6 )  h a v e  d e m o n s t r a t e d  a l o g - l i n e a r  
r e l a t i o n s h i p  b e t w e e n  L H - R H  p u l s e  d o s e  a n d  s e r u m  LH 
r e s p o n s e  w h e n  L H - R H  w a s  a d m i n i s t e r e d  to h y p o g o n a d o t r o p h i c  
h y p o g o n a d a l  m a l e s  in w h o m  p i t u i t a r y  a n d  g o n a d a l  f u n c t i o n  
h a d  b e e n  n o r m a l i s e d  by p r i o r  L H - R H  p u l s a t i l e  
a d m i n i s t r a t i o n .  L H - R H  w a s  g i v e n  i n t r a v e n o u s l y  at d o s e s  
b e t w e e n  7 . 5  a n d  2 5 0 n g / k g .  S p r a t t  et al m e a s u r e d  LH 
r e s p o n s e s  to s i n g l e  L H - R H  p u l s e s  in e a c h  p a t i e n t .  T h e y  
d i d  not i n v e s t i g a t e  t h e  e f f e c t  of r e p e a t e d  a d m i n i s t r a t i o n  
of L H - R H  at d i f f e r e n t  d o s e s .
S e v e r a l  a u t h o r s  h a v e  d e m o n s t r a t e d  i n c r e a s i n g  
g o n a d o t r o p h i n  r e l e a s e  in r e s p o n s e  to r e p e t i t i v e  L H - R H  
a d m i n i s t r a t i o n  ( R e i t a n o  et al, 1975; V a l k  et al, 1980). 
B e c a u s e  of t h i s  s e l f - p r i m i n g  p h e n o m e n o n ,  it is l i k e l y  
that t h e  d u r a t i o n  of LH — RH p u l s a t i l e  i n f u s i o n s  r a t h e r  
t h a n  p u l s e  d o s a g e  is i m p o r t a n t  in i n f l u e n c i n g  g o n a d o t r o p h  
r e s p o n s e  a f t e r  p r o l o n g e d  a d m i n i s t r a t i o n .  T h e  i n f l u e n c e  of 
i n f u s i o n  d u r a t i o n  on g o n a d o t r o p h i n  l e v e l s  is d e m o n s t r a t e d  
in t h e  c h a p t e r  d e a l i n g  w i t h  L H - R H  t r e a t m e n t  of 
i n f e r t i  1 ity.
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CHAPTER 5
SERUM GON ADOT ROPHIN RESPONSE TO PULSATILE LH-RH 
ADM INI ST RATION  IN THE DI FFE RENTI AL DIAGNOSIS OF DELAYED 
PUBERTY AND HY PQGQNADQTRQ PHIC HYPOGONADISM
5.1) INTRODUCTION
The distinction between patients with constitutional 
delayed puberty and those with idiopathic
hy pogona dotrophic  hy pogonadism remains one of the most 
difficult diagnostic problems in paediatric
endocrinology. The gonadotrophi n response to a standard
bolus injection of LH-RH has proved quite ineffective in
dif feren ti at ing between the two conditions (Bell et al, 
1973; Kelch et al, 1980; Mortimer et al, 1973a). More
recently, two papers from S i p p e l l ’s group (Sippell et al, 
1984; Partsch et al, 1985) have reported that
go nad otrophin responses following pulsatile infusion of 
LH-RH could differen tiate these conditions.
In order to further investigate this, the gonadotroph 
response to prolonged pulsatile LH-RH infusions was 
assessed in patients pres enting with a variety of 
abnorm ali ties of growth and development.
PROTOCOL
Day 1 Days 2-6 Day 7
i
15 minute j LH-RH LH-RH
1
1
15 minute | LH-RH
serum sampling | bolus test Infusion serum sampling I bolus test
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1
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I
1 4 ht
1
|
w
1
1
1
1
1
3 hrs 1 hr ► 
1 
I
1
1
1
■4 3 hrs ►]-« 1 hr ► 
1 
1
Figure 10 
Study protoco 1.
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5.2) PATIENTS AND METHODS
Thirty-five patients referred for investigation of 
either short stature or delayed puberty were studied. 
Patients were divided into 3 patient groups acc ording to 
the criteria outlined in the Experimental Section, namely 
a) delayed puberty b) short stature or c) 
h yp ogonado trophic hypogonadism. Tables 8 and 9 show the 
clinical details, including pubertal gradings, testicular 
volumes and chronological ages of the patients within 
each group. Also included are the details for one patient 
s ub seq uen tly shown to have anorchia.
In view of the results from the pre ceding study on 24 
hour hormone profiles during pulsatile infusions, it was 
decided to restrict the period of hormone mo nitoring to 3 
hour periods in the afternoons. It was felt impracticable 
to monitor for 24 hour periods in a large number of 
patients and furthermore, we have demonstrat ed  that 
consistent stimulation by pulsatile LH-RH administr ati on 
occurs only during the afternoon and early evening.
During the afternoon of the admission day, blood was 
sampled via an indwelling venous cannula, at 15 minute 
intervals over a period of 3 hours for subsequent 
measurement of plasma LH and FSH. Thereafter TRH (2 0 0 u g ) 
was given as an intravenous bolus and blood sampled at 30 
minute intervals over 1 hour for estimation of serum 
prolactin. The following morning after an overnight fast,
Patient
Genital
Staging
Testicular Chronological Bone Age
Volume Age (yrs)
(mis) • (yrs)
Delayed Puberty
1 G1P2 2/3 14.8 12.0
2 G2P1 5/5 15.4 12.5
3 G1P1 2/2 14.3 10.0
4 G2P1 6/8 15.6 12.0
5 G1P1 2/2 15.0 11.0
6 G2P1 3/3 14.7 13.5
7 G2P1 3/3 14.1 11.0
8 G2P2 6/6 16.8 13.5
9 G2P2 8/8 17.8 14.0
Short Stature
10 G2P2 2/2 14.0 13.5
11 G1P1 3/3 12.3 8.0
12 G1P1 2/2 13.0 11.5
13 G1P1 4/4 13.7 12.5
14 G2P2 8/8 14.1 12.5
15 G1P2 3/3 13.3 12.0
16 G3P3 6/6 15.8 13.0
17 G2P2 6/6 14.7 12.5
18 G3P3 4/4 13.9 13.0
19 G2P2 6/6 15.3 13.0
20 G1P2 4/4 15.3 12.0
21 G2P2 '6/6 13.9 10.5
22 G3P2 4/3 15.1 13.0
23 G3P2 12/12 17.7 13.0
Anorchia
24 G1P1 0/0 9.0
TABLE 8
Clinical details of males with short stature and delayed puberty 
undergoing pulsatile LH-RH infusions
Patient
25
26
27
28
29
30
31
32
33
34
35
Anosmia Genital
Staging
YES
NO
NO
NO
NO
NO
YES
NO
NO
YES
G5P5
G5P5
G2P1
G2P4
G5P5
G3P4
G2P2
G2P1
G1P2
G5P5
HYPOSMIA G3P3
Testicular
Volume
(mis)
12/12
3/3
3/3
3/4
4/4
10/10
3/3
Inguinal/j
1/1 Micro­
penis
hypospadias
0/1
1/0
R. orchido- 
pexy at 14 
years old
Chrological
age
(yrs)
27.8
26.8
20.4
22.5
25.5
27.9
24.6
20.3
17.4
41.1
20.5
Previous therapy
Prolonged therapy 
with HCG + Sslii'biiHo 
Sustanon
NIL
Sustanon x 3 
several years 
previously
Monthly sustanon 
for 2.5 years
NIL
NIL
NIL
NIL
Sustanon injection 
for 20+ years
HCG 3 months 
Sustanon 3 months
TABLE 9
Clinical details of male patients with hypogonadotrophic hypogonadism 
undergoing pulsatile LH-RH infusions
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pituitary function was assessed as described above. Serum 
testosterone was est imated at this time and care taken to 
ensure that subsequent estimates for testosterone were 
made at the same time of day. Thereafter subcutaneous 
pulsatile LH-RH therapy was commenced using an infusion 
pump (Graseby Medical, type MS 27) with delivery of LH-RH 
pulses every 90 minutes at a dosage of 2 4 0 n g / k g / p u 1s e .
Following 6 days treatment with LH-RH further venous
blood sampling every 15 minutes for 3 hours was
undertaken at the same time of day as the pre-infusion 
study, for estimation of LH and FSH. All samples from 
each patient were frozen at -20 degrees centigrade and 
assayed in one batch to eliminate inter-assay error. The 
pump was then disco nn ec ted and intravenous boluses of TRH 
(200ug) and LH-RH (lOOug) were injected 1 hour apart.
Blood was sampled at 30 minute intervals for estimation
of serum LH, FSH and prolactin. TRH and LH-RH tests were 
not carried out on all patients. The study protocol is 
illustrated d i a g r a m a t i c a 11y in fig. 10.
5.3) RESULTS
Figures 1 1— 12 show typical examples of the serum 
concentrations of LH and FSH measured over 3 hour periods 
immediately before and at the end of 6 days therapy with 
pulsatile infusion of LH-RH (2 4 0 n g / k g / p u 1s e ) for the 
three patient groups; a) delayed puberty b) short stature
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c) hyp og on ado trophic  hypogonadism.
The mean LH and FSH concentrations for each patient, 
measured over the 3 hour periods, before and at the end 
of the period of pulsatile LH-RH therapy are illustrated 
in figs. 13 - 14.
There were no significant differences in the mean 
basal gonadotrophin concentrations between the three 
groups of patients (table 10). All 9 patients with 
delayed p u b e r t y , 12 of 14 patients with short stature and 
all 11 patients with hypogonadotrophic hypo gonad ism 
showed significant rises in mean LH concentrations at the 
end of the pulsatile infusion period.
Although there was a significant increase in FSH 
co nc en tra tions after 6 days of pulsatile therapy when the 
patient groups were taken as a whole, the changes were 
more variable, with 4 patients showing no change and 6 
patients showing a reduced mean FSH concentration after 
treatment ( f i g . 14). There are significant correlations  
between the mean pre-treatment LH and FSH concentrati ons 
and the mean post-th erapy  concentration s in the boys with 
delayed puberty and short stature.
Increments in both mean LH and FSH co ncentrations 
were sig nificantl y greater for the patients with 
hy pogonadot rophic hy po gonad ism when compared to the other 
groups (table 10 ) Only one patient ( patient no. 27, 
table 9) showed a response characteristic of the younger 
boys. This patient was, however, grossly obese and poor
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absorption of LH-RH may have occured from the 
su bcutaneous site.
The results for one patient subsequently shown to 
have anorchia are also shown. In this patient serum 
gonadotrophin increments were higher than those found in 
patients with constitutional pubertal delay or short
stature. FSH rose to a greater extent than LH and the FSH 
: LH ratio therefore simulated that found in adult
patients with primary testicular failure.
The incremental increase in serum LH during pulsatile 
LH-RH therapy was also compared with the LH response 
during the pre-treatment bolus LH-RH test in 8 delayed 
puberty, 13 short stature and 10 hypogonado trophic 
patients. . As can be seen from figure 15, in the delayed 
puberty and short stature groups of patients there is no 
significant correlation between the rise in LH during 
pulsatile therapy and the rise during a bolus test. By
contrast, the LH response to pulsatile therapy in the
patients with hypogonadot rophic hypogonadism could be 
predicted by the pre -treatment bolus LH-RH test.
5.4) DISCUSSION
The reasons for the proportio nally greater
gonadotrophin response to pulsatile therapy in the men
with hy pogonad otrophic hypo gonadis m are unknown. It has
been shown that pre-treatment with LH-RH augments
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Figure 15
Increments In mean serum LH during pulsatile 
LH-RH infusions compared with Increments after 
standard bolus LH-RH injections ( lOOug i.v.) 
In the 3 patient groups.
Correlation line for 1111 patients? 
y = 1.8 + 0.4x R = 0.71 p < 0.05
pituitary res ponsiveness to the hormone (Reitano et al, 
1975; Yoshimoto, Iioridera and Imura, 1975; Snyder et al, 
1979).Barkan et al (1985) have shown that gonad otrophin 
responses in 8 men with hyp ogonadotrophic hypog on ad ism to 
pulsatile LH-RH depended upon the degree of endogenous 
LH-RH deficie ncy  which they characterised by measuring 24 
hour secretory pulses. Although many of the men with 
hy pogonadot rophic hy pogonadism in this series had 
undetectable gonadotrophin concentrations throughout the 
sampling period, 24 hour profiles were not undertaken. 
This would clearly have enhanced this work, but was not 
practicable for 1 observer to undertake. Prolonged 
exposure to intermittent release of LH-RH in our patients 
with hy pog onado trophic hypo gonadis m may have resulted in 
pituitary gonadotroph priming.
Against this hypothesis, however, are the results of 
the initial bolus LH-RH tests which were undertaken prior 
to the period of pulsatile infusion. These results showed 
conside rab le overlap in response to a standard bolus dose 
of LH-RH between the three patient groups. Boyar et al 
(1976) and Santora et al (1986) have dem onstra te d that 
the response to a bolus LH-RH test reflects the extent of 
endogenous LH-RH deficie ncy and therefore the three 
groups of hypogonadal patients are likely to have similar 
degrees of LH-RH deficiency and gonadotroph priming.
A second hypothesis to explain the enhanced 
gonadotroph response to pulsatile infusion in the
patients with hy pogonadot rophic hypogonadism might be 
reduced feedback inhibition of LH and FSH release by 
testicular secretions in this group. Previous workers 
have shown that patients with hy po gonadotro phic 
h yp ogo nad ism have impaired testosterone responses during 
HCG stimulation tests ( Bardin et al, 1969; Perheentupa, 
Dessypris and Aldercreutz, 1972; Santen and Paulsen, 
1973; Weinstein and Reitz, 1974; Dunkel, Perheent upa and 
Sorva, 1985a; Dunkel et al, 1985b). It might therefore be 
expected that patients with hypogo nad otrop hic 
hypogonadis m would have impaired testosterone increments 
in response to pulsatile infusion of LH-RH, and therefore 
reduced feedback inhibition of LH secretion. In favour of 
this hypothesis is the clearly enhanced LH and FSH 
response to pulsatile therapy demonstrated by the patient 
with anorchia. Testoste rone responses to pulsatile 
therapy are discussed below.
A further hypothesis is based on the results shown in 
the 24 hour profiles. It appears that exogenous LH-RH 
causes stimulate d LH release at times of hypothalamic 
dormancy. At periods of greatest hypothalamic activity it 
is difficult to clearly demonstrate enhanced 
gonadotrophin secretion with pulsatile therapy. It is 
possible therefore that there is interaction between 
endogenous and exogenous pulses resulting in antagonis m 
at pit uitary level. Even during times of relative 
hypothalamic quiesence there may be some LH-RH secretory
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pulses in the peripubertal boys. On the other hand the 
hy pogonadot rophic patients may have complet ely absent or 
very infrequent pulses (Spratt et al, 1987). Small but 
undetectable LH-RH pulses able to antagonise the
exogenous LH-RH pulses might explain the rel atively 
impaired responses to pulsatile infusion in the
peripubertal groups compared with the patients with
hy po go nadotrophic  hypogonadism.
Other factors such as the chronological age of the 
patient, or previous exposure to HCG or testosterone
esters might be important in the response to LH-RH 
infusion. Although numbers of hy po gonadotro phic
hypogonadal patients are small these facters do not seem
to influence the results. This work therefore is unable 
to explain the enhanced response to LH-RH pulsatile 
infusion demonst ra ted with hypogonadot ro phic
hypogonad ism.
Several studies have compared the gonadotrophin 
responses to pulsatile LH-RH therapy in patients with
delayed puberty and hy pogon adotrophi c hypogonadism. Valk
et al (1980) investigated 4 male and 2 female patients 
with isolated gonadotrophin deficiency given LH-RH (0.025 
ug/kg) i.v. every 2 hours for 5 days. The male patients 
showed si gnificant ly elevated  LH and FSH concent ra tions 
within 24 hours of treatment, and gonadotrophin 
co nc en tra tions continued to rise over the 5 day periods. 
FSH co ncentrati ons rose to a greater extent than LH
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concentr ati ons with FSH achieving con centrations at the 
upper limit of the adult male range in all patients.
The high initial response in FSH in the 4 patients 
investigated by Valk may reflect impaired testicular 
function in the small group studied. Lack of feedback 
inhibition by inhibin could explain the rise in FSH 
levels to greater concentrations than those normally 
found during puberty. A larger study might have shown a 
more varied FSH response. The magnitude of LH responses 
is similar to our own results.
Sippell et al ( 1984) reported the mean FSH rise for 
18 hypogonadal patients following 36 hours of pulsatile 
LH-RH infusion at a dose of 5ug i.v. every 90 minutes. 
Their patients were divided into 4 clinical groups; 
K a l l m a n n ’s syndrome (4 patients), idiopathic
hyp opi tu itaris m (6 patients), isolated hypogona dotrophic  
hy pogonadis m (3 patients), and constitutional delayed 
puberty (5 patients). They were able to show significant 
rises in FSH concentrati ons during the 36 hours of LH-RH 
infusion, compared with pretreatment nocturnal profiles 
in all patients with K a l l m a n n ’s syndrome and idiopathic 
hypopituitarism. No significant rise was seen in the 
patients with isolated hy pogonadotro phic hy po gon adism or 
in 3 of the 5 patients with constitutional delayed 
puberty. The difference in responses between the patients 
with K a l l m a n n ’s syndrome and idiopathic hypogo na dotroph ic  
hyp ogo nadi sm  is difficult to explain since the latter
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p a t i e n t s  h a d  h i g h e r  i n i t i a l  t e s t o s t e r o n e  c o n c e n t r a t i o n s  
a n d  m i g h t  h a v e  b e e n  e x p e c t e d  to be m o r e  a d e q u a t e l y  p r i m e d  
a n d  t h e r e f o r e  b e t t e r  a b l e  to r e s p o n d .  T h e  v a r i a b l e  
r e s p o n s e  in t h e  p a t i e n t s  w i t h  c o n s t i t u t i o n a l  d e l a y e d  
p u b e r t y  m a y  r e f l e c t  t h e i r  v a r i e d  d e g r e e  of g o n a d o t r o p h  
m a t u r a t  ion.
A s e c o n d  s t u d y  by t h e  s a m e  g r o u p  ( P a r t s c h  et al, 
1985) u s i n g  t h e  s a m e  s a m p l i n g  t e c h n i q u e s  a n d  i n f u s i o n  
p r o t o c o l ,  r e p o r t s  t h e  r e s u l t s  of p u l s a t i l e  i n f u s i o n  in 8 
p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  a n d  9 w i t h  
c o n s t i t u t i o n a l  d e l a y e d  p u b e r t y .  T h i s  l a t t e r  g r o u p  
c o n t a i n e d  4 p a t i e n t s  w i t h  t e s t i c u l a r  v o l u m e s  of 9 mis. or 
g r e a t e r  a n d  t h e s e  p a t i e n t s  c l e a r l y  h a d  t h e  h i g h e s t  
i n i t i a l  L H  a n d  F S H  c o n c e n t r a t i o n s  a n d  g r e a t e s t  i n c r e m e n t s  
in g o n a d o t r o p h i n s  w i t h  t h e r a p y .  T h e  h e t e r o g e n e o u s  
r e s p o n s e  in t h i s  g r o u p  is in a g r e e m e n t  w i t h  o u r  o w n  
r e s u l t s .  T h e  h y p o g o n a d o t r o p h i c  h y p o g o n a d a l  p a t i e n t s  on 
t h e  o t h e r  h a n d  d i d  n o t  s h o w  t h e  e x a g g e r a t e d  r e s p o n s e  
d e c r i b e d  in o u r  p r e s e n t  s t u d y .  T h e  s h o r t e r  p e r i o d  of 
t r e a t m e n t  a n d  t h e  d i f f e r e n t  d o s e  r e g i m e  m i g h t  e x p l a i n  t h e  
t h e  d i f f e r e n c e s  b e t w e e n  t h e  s t u d i e s .
B a r k a n  et al ( 1 9 8 5 )  s t u d i e d  8 p a t i e n t s  w i t h  
i d i o p a t h i c  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  w h o m  t h e y  
d i v i d e d  i n t o  t w o  g r o u p s ,  p a r t i a l  or c o m p l e t e  
g o n a d o t r o p h i n  d e f i c i e n c y ,  d e p e n d i n g  u p o n  t h e  p r e s e n c e  or 
a b s e n c e  of s e c r e t o r y  L H  p u l s e s  d u r i n g  2 4  h o u r  p r o f i l e s  of 
g o n a d o t r o p h i n  s e c r e t i o n .  T h e y  w e r e  a b l e  to s h o w  t h a t
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p u l s a t i l e  L H - R H  i n f u s i o n  ( 2 5 n g / k g ,  i . v . , e v e r y  2 h o u r s  
for 4 d a y s )  in p a t i e n t s  w i t h  c o m p l e t e  d e f i c i e n c y ,  
r e s u l t e d  in p r e d o m i n a n t  F S H  s e c r e t i o n  a n d  a b s e n t  or 
m i n i m a l  a u g m e n t a t i o n  of LH s e c r e t i o n .  In c o n t r a s t ,
p r e d o m i n a n t  L H  s e c e t i o n  o c u r r e d  in t h e  p a r t i a l  d e f i c i e n c y  
p a t i e n t s .  B o t h  g r o u p s  of p a t i e n t s  a c h i e v e d
s u p r a - p h y s i o l o g i c a 1 c o n c e n t r a t i o n s  of F S H  d u r i n g  L H - R H  
i n f u s i o n .  S t u d i e s  in L H - R H  d e f i c i e n t  a n i m a l s  a n d  ma n  
( W i l d t  et al, 1981; G r o s s  et al, 1987) h a v e  d e m o n s t r a t e d  
t h a t  a d m i n i s t r a t i o n  of L H - R H  at r a p i d  p u l s e  f r e q u e n c e s  
s t i m u l a t e s  p r e d o m i n a n t  LH s e c r e t i o n  a n d  at s l o w e r  
f r e q u e n c e s  s t i m u l a t e s  p r e d o m i n a n t l y  F S H  s e c r e t i o n .  T h u s  
it is p o s s i b l e  t h a t  t h e  p u l s e  f r e q u e n c y  of t w o  h o u r s
c h o s e n  by B a r k a n  et al w a s  t o o  s l o w  to e l i c i t  
p h y s i o l o g i c a l  h o r m o n e  r e s p o n s e s .  R e c e n t  s t u d i e s
( M a t s u m a t o  a n d  Bremner-, 1984; V e l d h u i s  et al, 1984) u s i n g  
f r e q u e n t  s a m p l i n g  s u g g e s t  t h a t  t h e  p h y s i o l o g i c a l  p u l s e  
i n t e r v a l  in m a n  is c l o s e r  to 9 0  m i n u t e s ,  w h i c h  w a s  t h e  
f r e q u e n c y  u s e d  in o u r  s t u d y .  B a r k a n ’s s t u d y  d i d  n o t  
c o m p a r e  r e s u l t s  of h y p o g o n a d o t r o p h i c  p a t i e n t s  w i t h  
d e l a y e d  p u b e r t y  p a t i e n t s  of s i m i l a r  g o n a d o t r o p h i n  
d e f  i c i e n c y .
W a g n e r  et al ( 1 9 8 6 )  i n v e s t i g a t e d  t w o  g r o u p s  of 
p a t i e n t s  w i t h  d e l a y e d  p u b e r t a l  d e v e l o p m e n t  w h o m  t h e y
d e f i n e d  as e i t h e r  d e l a y e d  p u b e r t y  or p e r m a n e n t  
h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  a c c o r d i n g  to t h e  p r e s e n c e  
or a b s e n c e  of n o c t u r n a l  L H  p u l s e s .
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N i n e  of t h e  10 b o y s  s t u d i e d  w e r e  u n d e r  2 0  y e a r s  of 
ag e  a n d  t h e  f o l l o w - u p  p e r i o d  w a s  o n l y  9 0  d a y s .  T h e  b o y s  
w i t h  a b s e n t  n o c t u r n a l  p u l s e s  m a y  be e x a m p l e s  of 
p r e p u b e r t a l  b o y s  w i t h  s i m p l e  d e l a y e d  p u b e r t y  a n d  m i g h t  
not be e x p e c t e d  to s h o w  f u r t h e r  p u b e r t a l  d e v e l o p m e n t  
d u r i n g  t h i s  s h o r t  f o l l o w - u p  p e r i o d .  LH s e c r e t i o n  w a s  
i n c r e a s e d  in b o t h  g r o u p s  of p a t i e n t s ,  a l t h o u g h  t h i s  o n l y  
r e a c h e d  s t a t i s t i c a l  s i g n i f i c a n c e  for t h e  g r o u p  w i t h  
a b s e n t  n o c t u r n a l  p u l s e s .  S i m i l a r l y  o n l y  t h e  l a t t e r  g r o u p  
s h o w e d  s i g n i f i c a n t  F S H  a u g m e n t a t i o n .  T h e  r e s u l t s  for 
i n d i v i d u a l  p a t i e n t s  a r e  n o t  g i v e n ,  m a k i n g  f u r t h e r
i n t e r p r e t a t i o n  of t h e  d a t a  d i f f i c u l t .  If t h e  g r o u p  of 
p a t i e n t s  s h o w i n g  no n i g h t - t i m e  p u l s a t i l i t y  w e r e  i n d e e d  
p a t i e n t s  w i t h  p e r m a n e n t  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  
t h e  r e s u l t s  of W a g n e r  et al s u g g e s t  t h a t  t h i s  g r o u p  of
p a t i e n t s ,  d e s p i t e  h a v i n g  l o w e r  e n d o g e n o u s  L H - R H
s e c r e t i o n ,  h a v e  a g r e a t e r  i n i t i a l  r e s p o n s e  to p u l s a t i l e  
L H - R H  i n f u s i o n . T h e s e  r e s u l t s  w o u l d  t h e r e f o r e  be in
a g r e e m e n t  w i t h  o u r  own.
W h e t h e r  c l a s s i f i c a t i o n  as e i t h e r  d e l a y e d  p u b e r t y  or 
h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  on t h e  b a s i s  of 2 4  h o u r  LH 
p r o f i l e s  is j u s t i f i e d ,  is a m a t t e r  for c o n j e c t u r e .  
S t a n h o p e  et al ( 1 9 8 7 )  d e m o n s t r a t e d  a b s e n t  n o c t u r n a l  LH  
s e c r e t i o n  in a 16 y e a r  o l d  f e m a l e  s u b s e q u e n t l y  s h o w n  to 
h a v e  c o n s t i t u t i o n a l  d e l a y  of p u b e r t y .  S p r a t t  et al 
( 1 9 8 7 ) ,  in a l a r g e  s e r i e s  of h y p o g o n a d o t r o p h i c  m a l e s ,  
d e m o n s t r a t e d  n o c t u r n a l  p u l s e s  in 3 of 5 0  p a t i e n t s
s t u d i e d .  P r e s e n c e  of n o c t u r n a l  LH p u l s e s  m a y  t h e r e f o r e  
no t  be a g o o d  d i s c r i m i n a t o r  b e t w e e n  t h e s e  t w o  c o n d i t i o n s .
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CHAPTER 6
R E S P O N S E S  T O  B O L U S  I N J E C T I O N S  O F  L H - R H
6.1) I N T R O D U C T I O N
T h e r e  is g e n e r a l  a g r e e m e n t  t h a t  at p u b e r t y  LH  
r e s p o n s i v e n e s s  to a b o l u s  d o s e  of L H - R H  i n c r e a s e s  in 
m a l e s  at t h e  s a m e  t i m e  as n o c t u r n a l  s u r g e s  of LH a p p e a r ,  
as d e s c r i b e d  by B o y a r  et al ( 1 9 7 2 ) .  T h i s  i n c r e a s e  of
r e s p o n s i v e n e s s  c o n t i n u e s  t h r o u g h o u t  p u b e r t y .  H o w e v e r
t h e r e  is l a c k  of c o n s e n s u s  r e g a r d i n g  t h e  F S H  r e s p o n s e  to 
L H - R H .  A c c o r d i n g  to s o m e  w o r k e r s  r e s p o n s i v e n e s s  in 
p u b e r t y  r e m a i n s  s i m i l a r  to p r e - p u b e r t y  ( R o t h  et al, 1972; 
F r a n c h i m o n t  et al, 1973) w h i l s t  o t h e r  w o r k e r s  h a v e  
d e s c r i b e d  p u b e r t a l  i n c r e a s e s  of F S H  r e s p o n s e s  ( J o b  et al, 
1972; G r u m b a c h  et al, 1974; K a s t i n  et al, 1972; K e l c h  et 
al, 1975).
T h e  r e s p o n s e  to b o l u s  L H - R H  i n j e c t i o n s  in p a t i e n t s  
w i t h  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  c a n  be n o r m a l ,
m i n i m a l  or s u b - o p t i m a l  (H a s h  i m o t o  et al, 1972; R o t h  et 
al, 1972; E s p i n e r  a n d  D o n a l d ,  1973; M o r t i m e r  et al, 
1 9 7 3a). T h i s  led B e l l  et al ( 1 9 7 3 )  to c o n c l u d e  t h a t  t h e r e  
w a s  t o o  m u c h  h e t e r o g e n e i t y  in g o n a d o t r o p h i n  r e s p o n s e  to 
b o l u s  d o s e s  of L H - R H  to a l l o w  i d e n t i f i c a t i o n  of t h i s  
c o n d i t i o n  .
S e v e r a l  p r e v i o u s  s t u d i e s  h a v e  s h o w n  t h a t  p r o l o n g e d
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a d m i n i s t r a t i o n  of L H - R H  c a n  r e s u l t  in i n c r e a s e d  s e c r e t i o n  
of g o n a d o t r o p h i n s  in p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  
h y p o g o n a d i s m  ( J a c o b s o n  et al, 1979; R e i t a n o  et al, 1975; 
S n y d e r  et al, 1979; Y o s h i m o t o  et al, 1975). T h e s e  
s t u d i e s ,  h o w e v e r  u s e d  p h a r m a c o l o g i c a l  d o s e s  of L H - R H ,  
a d m i n i s t e r e d  as e i t h e r  i n f u s i o n s  or i n j e c t i o n s  w h i c h  d i d  
no t  s i m u l a t e  t h e  n o r m a l  e n d o g e n o u s  p u l s a t i l e  r e l e a s e  of 
L H - R H .
It w a s  t h e r e f o r e  of i n t e r e s t  to i n v e s t i g a t e  w h e t h e r  
a u g m e n t a t i o n  of g o n a d o t r o p h i n  r e s p o n s e  to b o l u s  L H - R H  
i n j e c t i o n s  o c c u r r e d  f o l l o w i n g  p u l s a t i l e  L H - R H  i n f u s i o n s  
in p u b e r t a l  b o y s  a n d  p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  
h y p o g o n a d  ism.
6 . 2 )  P A T I E N T S  A N D  M E T H O D S
S t a n d a r d  b o l u s  L H - R H  t e s t s  w e r e  c a r r i e d  ou t  
i m m e d i a t e l y  p r i o r  to p u l s a t i l e  i n f u s i o n  of  L H - R H  in 8 
p a t i e n t s  w i t h  d e l a y e d  p u b e r t y ,  13 p a t i e n t s  w i t h  s h o r t
s t a t u r e  a n d  10 p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c
h y p o g o n a d i s m .  I m m e d i a t e l y  f o l l o w i n g  t h e  p u l s a t i l e  
i n f u s i o n  f u r t h e r  b o l u s  L H - R H  t e s t s  w e r e  c a r r i e d  o u t  in 7 
p a t i e n t s  w i t h  d e l a y e d  p u b e r t y ,  12 p a t i e n t s  w i t h  s h o r t
s t a t u r e  a n d  6 p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c
h y p o g o n a d i s m .  All b u t  o n e  of t h e  p a t i e n t s  w i t h  
p o s t - i n f u s i o n  r e s u l t s  h a d  a l s o  u n d e r g o n e  p r e - i n f u s i o n  
t e s t s .  T h e  p r o t o c o l  for t h e  s t u d y  is s i m i l a r  to t h a t
PROTOCOL
Day 1 Days 2-6 Day 7
i
15 minute [ LH-RH LH-RH
1
15 minute | LH-RH
serum sampling ( bolus test Infusion serum sampling I bolus test
for LH/FSH i 
1
(240ng/kg/pulse) for LH /FSH I 
1
1 ■4 ii
1
|
w 1
1
1
1
1
4 3 hrs 1 hr ► 
1 
1
1
1
1
4 3 hrs lh r  ► 
1 
1
F i g u r e  16 
S t u d y  p r o t o c o l .
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d e s c r i b e d  in C h a p t e r  5 a n d  is s h o w n  in d i a g r a m m a t i c a l  
f o r m  in f i g u r e  16.
6.3) R E S U L T S
G o n a d o t r o p h i n  r e s p o n s e s  to b o l u s  t e s t s  a r e  c o m p a r e d  
b e f o r e  a n d  a f t e r  p u l s a t i l e  L H - R H  i n f u s i o n s  b o t h  b e t w e e n  
g r o u p s  a n d  w i t h i n  g r o u p s .
6.3. 1) C o m p a r i s o n  of LH r e s u l t s  b e t w e e n  g r o u p s
F i g u r e s  17 a n d  18 a n d  t a b l e  11 s h o w  t h e  LH  r e s p o n s e s  
to s t a n d a r d  b o l u s  i n j e c t i o n s  of L H - R H  i m m e d i a t e l y  p r i o r  
to a n d  f o l l o w i n g  t h e  p e r i o d s  of p u l s a t i l e  L H - R H  i n f u s i o n ,  
for t h e  3 p a t i e n t  g r o u p s .
R e s u l t s  of t h e  i n i t i a l  L H - R H  b o l u s  t e s t s  s h o w  
c o n s i d e r a b l e  o v e r l a p  of b a s a l ,  p e a k  a n d  i n c r e m e n t a l  
c h a n g e s  in L H  b e t w e e n  t h e  p a t i e n t  g r o u p s  ( f i g  17). T h e r e  
w e r e  no s i g n i f i c a n t  d i f f e r e n c e s  in p r e - t r e a t m e n t  b a s a l  LH 
c o n c e n t r a t i o n s  b e t w e e n  t h e  g r o u p s  ( t a b l e  11). T h e
p r e - t h e r a p y  p e a k  LH  a n d  i n c r e m e n t  in L H  w e r e  
s i g n i f i c a n t l y  g r e a t e r  in t h e  s h o r t  s t a t u r e  g r o u p  w h e n
c o m p a r e d  w i t h  t h e  h y p o g o n a d o t r o p h i c  a d u l t s .
F o l l o w i n g  t h e  t r e a t m e n t  p e r i o d  t h e  p a t i e n t s  w i t h
h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  s h o w e d  s i g n i f i c a n t l y  
h i g h e r  b a s a l  LH c o n c e n t r a t i o n s  w h e n  c o m p a r e d  w i t h  the 
o t h e r  t w o  g r o u p s  ( t a b l e  11). P e a k  LH  c o n c e n t r a t i o n s  in
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T h e  b a s a l  a n d  p e a k  s e r u m  LH r e s p o n s e s  to b o l u s  
L H - R H  a d m i n i s t r a t i o n  ( l O O u g  i.v.) p r i o r  to 
p u l s a t i l e  L H - R H  i n f u s i o n s  in p a t i e n t s  w i t h  a) 
d e l a y e d  p u b e r t y  b) s h o r t  s t a t u r e  a n d  c) 
h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .
Delayed Puberty
3
uCJ
cn
u
CJ
CO
25 i
20 "
15"
10 "
Basal Peak
Short Stature
25 i
20-
15"
Basal Peak
Hypogonadotrophic Hypogonadism
25"
20"
15"
r* io-
UaCO 5"
0
Basal Peak
F i g u r e  18
T h e  b a s a l  a n d  p e a k  s e r u m  LH r e s p o n s e s  to b o l u s  
L H - S H  a d m i n i s t r a t i o n  ( lOOug i.v.) f o l l o w i n g  
p u l s a t i l e  L H - S H  i n f u s i o n s  in p a t i e n t s  w i t h  a) 
d e l a y e d  p u b e r t y  b) s h o r t  s t a t u r e  a n d  c) 
h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .
BASAL LH (u/1)
Patient
Group
DP
SS
HH
Pre-treatment
1.8
Post- treatment
q
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Z
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Z
(0.9 - 4.2)-<------- NSD---->-(1
2.3
.7 - 6.9) Q
co |
2.5
(0.9 - 6.4)-*
2.0 o  o
-NSD >-(0.9 - 4.2f*TL v
P  cx oco ' |
£  1-3 4.6 V
(0.9 - 1.9)-<----- p < 0.05— >- (2.8 - 8.1) I
PEAK LH (u/1)
Pre-treatment
DP
SS
HH
19
Q  (4.0 - 24)-*-
q
CO
Zu
co
18
^ ( 1 . 3  - 36)-*
q
^  8-9
(1.7 - 15)-*-
Post- treatment
-NSD-
NSD-
1 0 . 0  -*-i-
->-(5.4 - 22) Q.
co
12.0 
->-(2'.2 - 23)
7.9
-p< 0.05— >-(4.6 - 17)
q
CO*
z
q
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INCREMENT IN LH (u/1)
Pre-treatment
DP
SS
HH
CO
q *
CO
Z  »n o  
o  
V
-|— >- 16.5
Q  (0.5 - 20.9)-
15.2 
(0.4 - 29.6)-
8.0
(0.6 - 13.1)^*
Post- treatment
8.1
NSD >-(2.8 - 15.1)
_rq
cd
Z
9 •1 - * - j  9
-NSD >-(1.3 - 22.1 )-<-t ^
q
3.4 g
-NSD >-(0.4 - 8.9) _
TABLE 11
LH responses to a standard bolus LH-RH test (100 ug IV) prior’ 
to, and immediately following 6 days of pulsatile LH-RH infusion.
DP = constitutional delayed puberty 
SS = short stature
HH = hypogonadotrophic hypogonadism 
NSD= not significantly different
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the post- the rapy tests were, however not significantly 
different between the groups ( table 11,figure 18).
6.3.2) Comparison of LH results within groups
When the LH responses to bolus tests were compared 
before and following LH-RH pulsatile administration, the 
delayed puberty and short stature groups showed no 
significant differences in basal or peak LH, or 
increments in LH (table 11).
Patients with hy pogonadotro phic hypogonadism, on the 
other hand, had significant ly higher basal and peak LH 
conce ntr ations in the second bolus tests, although the 
incremental increases in LH were unchanged. Thus, the 
higher peaks in the post-infusion tests simply reflect 
the higher basal concent rations at this time.
6.3.3) Comparison of FSH results between groups
Basal FSH co ncentration s prior to therapy were lowest 
in the hypogona dotrophic  group and this reached 
statistical significance when compared with the delayed 
puberty group. Peak FSH levels in the first bolus tests 
were sig nif icantly reduced in the hyp og onadotrophic  males 
when compared with the other two groups. However there 
was again significant overlap between the groups (fig 19) 
so that this test could not discriminate well between the
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Figure 19
The basal and peak serum FSH responses to 
bolus LH-FH administration ( lOOug i.v.) prior 
to pulsatile LH-FH infusions in patients with 
a) delayed puberty b) short stature and c) 
hypogon ado trophic  hy pog o n a d i s m .
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g r o u p s .
B a s a l  F S H  c o n c e n t r a t  ions in the s e c o n d  b o l u s  t e s t s  
w e r e  h i g h e s t  in t h e  h y p o g o n a d o t r o p h i c  p a t i e n t s  a l t h o u g h  
t h i s  d i d  n o t  r e a c h  s t a t i s t i c a l  s i g n i f i c a n c e  ( t a b l e  12, 
f i g  20). T h e r e  w e r e  no s i g n i f i c a n t  d i f f e r e n c e s  in p e a k  
F S H  or~ i n c r e m e n t s  in F S H  b e t w e e n  the g r o u p s  in t h e  p o s t  
i n f u s i o n  L H - R H  t e s t s  ( t a b l e  12).
6 . 3 . 4 )  C o m p a r i s o n  of F S H  r e s u l t s  w i t h i n  g r o u p s
P a t i e n t s  w i t h  d e l a y e d  p u b e r t y  h a d  s i g n i f i c a n t l y  
r e d u c e d  b a s a l ,  p e a k  a n d  i n c r e m e n t a l  c h a n g e s  in F S H  in t h e  
s u b s e q u e n t  L H - R H  t e s t s  ( f i g s  19 - 20, t a b l e  12). T h e
s h o r t  s t a t u r e  p a t i e n t s  s h o w e d  no c h a n g e s  in b a s a l  or p e a k  
F S H  c o n c e n t r a t i o n s .  H o w e v e r ,  th e  i n c r e m e n t a l  c h a n g e  in 
F S H  w a s  s i g n i f i c a n t l y  l o w e r  in the s e c o n d  b o l u s  t e s t  
( t a b l e  12).
P a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  s h o w e d  
s i g n i f i c a n t l y  h i g h e r  b a s a l  and p e a k  F S H  c o n c e n t r a t i o n s ,  
w h i l s t  the i n c r e m e n t a l  i n c r e a s e s  in F S H  r e m a i n e d  
u n c h a n g e d  in t h e  s e c o n d  tes t .  It m u s t  be s t r e s s e d ,  
h o w e v e r ,  t h a t  s o m e  of t h e  c h a n g e s  in c o r r e s p o n d i n g  F S H  
c o n c e n t r a t i o n s  w e r e  s m a l l  a n d  c l o s e  to t h e  c o e f f i c i e n t  of 
v a r i a n c e  of t h e  a s s a y .
F i g u r e s  21 a n d  2 2  c o m p a r e  t h e  i n c r e m e n t a l  c h a n g e s  in 
LH a n d  F S H  b e f o r e  a n d  a f t e r  th e  p e r i o d s  of p u l s a t i l e  
i n f u s i o n .  All f i v e  p a t i e n t s  w i t h i n  th e  d e l a y e d  p u b e r t y
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Figure 20
The basal and peak serum FSH responses to 
bolus LH-RH administration ( lOOug i.v.) 
following pulsatile LH-RH infusions in 
patients with a) delayed puberty b) short 
stature and c) hypogonadotrophic hypogonadism.
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TABLE 12
FSH responses to a standard bolus LH-RH test (100 ug IV) prior 
to, and immediately following 6 days of pulsatile LH-RH infusion.
DP = constitutional delayed puberty 
SS = short stature
HH = hypogonadotrophic hypogonadism 
NSD= not significantly different
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a n d  s h o r t  s t a t u r e  g r o u p s ,  w h o  h a d  i n i t i a l  i n c r e m e n t s  in 
LH t 5 m U / L  s h o w e d  i n c r e a s e d  i n c r e m e n t s  f o l l o w i n g  
p u l s a t i l e  L H - R H .  On t h e  o t h e r  h a nd, o n l y  2 of 13 p a t i e n t s  
w i t h  i n i t i a l  i n c r e m e n t s  >5 m U / L  s h o w e d  a u g m e n t e d  
i n c r e m e n t s  in t h e  s e c o n d  b o l u s  test. No s u c h  t r e n d  w a s  
i d e n t i f i e d  w i t h  LH i n c r e m e n t s  in t h e  p a t i e n t s  w i t h  
h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  a l t h o u g h  n u m b e r s  in t h i s  
l a t t e r  g r o u p  w e r e  s m a l l .
6 .4) D I S C U S S I O N
T h e  r e s u l t s  of t h e  p r e - i n f u s i o n  L H - R H  b o l u s  t e s t s  
c o n f i r m  t h e  r e s u l t s  of p r e v i o u s  w o r k e r s  w h o  h a v e  
d e m o n s t r a t e d  t h a t  s t a n d a r d  L H - R H  b o l u s  t e s t s  a r e  u n a b l e  
to d i s t i n g u i s h  b e t w e e n  d i f f e r e n t  g r o u p s  of 
h y p o g o n a d o t r o p h i c  p a t i e n t s  ( J o b  et al, 1976, 1977;
C o n t e  et al, 1980).
V a l k  a n d  c o l l e a g u e s  s t u d i e d  L H - R H  b o l u s  t e s t s  
f o l l o w i n g  a p e r i o d  of p u l s a t i l e  L H - R H  i n f u s i o n  in 4 m a l e s  
a n d  2 f e m a l e s  w i t h  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .  L H - R H  
w a s  g i v e n  at a d o s e  of 0 . 0 2 5 u g / k g / p u 1se e v e r y  2 h o u r s  for 
5 d a y s .  S e r u m  L H  c o n c e n t r a t i o n s  a n d  i n c r e m e n t a l  r e s p o n s e s  
to b o l u s  L H - R H  t e s t s  r o s e  d u r i n g  th e  s t u d y  in b o t h  s e x e s .  
H a l e s  s h o w e d  i n c r e a s i n g  a n d  f e m a l e s  d e c r e a s i n g  
i n c r e m e n t a l  F S H  r e s p o n s e s  to L H - R H .  T h e i r  r e s u l t s  
t h e r e f o r e  s i m u l a t e  t h e  c h a n g e s  p r e v i o u s l y  d e s c r i b e d  
d u r i n g  n o r m a l  p u b e r t a l  d e v e l o p m e n t  ( J o b  et al, 1972; R o t h
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Figure 21
Increments (peak - basal) in serum LH after 
bolus LH-EH administration to the 3 patient 
groups prior to, and following pulsatile -H
infus ions.
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Increments (peak - basal) in serum FSH after 
bolus LH-RH administration to the 3 patient 
groups prior to, and following pulsatile LH-RH 
infusions.
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et al, 1972; F r a n c h i m o n t  et al, 1974; G a r n i e r  et al,
19^4) a n d  l e a d  t h e  a u t h o r s  to c o n c l u d e  t h a t  r e p e t i t i v e  
low d o s e  a d m i n i s t r a t i o n  of L H - R H  i n d u c e d  r a p i d  m a t u r a t i o n  
of p i t u i t a r y  g o n a d o t r o p h  s e c r e t i o n .
V a l k ’s s t u d y  i n v o l v e d  o n l y  a s m a l l  n u m b e r  of
p a t i e n t s ,  all ol w h o m  h a d  LH a n d  F S H  i n c r e m e n t s  at or
b e l o w  t h e  l o w e r  l i m i t  of n o r m a l  for p r e p u b e r t a l  p a t i e n t s ,  
d u r i n g  t h e  i n i t i a l  b o l u s  t e s t s .  T h e  two f e m a l e  p a t i e n t s  
s t u d i e d ,  h o w e v e r ,  h a d  h i g h e r  i n i t i a l  F S H  r e s p o n s e s  a n d
the d i f f e r e n c e  b e t w e e n  t h e  m a l e s  a n d  f e m a l e s  m a y  s i m p l y  
r e f l e c t  t h e  level of i n i t i a l  r e s p o n s e s .
P a r t s c h  a n d  c o l l e a g u e s  ( 1985) h a v e  i n v e s t i g a t e d  8 
m a l e  p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m  a n d  9 
p a t i e n t s  w i t h  s i m p l e  d e l a y e d  p u b e r t y  u s i n g  a r e g i m e n  of 
L H - R H  c o n s i s t i n g  of 5 u g / p u l s e  e v e r y  9 0  m i n u t e s  for 3 6  
h o u r s .  B a s a l  LH c o n c e n t r a t i o n s  w e r e  g r e a t e r  a f t e r  t h e
p e r i o d  of p u l s a t i l e  i n f u s i o n ,  in b o t h  g r o u p s ,  a l t h o u g h
i n c r e m e n t s  in LH to b o l u s  t e s t s  w e r e  r e d u c e d ,
p a r t i c u l a r l y  in t h e  p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  
h y p o g o n a d i s m .  B a s a l  a n d  p e a k  F S H  c o n c e n t r a t i o n s  w e r e  
i n c r e a s e d  in b o t h  g r o u p s ,  a l t h o u g h  i n c r e m e n t s  in F S H  w e r e  
r e d u c e d  in both.
F i v e  p a t i e n t s  in t h e  g r o u p  w i t h  d e l a y e d  p u b e r t y  h a d  
b a s a l  g o n a d o t r o p h i n  a n d  t e s t o s t e r o n e  c o n c e n t r a t i o n s  
w i t h i n  t h e  n o r m a l  a d u l t  r a n g e  a n d  4 had t e s t i c u l a r
v o l u m e s  of 9 m l s  or greater'. F i v e  p a t i e n t s  w i t h  d e l a y e d
p u b e r t y  h a d  i n i t i a l  LH i n c r e m e n t s  > 1 5 m U / L  w i t h  o n l y  o n e
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p a t i e n t  h a v i n g  an i n c r e m e n t  less t h a n  5 m U / L .  T h i s  s t u d y  
w h i c h  c o m p a r e d  a group' of p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c  
h y p o g o n a d i s m  a n d  a g r o u p  of b o y s  w i t h  s i m p l e  d e l a y e d  
p u b e r t y  is b i a s e d  by th e  p r e s e n c e  in th e  l a t t e r  g r o u p  of 
a m a j o r i t y  s h o w i n g  a d u l t  or a l m o s t  a d u l t  h o r m o n e  
p r o f  i 1 e s .
A l t h o u g h  it is not p o s s i b l e  to m a k e  e x a c t  c o m p a r i s o n s  
w i t h  t h e  p r e s e n t  s t u d y  s i n c e  P a r t s c h  et al h a v e  not 
c o m p a r e d  i n c r e m e n t s  in g o n a d o t r o p h i n s  for i n d i v i d u a l  
p a t i e n t s  b e f o r e  a n d  a f t e r  th e  p e r i o d  of p u l s a t i l e  
i n f u s i o n ,  it is c l e a r  f r o m  t h e  d a t a  p r o v i d e d  t h a t  t h o s e  
p a t i e n t s  w i t h  s i m p l e  d e l a y e d  p u b e r t y  s h o w i n g  t h e  h i g h e s t  
i n i t i a l  i n c r e m e n t s  in LH, h a d  r e d u c e d  i n c r e m e n t s  in t h e  
s e c o n d  b o l u s  t e s t  a n d  t h e i r  r e s u l t s  m a y  be in b r o a d  
a g r e e m e n t  w i t h  o u r  own.
D e l e m a r e - v a n  de W a a l ,  V a n  d e n  B r a n d e  a n d  S c h o e m a k e r  
(19 8 5 )  i n v e s t i g a t e d  t h e  r e s p o n s e s  to b o l u s  L H - R H  t e s t s  
( t h r e e  L H - R H  i n j e c t i o n s  of l O O u g / m 21 i.v. at 2 h o u r l y  
i n t e r v a l s )  b e f o r e  a n d  f o l l o w i n g  p u l s a t i l e  L H - R H  i n f u s i o n  
( e i t h e r  l O u g  e v e r y  9 0  m i n u t e s  or 2 0 u g / 1 . 7 3 m 3 e v e r y  9 6  
m i n u t e s  i.v. for 7 d a y s ) .  T h e y  s t u d i e d  p a t i e n t s  w i t h  a 
l a r g e  n u m b e r  of h y p o t  ha  1 a m i c - p i t u i t a r y - g o n a d a 1 d i s o r d e r s  
a n d  d i v i d e d  t h e  p a t i e n t s  i n t o  4 m a i n  g r o u p s :  G r o u p  1
c o n s i s t e d  of 2 g i r l s  a n d  1 boy w i t h  p r i m a r y  g o n a d a l  
f a i l u r e ;  g r o u p  2 of 1 g i r l  a n d  2 b o y s  w i t h  h y p o t h a l a m i c  
d i s f u n c t i o n ;  g r o u p  3 of 11 g i r l s  a n d  13 b o y s  w i t h  v a r i o u s  
c e n t r a l  e n d o c r i n e  d i s o r d e r s  i n c l u d i n g  g r o w t h  h o r m o n e
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d e f i c i e n c y  m u l t i p l e  p i t u i t a r y  h o r m o n e  d e f i c i e n c i e s ,  
d e l a y e d  p u b e r t y  a n d  p a t i e n t s  w i t h  t u m o u r s  of t h e  
p i t u i t a r y  or s u r r o u n d i n g  a r e a ,  a n d  g r o u p  4 , two p a t i e n t s  
w i t h  p u b e r t a l  a r r e s t  of u n k n o w n  o r i g i n .
O n l y  4 p a t i e n t s  of 3 2  ar e  c l a s s i f i e d  as s i m p l e  
d e l a y e d  p u b e r t y  a n d  t w o  of t h e s e  p a t i e n t s  w h o  w e r e  
p r e p u b e r t a l  at t h e  a g e s  of 17.7 a n d  18.2 y e a r s ,  m a y  be
e x a m p l e s  of i d i o p a t h i c  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .  
A l t h o u g h  it is d i f f i c u l t  to d r a w  c o m p a r i s o n s  w i t h  t h i s  
s t u d y  b e c a u s e  of t h e  l a r g e  n u m b e r  of c l i n i c a l  d i a g n o s e s  
w i t h i n  t h e  g r o u p s ,  it. a p p e a r s  t h a t  th e  h i g h  d o s e s  of
L H - R H  u s e d  by t h e  i n t r a v e n o u s  r o u t e  in t h i s  s t u d y
r e s u l t e d  in c o n s i d e r a b l e  a u g m e n t a t i o n  of g o n a d o t r o p h i n  
r e s p o n s e s  to t h e i r  ’t r i p l e  L H - R H  t e s t s ’ . T w e n t y  e i g h t  of 
30 p a t i e n t s  a c h i e v e d  i n c r e a s e d  LH p e a k s  a n d  2 7  of 31
p a t i e n t s  a c h i e v e d  i n c r e a s e d  F S H  p e a k s .
T h e  p r e s e n t  s t u d y  s u g g e s t s  t h a t  t h e  b a s a l  
g o n a d o t r o p h i n  c o n c e n t r a t i o n s  d u r i n g  p u l s a t i l e  L H - R H  
t h e r a p y  a r e  b e t t e r  t h a n  s t i m u l a t e d  l e v e l s  d u r i n g  b o l u s  
L H - R H  t e s t s  in d i s c r i m i n a t i n g  b e t w e e n  d i f f e r e n t  g r o u p s  of 
h y p o g o n a d o t r o p h i c  m a l e s .
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CHAPTER 7
SERUM T EST OS TERONE RESPON SE TO PULSATILE LH-RH THERAPY 
7. 1 ) INTRODUCTION
Previous studies using HCG have suggested that in 
early puberty there may occur in response to rising serum 
gonadotrophin levels, a progressive increase in Leydig 
cell responsiv eness to ci rcu lating LH (Winter, Taraska 
and Faiman, 1972; Josefsberg  et al, 1976). Winter and 
co lleagues (1972) have shown that following 3 daily 
injections of HCG (2000 IU), testosterone increments 
pr ogressi vely rise with advancing pubertal stages.
Bardin et al (1969) compared the testosterone rise 
following HCG (4000 IU daily for 4 days) in 
hypogon adotrophi c males, normal adult males and 
prepubertal boys and incorrectly concluded that patients 
with hypogon adotr op hic hypo gonadism had a fixed defect in 
Leydig cell function. Subsequent studies (Anderson et al, 
1970; Boyar et al, 1973) have shown that more pro longed 
therapy with HCG allows hypogonadotrophic patients to 
achieve normal serum testosterone concentrations. It 
would appear therefore, that the extent of prior exposure 
to go nad otrop hins is important in the immediate Leydig 
cell response to stimul ation by HCG. It was of interest 
therefore to measure the testosterone response to
PROTOCOL
Day 1 Days 2-6 Day 7
i
15 minute [ LH-RH LH-RH
1
1
15 minute | LH-RH
serum sampling | bolus test Infusion serum sampling I bolus test
for LH/FSH I 
1
(240ng/kg/pulse) for LH/FSH I 
1
1 4 it
1
|
w
1
1
1
1
1
< 3 hrs 1 hr ► 
1 
1
1
1
1
■i 3 hrs 1 hr ► 
1 
1
Figure 23 
Study protocol
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pulsatile LH RH therapy in order to see whether a similar 
graded response occured in pubertal boys and to identify 
any differences between the groups of hypogonadal 
patients studied.
7.2) PA TIE NTS AND METHODS
Serum testosterone was measured on 8 of 9 patients 
with del ayed puberty, and all patients with short stature 
and hyp og on adotro ph ic hypogonadism who underwent the 
study des cr ibed in Chapter 5. The protocol for this study 
is therefore the same as that described in the above 
chapter. The protocol diagram is reproduced as figure 23 
for reference.
In view of the wide diurnal variation in serum 
testosterone d em on strate d in Chapter 3, care was taken to 
ensure that blood was withdrawn for testoste rone 
estimation at exa ctly the same time of day, for each 
pat i e n t .
7.3) RESULTS
Figures 24 and 25 show the basal and peak values of 
testosterone in the delayed puberty and short stature 
groups following the period of pulsatile LH-RH therapy, 
as a function of bone age. The results for the patients 
with hy po gonado tr ophic hypo gonad ism are shown in table
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13. It is notable that patients 31 and 32 who both have 
histories of cryptorchidism, had low basal testosterone 
conce ntr ations and poor response to LH-RH therapy. 
However patient 25 who gave no such history failed to 
demonstrate any tes tosterone rise during the study 
per i o d .
Si gni ficant moderate correlation was shown between 
basal values, peak values and increments in testosterone 
with bone age (r=0.5 p<0.05, respectively) following
pulsatile LH-RH exposure. Basal testosterone appeared to 
be lower in the delayed puberty group for a given bone 
age. There did not appear to be any significant 
differences in incremental testosterone rises following 
pulsatile LH-RH infusion in the different study groups.
Tes tos terone values in subjects of bone age >12 years 
were signi fi ca ntly higher than in subjects with a bone 
age of 12 years or less (p<0.05). The testoste rone 
increments following pulsatile LH-RH infusion also show a 
significant difference between patients with bone ages of 
12 years or greater, and those with bone ages <12 years 
(p<0.02). Only one patient in the present study with a 
bone age less than 12 years showed a testost ero ne rise 
following LH-RH infusion.
7.4) DIS CUS SION
The changes seen in the present study, in basal
Patient No Genital Staging Initial Final
Testosterone Testosterone
(nmol/1) (nmol/1)
25 G5P5 T.V. 12/12 9.2 13.2
26 G5P5 T.V. 3/3 2.1 3.3
27 G2P1 T.V. 3/3 <0.5 < 0 . 5
28 G2P4 T.V. 3/4 1.4 6.4
29 G5P5 T.V .4/4 1.5 4.3
30 G3P4 T.V. 10/10 3.9 13.0
31 G2P2 T.V. 3/3 4.8 2.2
32 G1P1 T.V. 1/1 2.4 7.0
33 G2P1 T.V. Ing/j 0.9 <  0.7
34 G5P5 T.V. 0/1 1.6 2.4
35 G3P3 T.V. 1/0 0.9 1.4
TABLE 13
Serum testosterone response to 6 days pulsatile LH-RH infusion 
in men with hypogonadotrophic hypogonadism
T.V. = testicular volume. Ing = inguinal ^ = undescended
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testosterone levels with bone age are very similar to 
those of previous workers, who have shown that 
testosterone con cen tr ations are fairly constant up to 
about 12 years of age, following which a sharp rise 
occurs and continues though the pubertal years. (Winter 
and Faiman, 1972; Sizonenko and Paunier, 1975; Pakarinen, 
Hammond and Vihko, 1979).
Valk et al, 1980) in an early study of pulsatile 
LH-RH admini stration (using 0.025ug/kg i.v. every 2 hours 
for 5 days) investigated 4 males with isolated 
gonadotrophin deficiency. They dem onstrated a significant 
rise in serum testosterone by day 4, when the results for 
the 4 patients were grouped together. Individual results 
are not given. Three of the patients studied had bone 
ages which were advanced by previous therapy with either 
testosterone or HCG and it is not possible therefore to 
compare their data directly with the present study.
Sippell et al (1984) compared the testosterone 
response to i.v. LH-RH, 5ug every 90 minutes for 36 
hours, in 13 males with hypogonadotrophic hypogon adism 
and 5 with delayed puberty. They showed a significant 
rise in serum testosterone in the patients with delayed 
puberty only. However it is clear that the delayed 
puberty group had achieved greater testicular maturation 
since testicular volumes were greater and basal serum 
testosterones were sign if icantly  higher (p< 0.005) in 
this group.The improved testicular response to pulsatile
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LH— RH in the delayed puberty patients may therefore 
reflect the more advanced testicular development in this 
group.
A second paper from the same group (Partsch et al, 
1985) com pared  the testosterone response to pulsatile 
LH-RH ad ministrat ion in 8 men with hypogonadotro phic 
hypogon adi sm and 9 males with delayed puberty. Again a 
significant rise in serum testosterone was found only in 
the patients with del ayed puberty. Only one patient in 
the delayed puberty group failed to show a significant 
testosterone rise and this patient had the lowest 
testicular volume. The hypog onadotrophic hypogonadal 
patients had a lower mean basal testosterone ( mean ± 
S.E.; 30 +11 n g / d l ) compared with the delayed puberty 
subjects ( mean + S.E.; 104 + 40 ng/dl) although the
difference did not reach statistical significance. There 
was also significant over lap of testosterone values after 
pulsatile LH-RH which included particularly those delayed 
puberty patients with lower bone ages and lower 
testicular volumes. This study would also confirm that 
testicular response to a short course of LH-RH is
dependent upon the extent of testicular priming by 
endogenous gonadotrophins. The lack of testicular
response in the hypothal amic hypogonadal patients cannot
fully be explained by the immaturity of testicular 
development in this group and the reason for the 
difference with the present study is unknown.
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Barkan et al ( 1985) studied testosterone levels after 
LH-RH therapy in 4 males with ’p a r t i a l ’ and 4 with 
’c o m p l e t e ’ hypogona dotro ph ic hypogonadism as defined by 
the presence or absence of nocturnal LH pulses in the 
pretreatment period. Three of the 4 men with complete 
gonadotrophin def icie nc y had undetectable basal serum 
testosterone and no patient in this group showed a rise 
in testosteron e at 4 days. Results for 3 of the 4 
patients with partial gonadotrophin deficiency are given 
and all showed a rise in serum testosterone, with the 
greatest rise occ urring in the patient with the highest 
initial concentration.
On the other hand, Wagner et al (1986) compared  serum 
testost ero ne after 10 days exposure to pulsatile LH-RH in 
5 patients with spontaneous night-time LH pulses and 5 
patients without such pulses and failed to show any 
significant differences between the two groups. Despite 
the difference in nocturnal gonadotrophin secretion 
between the groups, there were no obvious differences in 
bone age, testicular volumes or basal serum tes tosterone 
during HCG stimulation tests between the two groups of 
patients and this might explain the similar testosterone 
increments achieved by both groups during LH-RH infusion.
Hawthorne et al (1985a) failed to dem onstrate a 
significant testoste rone rise in 5 hypogona do trophic  
hypogonadal males unde rgoing pulsatile LH-RH infusion. 
Their regimen used a small dose of LH-RH (24ng/kg) given
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2 hourly for 72 hours and this may have been insufficient 
to ade quate ly stimulate the testes. Individual patient 
results are not given, nor are details of testicular 
size. Poor testicular development or function in one or 
more patients might have resulted in insignificant 
testosterone rises for the group as a whole.
D e 1emare-van de Waal et al (1985) studied a group of 
patients with a variety of hypothalamic or pituitary 
disorders which included 4 patients with delayed puberty 
and one with K a l l m a n n ’s syndrome. All patients showed 
significant test osteron e increments but because the 
number of patients in each group is small, further 
interpretation of the results is not possible.
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CHAPTER 8
THE PROLACTIN RESPONSE TO TRH 
8. 1 ) INTRODUCTION
The rel ations hi p between various states of 
hypogon adi sm and the prolactin response to dynamic tests 
remains uncertain, due to previous confli cting reports. 
In the syndrome of isolated gonadotrophin deficiency, 
both intact and att enu ated PRL responses following TRH 
have been des cribed (Antaki et al, 1974; Winters,
Mec klenburg and Sherins, 1978; Yamaji et al, 1977; Spitz, 
Hirsch and Trestian, 1983; Hawthorne et al, 1985b).
Similarly in patients with K1 inefe 1 t e r ’s syndrome, both
normal and ex aggerated  PRL responses to TRH have been
reported (Burman et al, 1975; Spitz et al, 1979). More
recently, Gooren et al (1984) reported impaired PRL 
response to TRH in a group of patients with K a l l m a n n ’s 
syndrome when compar ed with a group of hy pergonadot roph ic 
hypogonadal patients with similar serum testosterone 
concentrations. They postulated a direct relationsh ip  
between end oge nous LH-RH secretion and PRL release.
In order to test this hypothesis and assess the
effect of exposure of the pituitary to exogenous LH-RH, 
the prdlactin response to TRH was measured both prior to 
and following pulsatile LH-RH infusions in patients with
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Day 1 Days 2-6 Day 7
15 min serum
1
1 TRH  |
i
Combined LH-RH
I
15 minute serum 1 TRH
!
1 LH -R H
sampling , bolus pituitary Infusion sampling 1 bolus 1 bolus tes
for LH/FSH 1 test
i
funtion test for LH/FSH j test 1
I
1
1
1
U------
1
. !
!
1
t
1
I
A 3 hrs
i
>1a  1 hr ►
1
1
1
A  2 hrs H  
1 
1
1
A 3 hrs
1
1
1 hr
1
►H 1 hr ►
1
I
Figure 26 
Study protocol
Patient Genital Testicular Chronological
Staging Volume (mis) Age (yrs)
1 G1P1 2/3 14.8
2 G2P1 5/5 15.4
3 G2P1 6/8 15.6
4 G1P1 2/2 15.0
5 G2P1 3/3 14.7
6 G2P1 3/3 14.1
7 G1P1 3/3 15.0
8 G2P2 8/8 14.1
9 G2P2 6/6 14.7
10 G3P2 4/3 15.1
11 G3P3 6/6 16.9
TABLE 14
Clinical details of patients undergoing bolus TRH 
tests (200 ug IV) prior to, and 
following 6 days of pulsatile LH-RH infusion
Bone
Age
(yrs)
12.0
12.5 
12.0 
11.0
13.5 
11.0
13.0
12.5
12.5
13.0
13.0
Peripubertal
boys
Hypogonadotrophic 
Hypogonadism
Pre-LH-RH 
inf usion 
Serum T 
(nmol/I)
1.8
*<0.7 - 19.6)
2.1
*<0.5 - 9.2)
TABLE 15
Post-LH-RH 
infusion 
Serum T
(nmol/1) Significance
5.9
C<0.7 - 30.6) p < 0.02
6.4
« 0 . 5  - 13.2) p<J.05
Serum testosterone concentrations (median and range) 
for the peripubertal boys and hypogonadotrophic males 
prior to and following pulsatile LH-RH infusions.
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delayed puberty and hypogonadotrophic hypogonadism.
8.2) PATIENTS AND METHODS
The serum prolactin response to an intravenous bolus 
injection of TRH (2 0 0 u g ) was measured in 11 pre-pubertal 
and pubertal boys and 7 males with hypogonadotroph ic 
hypogonadism, immediately prior to, and following six
days pulsatile LH-RH infusion (2 4 0 n g / k g / p u 1s e ). The study 
protocol is illustrated in diagramatic form in figure 26.
The clinical details of the p e r i - p u b e r t a 1 boys are
shown in table 14 and the patients with hypogonadotrop hic 
hypogonadism who underwent this study are listed below. 
(Patient numbers, 25-28, 30, 32, 33, table 9)
8.3) RESULTS
All patients showed a rise in mean serum LH measured 
by 15 minute sampling over 3 hour periods immediately 
prior to and at the end of the LH-RH infusions. Both
groups of patients showed significant rises in serum
testosterone conc en trati ons (table 15).
There was consi derable overlap in basal and peak
prolactin responses to TRH between both groups of
patients both before and following the period of
pulsatile LH-RH ad ministr ation (figs 27 - 28). There were
no significant difference s in basal or peak serum
Peri-pubertal Patients
2000 1
c
I 1000 -
u
CJ
cn
Basal Peak
Hypogonadotrophic Patients
2000 1
|  1000 - 
£
a
PeakBasal
F i g u r e  27
T h e  b a s a l  a n d  p e a k  s e r u m  p r o l a c t i n  r e s p o n s e  to 
T R H  ( 2 0 0 u g  i.v.) in p e r i - p u b e r t a  1 b o y s  a n d  
h y p o g o n a d o t r o p h i c  m a l e s ,  p r i o r  to p u l s a t i l e  
L H - R H  i n f u s i o n s .
Peri-puberta l Patients
2000 1
c
2 1000 -  
o
PeakBasal
Hypogonadotrophic Patients
2000 1
«  1000 -
PeakBasal
Figure 28
The basal and peak serum prolactin response to 
TKH (200ug i.v. ) in peri-puberta 1 boys and 
hypogonadotrophic males, during pulsatile 
LH-FH infusions.
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prolactin or increments in prolactin during the TRH tests 
following the periods of pulsatile therapy in either 
group of patients (table 16).
There was no correlation between the changes in
prolactin increments and the rises in either serum LH or
testosterone d e m o n stra te d by both patient groups.
8.4) DI SC USSIO N
There was consider able overlap between the prolactin 
responses to TRH in the group of pubertal boys when 
compared to the males with hypogonadotrophic hypogonadism  
either before or following exposure to pulsatile LH-RH 
administration. Spitz et al (1983) showed that patients 
with con stitutional delay of puberty had, after TRH 
stimulation, a rise above basal in the serum prolactin of
greater than 396mU/l, whereas 9 of 10 patients with
hy pog onadotr ophic hypogona dism had an attenuated 
response. However other workers have reported differing 
responses in isolated gonadotrophin deficiency. Yamaji et 
al, (1977) reported an heterogeneous response in 
untreated males with hypogon adotrophi c hypogonadism. In 
only 4 of 8 such patients was the TRH mediated prolactin 
release blunted. Hawthorne et al (1985b) found no 
significant difference in either basal or maximum 
increment of serum prolactin following TRH between 6 
patients with hyp og on adotro ph ic hypogonadism and 8 normal
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adult males. It would appear therefore, that the 
prolactin response to TRH is variable in hypogonadal
states and the small numbers of patients studied in these 
reports could explain the differences between them.
The relative importance of endogenous LH-RH secretion 
and the sex steroid concentrations in influencing
prolactin remains unknown. Spitz et al (1977, 1979, 1982,
1983) have argued strongly in favour of the steroid
milieu having a major influence. Spitz et al (1982) 
demonstrated that during treatment with HCG, prolactin
release could be restor ed to normal in male patients with 
hypogonadotroph ic hypogonadism. This work, however does 
not differ entiat e between an effect due to stimulation of 
gonadal steroids and a direct effect of HCG which has LH 
activity. Winters, Joh nsonbaugh and Sherins, (1982) have 
shown that the prolactin response to c h 1 orpromazine was
enhanced by HCG or testosterone in 3 of 6 patients with
hypogonadotroph ic hy pogonadism and 10 patients on
long-term replacement therapy with HCG or testosterone
showed normal prolactin reserve using c h 1 orpromazine or 
TRH. On the other hand, Yamaji et al (1977) demonst rated 
reduced prolactin reserve in 4 of 7 patients with
h yp ogonado trophic hy pog ona dism on long-term testosterone 
replacement. In the study of Spitz et al (1983) the
impaired prolactin response in idiopathic
hy pogonadot rophic hypogonad is m compared to pubertal boys 
cannot be exp laine d by altered sex steroid milieu since
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both groups had similar serum testosterone 
concentrations. Elevation of oestradiol is a major factor 
in e s ta blishi ng  prolactin responsiveness in both man and 
the rat (Jaques and Gala, 1979; Spitz et al, 1982) and 
since the major source is from aromatization of 
testosterone, it is unlikely to have been signif ica ntly  
different in the two groups studied by Spitz et al in 
1983.
Gooren et al (1984) compared the prolactin response 
to TRH in patients with K a l l m a n n ’s syndrome and a group 
of h y p er gonado tr ophic hypogonadal patients having 
comparable serum tes tosterone concentrations. They 
demonst rat ed a direct relationship between
LH-RH-stirau1 ated gonadotr ophin concentrations and the 
prolactin response to TRH. They also reported that the 
prolactin response to -TRH was greater following a 4 hour 
infusion of LH-RH in 8 of 9 normal subjects.
This study led the authors to postulate that LH-RH 
itself may have an effect on prolactin secretion. Herbet 
and Rennels, (1977) reported a stimulatory effect of low 
concentrati ons (0.08 - 8ng/ml) of LH-RH on prolactin 
release in a clonal strain of pituitary cells, while at 
higher conce ntrat io ns an opposite effect was observed. 
However, Sandow and Robyn (1973) found a decrease of 
prolactin after i.v. or subcutaneous or intrapituitary 
injections of LH-RH in male rats. In man, no change of 
prolactin levels was measured after adm inistration of a
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bolus of LH RH, even after short-term
oe str ogen/p ro ge stero ne  pretreatment (Debeljuk, Arimura 
and Schally, 1972? Kastin et al, 1973). Gooren et al
(1984) have postulated that the mechanism of LH-RH 
regulation of prolactin release is indirect, through an 
inhibitory effect on dopamine secretion into the 
hypophoseal portal system. In the- median eminence an 
axo-axon ic contact between LH-RH and dopamine-neuronal 
system has been reported. (McNeill and Sladek, 1978) 
Increased dopaminergi c activity in the median eminence is 
associated with an inhibition of LH secretion (Lofstrom
et al, 1976) via a neuronal interaction between LH-RH and 
dopamine (Judd, Rakoff and Yen 1978; Quigley et al, 1979) 
and Gooren et al (1984) have suggested LH-RH tone might 
lead to decre ased dopamine secretion, res ulting in 
decreased inhibition of prolactin synthesis and secretion 
from the lactotroph.
A further mechanism by which LH-RH can influence
lactotroph activity has been proposed by Nikolics et al
(1985) who identified a peptide sequence at the
c a r b o x y - t e r m i n a 1 of the LH-RH precursor which can 
suppress prolactin.
Hawthorne et al (1985b) compared the prolactin
increments to TRH stimulation in patients with
hY P°gonado trophic hypogon ad is m and normal controls. It is 
interesting to note that the three patients with
hy pogonadot rophic hyp ogon adism  who had not received LH-RH
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pulsatile therapy within 3 weeks of the study, had the 
smallest increments.
More recently Spratt et al (1987) have demonstrated 
that serum prolactin concentrations were higher in 
hypogonado tro phic hypogonadal patients with detectable LH 
pulses than in those patients with complete absence of 
endogenous pulsatility. This work lends further support 
to the theory that physiological LH-RH secretion 
influences prolactin release.
If indeed LH-RH stimulates prolactin release either 
directly or indirectly, an enhanced secretion in response 
to TRH would have been expected following prolonged 
pulsatile administration. A significantly greater effect 
might have been pr edicted in the patients with complete 
hypogona dot rophic hyp ogo nadis m and thus absolutely 
deficient in LH-RH prior to treatment. This study has, 
however failed to demonstrate any differences in 
prolactin release between the two patient groups either 
before or following pulsatile LH-RH administration and no 
changes within either group following therapy. It would 
appear therefore that exogenous LH-RH exerts no influence 
on lactotroph activity. The present work, however does 
not exclude the po ssi bility that endogenous prolactin 
synthesis and release could influence prolactin secretion 
by indirect mechanisms.
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PHAFTER 9
INFERTILITY TR EATMENT  WITH PROLONGED PUL SATILE 
LH-RH A D M I N I STRAT IO N IN HYPOGONADOTROPHIC 
HYPOGONADISM
9.1) INTRODUCTION
Jacobson and co lleagues (1979) were first to report 
the use of portable infusion pumps for delivering LH-RH 
in a pulsatile manner. More recently, chronic pulsatile 
infusions of LH-RH have been used to induce all the 
changes of puberty in men with hypo go nadotrophic 
hypogonadism including spe rmatogenesis (Hoffman and 
Crowley, 1982; Skarin et al, 1982; Morris et al, 1984;
Santoro et al, 1986). In order to obtain experience of
this tec hnique for inducing fertility and to attempt to 
predict patients likely to benefit from this therapy,
hypogonadal adult males who expressed a wish to achieve 
fertility were offe red pulsatile LH-RH as a first-line 
t r e a t m e n t .
9.2) PAT IE NTS AND METHODS
Six adult males were subsequently treated. All
patients had failed to undergo puberty sp on taneously by
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the age of 18 years and had low circulat ing
concentrations of gon adotrophins and testosterone. 
Combined anterior pituitary function testing, as 
described in the methods section, had demo nstra ted normal 
basal and stim ulated  levels of growth hormone, cortisol, 
TSH and prolactin in all patients with the exception of 
Patient 1 who had previous ly been diagnosed as having the 
cytomegalic variety of congenital adrenal hypoplasia. 
This patient was on standard cortisol replacement
treatment (hydrocortisone 20mg mane and lOmg nocte) at 
the time of the present study. Skull x-rays and
chromosome analysis was normal in all cases. Patients 2,
3, and 6 had life-long anosmia.
The nature of the treatment protocol and details of 
alternative therapy with the gonadotrophins HCG and HMG 
(Pergonal) were ex pla ine d to each patient prior to 
obtaining informed consent. Testosterone replacement 
therapy was withdrawn at least 6 weeks prior to 
commencing pulsatile LH-RH treatment.
In patients 2 to 6, treatment was started at a dose 
of 5ug LH-RH/pulse, each pulse occuring every 90 minutes. 
Patient 1 was co mm enced on a dose of 2.8ug/pulse 
increasing in a stepwise fashion to a maximum dose of 
22ug/pulse. Treatment was continued for 8 to 34 weeks 
(median 10.5 weeks).
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9.3) CASE HIS TO RIES AND INDIVIDUAL PATIENT RESULTS
The serum testosterone, LH, and FSH responses to 
prolonged, pulsatile LH-RH infusion for individual 
patients are illustrated in figures '29 to 34.
9.3. 1) Pat ient 1
This patient has been the subject of several case 
reports; Uttley (1968), Hay et al (1981) and Cohen et al 
(1982).Two of his 8 male siblings had died in the early 
neonatal period and one male sibling had died at 11 days. 
Post mortem exami nation of this last child revealed 
cytomegalic adrenocortical hypoplasia.
In this patient h y p o a d r e n a 1 ism was diagnosed at 5.4 
years and he was treated initially with cortisone acetate 
and f 1u o d r o c o r t i s o n e . After an otherwise uneventful 
childhood he was rea ss essed  at 15.3 years and found to be 
below the 3rd percentile in height; he had pre-pubertal 
genital and pubic hair staging with testicular volumes of 
4 mis bilaterally. Bone age was 11.5 years. When aged 16 
years he was treated for 5 months with HCG and an attempt 
to induce puberty with adrenal androgen admin istra tion 
was made at the age of 23 years. At 24 years injections 
of testosterone  esters were commenced and subse quently 
stopped 8 weeks prior to the present study.
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Patient 1 was treated for a total of 16 weeks with 
increasing doses of LH-RH as shown in figure 29. Serum 
gonadotrophins remain ed low throughout the treatment 
period. Basal serum tes tosterone was measured at 7.6 
nmol/1 and the concent ration of testosterone fell in an 
exponential fashion during  the subsequent weeks reaching 
the limit of assay detection by week 10. This would 
reflect the loss of exogenous testosterone following 
withdrawal of Sustanon (Organon Labs Ltd, Cambridge.) 8 
weeks earlier. At no time during the treatment period 
were sperm det ec ted in ejaculate and there was no change 
in testicular volume. These results dem onst rated a 
failure in gonadotroph response to pulsatile LH-RH 
administration over a wide dose range and the treatment 
was therefore stopped. The patient decided to postpone 
further attempts at inducing fertility and he was 
restarted on tes tosterone  replacement therapy.
9.3.2) Patient 2
This patient presented at 19.5 years with delayed 
pubertal development, and a history of lifelong anosmia. 
Pubertal develop ment was G2 P2 and testicular volume was 
6 mis bilaterally. He defau lted from follow-up but was 
re-referred at age 25.7 years when he was started on 
monthly injections of testosterone esters. This therapy 
was also stop ped 8 weeks prior to the present study.
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Patient 2 underwent pulsatile LH-RH infusion for a 
total period of 34 weeks. Basal gonadotrophin
concentrations were undetectable throughout the 
pretreatment sam pling  period. The basal testosterone of 
9.2 nmol/1 again ref le ct ed the recent withdrawal of sex 
hormone rep lac em ent therapy. Following commencement of 
LH-RH therapy there was a rise in serum gonadotrophins by 
week 1 with FSH rea chi ng a peak at week 2 while LH 
continued to rise ach ie ving s u p r a - p h y s i o 1o g i c a 1 levels by 
week 4 and peak ing  at week 6. Thereafter the
gonadotrophin levels declin ed  into the normal adult range 
(fig 30).
Serum tes tost erone also rose gradually until week 6 
falling to low normal values by week 9. From week 28
however, there was a gradual decline in LH and
testosterone despite increasing the dose of LH-RH
adrai nistered.
Analysis of seminal fluid showed no sperm present 
prior to therapy. Sperm became detectable at 4 weeks
achieving a peak count of 6 million/ml at 12 weeks. 
Thereafter sperm count ranged from 3 to 5 million/ml 
until week 32 when the count fell to 1.5 million/ml. As 
part of a separate study the patient was given a standard 
bolus intravenous injection of LH-RH at this time. This 
resulted in an immediate urticarial reaction at the site 
of previous sub cuta neous injections. It was concluded 
that the patient had developed sensitivity to the
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infusion fluid and treatment was stopped. He was 
subsequently treated by HCG (1500 units three times 
weekly) and HHG (75-150 units twice week 1y ).Sperm density 
again increased to 9 million/ml a further 8 months later 
at which time his wife conceived and subsequently gave 
birth to a healthy male child.
9.3.3) Pat ient 3
Patient 3 was referr ed at the age of 23.1 years 
because of lack of pubertal development. At presentation 
genital develop me nt  was G1 P3 (female hair distribution), 
testicular volumes 3mls bilaterally. Although his sister 
had pr ev iou sly  been dia gn os ed as a case of K a l l m a n n ’s 
syndrome he had refused investigation until this time. 
Following di agn osis he was started on testosterone 
replacement therapy which was continued for 10 months 
until it was stopped 6 weeks before entry into the 
present study.
This patient co ntinued pulsatile LH-RH therapy for a 
total of 8 weeks at which time he took up a manual form 
of employm ent  and found wearing the syringe driver 
imposs i b l e .
Serum gon adotro ph in s rose rapidly reaching peak 
co nce ntrations on week 5 of treatment with LH-RH. Despite 
achieving LH and FSH levels above the normal adult range 
serum tes tos tero ne  rose only marginally from a baseline
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of 4.8 to 7.8 nraol/1. (fig 31). No ejaculate was produced 
during the time of the infusion. Treatment with HCG and 
HMG was the reafter  started and continued for 16 months. 
Despite increasing the dose regimen from HCG 5000 units 
twice weekly plus HMG 75 units three times per week to 
HCG 5000 units and HMG 150 units thrice weekly a maximum 
sperm density of only 2 million/ml was achieved and the 
patient remained infertile. The couple were referred for 
artificial insemination by donor.
9.3.4) Pat i en t 4
Referral of this patient for investigation of delayed 
pubertal develo pment was made at the age of 23.1 years. 
There was no family history of hypogonadism and the 
p a t i e n t ’s sense of smell was intact. Following diagnosis 
of h y p og onadotr op hic hypo gonadism treatment with Sustanon 
was started and continued for 12 months before entry into 
the present study.
Pulsatile LH-RH therapy was administered for 9 weeks 
when treatment was ceased  because it bacame difficult for 
the patient to continue wearing the pump and undertake 
the manual tasks required of him while working in the 
family dem olition  business.
Basal g o na dotrop hi ns were undetectable throughout the 
initial sam pl ing period and rose to s u pra— physiological 
levels on week 2 (fig 32). The testosterone
127
concentrations fell from 5.9 nraol/1 to 1.2 nmol/1 during 
the infusion period (Sustanon had been withdrawn 7 weeks 
before this investigation).
Ejaculate prior to treatment failed to show the
presence of sperm. By week 6 of LH-RH therapy the patient 
was unable to produce further ejaculate. Following 
failure of this therapy an attempt at testicular biopsy 
was made. U n f o r tu nately  mainly epididimal tissue was 
obtained and it was not considered justified to repeat 
this procedure.
Combi ne d therapy with HCG and HHG was started some 19 
months later when the patient again expressed a wish to 
attain fertility. Despite treatment over a 16 month
period, monthly  sperm counts showed no significant rise 
and therapy was abandoned. He and his wife have now 
applied for adoption.
9.3.5) Pat i ent 5
Patient 5 was referred at the age of 23.4 years 
because of failure of development of secondary sexual 
c h a r a c t e r i s t i c s . There was no significant family history 
and no anosmia. Pubertal development at presentation was 
G1 P2 with tes ticular volumes of 4mls bilaterally. 
Testosterone replac ement therapy in the form of
intamuscular injections of Sustanon was given for a total 
of 23 months and withdrawn 8 weeks prior to LH-RH
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infus i o n .
The res ponse  to pulsa tile LH-RH infusion therapy is 
illustrated in figure 33. Again a peak gonadotrophin
response o c c urred at week 2 after which time the
concentrat i ons of LH and FSH fell back to more
physiological levels. At week 9 the patient developed an 
abscess at the infusion site and gonadotrophin
concentrations fell, only to rise again, following 
resiting of the needle, to a second peak after a further 
2 weeks.
Serum testos te rone rose from a basal level of 1.5
nmol/1 to 4.3 nmol/1 at the end of the first week. During
the entire treatment period the testosterone
concentration never achieved  normal adult levels and no 
sperm were identified on semen analysis. Treatment was 
stopped at the end of 12 weeks because treatment
interfered with his work as a welder. He was lost to 
follow up for 5 months and then restarted on testosterone 
replacement since he no longer wished to become fertile.
9.3.6) Patient 6
This patient was ref er red initially in 1970 at the 
age of 25.3 years when he was found to have failure of 
pubertal devlopment, an undescende d right testis and an 
atrophic left testis. A diagnosis of hy pogonad otrophic 
hypogonadism was made on the basis of low serum FSH and
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testosterone concent rations . He was found to be 
azospermic on several semen analyses. He was given a 
short course of HCG in an attempt to encourage descent of 
the right testis and was referred for orchidopexy. A 
right or ch i d e c t o m y  was however performed on an atrophic 
testis. No hist ol og y on this organ was reported. The 
patient was then com m e n c e d  on testosterone replacement
therapy and lost to follow up until 1986 when a history
of lifelong an osmia was obtained. He was reinvestigat ed 
prior to startin g pulsatile LH-RH treatment which was 
continued for only 6 weeks.
Serum g o n a d o t r o p h i n s  rose steadily during the first 5 
weeks of treat ment before plateauing at significantly
elevated c o n c e n t r a t i o n s  of both LH and FSH. Testosterone 
rose from 1.6 nmol/1 to 4.4 nmol/1 during the treatment 
period and the patient remain ed azospermic (fig 34). On 
week 8 the patient d e v e lo ped an abscess at the infusion 
site req uir in g admission to his local general hospital. 
It was then de cided to stop treatment because the hormone 
response s u g g es ted poor testicular function. Sustanon 
injections were resta rt ed and no futher attempts to
induce fertility have been made.
9.3.7) The value of stimulation tests in predicting 
bio chemical outcome of pulsatile LH-RH therapy.
All patient s und erwent standard LH RH
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stimulation tests prior to pulsatile therapy in an
attempt to assess the h y p o t ha lamic—pit ui tary— testicular 
axis. The results of these investigations are illustrated 
in table 17. The gon ad otrophi n responses to LH-RH tests 
were very variable, a finding which is well recognised in 
patients with hypo g o n a d o t r o p h i c  hypogonadism (Bell et al, 
1973). The bolus L H — RH tests did not predict the outcome 
of prolonged pulsat ile therapy and this finding is in
agreement with the results of other workers. (Morris et 
al, 1984; A b d u lw ahid et al, 1985) The bolus LH— RH test 
correctly pr edicte d the lack of gonadotrophin response in 
patient 1. However, patient 6 who also had a very flat 
response to a bolus dose of LH-RH, maintained an 
exaggerated rise of LH and FSH during treatment. 
Pulsatile infusion of LH-RH has been shown to increase 
pituitary g o n a d o tr op hin reserve, (Yoshimoto et al, 1975) 
thus e xp la ining  the inability of bolus tests to predict 
gonadotrophin release after more prolonged exposure.
There is no clea rly defined normal response to HCG 
stimulation tests and many different protocols are used. 
However, it is usually accept ed that a rise of serum
testosterone into the normal adult range during the test
indicates normal testicu lar function. Only patient 5 
fulfilled this criterion. Despite this, his testosterone 
rose to a maximum of only 5.5nmol/l during treatment. 
Santoro et al (198G) have shown that a subthres hold dose 
of LH-RH ( l O n g / k g ) can result in a rise of gonadotrophins
HCOa a f-
3 a 22 o
= 2 a
a2O
tov H
3 00s o>«a a 2to.X 002< < a O2 s H 2
zr*a •—t2 22 2 2 D;Xo o 2 —1 rH< 22 a H a oo2 o < s aQ 2to< Ha 2 2 a—IO a aC-HO aa 3'< 2 < —to2;O a _,
a 2 a a a05a0.aXo <2 s ai-l2 a2 aa *—.
z 2< aa a2 —■2 aa 2H 22 aa oH >
oaa a< <a a2 Cm r™1aa 2t-HaCOH J<o m2 <
— CO r“<
5»
a,< < —z M COto Cm Uo •
H
2z H1 2 -3CO a <a H co r: ■< COto 2 CO u, ■a ZM 1H< aCOa <2 w n:a a. -2 ,
a < o a
ato
o  to
o
UJ
r- •J3 J aJ
CO \ _3 2^
o <
o r-> H Q 23
cz CJ 51 O o rHU-. J uc 51 21
\ H 2 2 OC
-0 IjJ o uc
co zz CO o C-H
< 21 r^ U-
21 CD C\J r^ <
CO2 r\J
2 to to CO to a 15
CO to a 2 a a < H
H< O
T
e
s
t
s
 
of
 
tu
e 
p 
j 
t
u
. t
ai
 
y-
 
le
s 
I 
ic
ul
ar
 
ax
is
 
pr
io
r 
to 
p
r
o
l
o
n
g
e
d
 
p
u
l
s
a
t
i
l
e
 
Ll
l-
Hl
i 
th
er
ap
y 
an
d 
o
u
t
c
o
m
e
 
of
 
t
r
e
a
t
m
e
n
t
.
131
into the norma 1 adult range without adequate testosterone 
stimulation. However the dose of LH-RH used in our
patients was much greater than lOng/kg and resulted in 
supraphysio1ogica 1 serum levels of gonadotrophins. 
Undertreatment cannot therefore explain the poor 
testicular resonse to pulsatile therapy in this patient. 
Patient 2, on the other hand did not quite achieve
physiological test os terone concentrations during his HCG
test. He did however show a rapid rise of testosterone 
into the mid-adult  range during pulsatile therapy. In 
this small series of patients, therefore, neither the 
LH-RH nor the HCG tests were able to adequately predict
the biochemical response s to prolonged pulsatile LH-RH 
exposure.
9.4) DIS CUS SION
9.4.1) The outcome of prolonged LH-RH therapy.
Unlike previous workers who have reported ready
acceptability of pr ol onged therapy with LH-RH, (Morris, 
1986; Skarin et al, 1982) the patients in this series
found the tr eat ment intrusive and in several cases 
incompatible with a manual occupation. In addition 2 
patients de v e l o p e d  abscesses at needle sites, in one case 
requiring hospital admission. One patient developed a
hypersensitivity reaction to the gonadotrophin
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prepar ati on which was similar to other cases described in 
small series of patients receiving prolonged treatment 
and the refore sug ge st ing that this may occur commonly 
after ext en de d sub cuta neous treatment. (Morris et al, 
1984; Santoro et al, 1986)
With the exception of patient 1, there was a
dis cernible rise in serum gonadotrophins by the end of 
the first week of LH-RH treatment. In patients 3, 4, and
5, peak LH levels were achieved by the second week of 
treatment. The rise of LH in patient 2 was slower with 
maximal con c e n t r a t i o n s  occ urri ng  on week 6. Patient 6 who 
had one atrophic testis showed a gradual rise in
gonadotroph ins until week 5 and he showed no subsequent 
fall thereafter. The decrease in LH after the initial 
stimulation has been a ttribut ed  by previous workers to 
the feedback inhibition of testosterone. (Hoffman and 
Crowley, 1982) In agreement with this hypothesis would be 
the results for patient 6 who acheived a testosterone 
concentration of only 5 nmol/1 after 8 weeks of therapy
and who d e m o n s t r a t e d  a co nti nued rise in gonadotrop hins
which were main ta ined at supraphysiological levels. It is 
interesting to note however, that LH stimulation and 
supression o c c ur red in patient 4 who had falling levels 
of tes toste ro ne  durin g the treatment period and in 
patient 5 who had only a very modest rise in testosterone 
during the initial weeks of therapy. This may indicate 
that there is a short feedback loop at the level of the
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pituitary cells; a phy siological down regulation in 
response to pulsatile LH-RH exposure.
The serum testosterone  response to LH-RH therapy was 
also variable with only patients 2 and 3 showing a brisk 
rise in response to stimu la ted LH concentrations. This 
would be in agreement with the results of Morris et al 
(1984) who were able to demonstrate a te sto ste rone rise 
in response to increasing gonado tro phin con ce ntrati on s in 
only 3 of 10 patients with hy po gonadot ro phic 
hy po gona d ism.
9.4.2) The case of congenital adrenal
hypoplas i a .
Cyt om eg alic adrenocort ical hypoplasia is a rare 
X-link ed disease a s s o cia te d with h y p ogo na dotroph ic  
h ypogo na di sm (Brook et al, 1973; Sperling, Wolfsen and 
Fisher, 1973; Kelly et al, 1977; Black et al, 1977; 
Richards et al, 1978; Hay et al, 1981). A report by Kruse 
et al (1984) has sugge sted that a hypothala mi c lesion is 
re sp onsi bl e for the hypogonadal state and that low dose 
pu lsatile LH-RH therapy might be of value in initiating 
pube rty  in such patients. The patient in the present 
study, however, failed to show any increase of serum LH, 
FSH or te st ost erone in response to gra dually increasing 
doses of LH-RH given over a 16 week period.
Kruse et al adm i n i s t e r e d  LH-RH intravenously at a
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dose of 5ug/pulse over a period of 26 hours to 2 patients 
with congenital adrenal hypoplasia. They inferred from
their data that a significant rise of serum LH and FSH 
oc cur re d in one patient and a significant rise in FSH 
alone occurred in the second patient. The changes
d e m o n stra te d however were small. Furthermore, during 
LH-RH infusion they measured serum gon ado trophin
c on ce n t r a t i o n s  half an hour after each pulse; a time when 
peaks would be expected. They therefore compared mainly 
peak c o ncentr at io ns during infusion with peak and trough 
c o n c e ntra ti on s prior to infusion. The data is therefore
unconv incing.
A more severe degree of hy pogonadism in our patient 
might, however, explain differ ences  between these 
studies. Our patient had low basal gon adotr ophin
c o n c e ntra ti on s and ad mi ni strati on  of i.v. LH-RH failed to
evoke LH or FSH secretion to within the normal pubertal 
range. The patients of Kruse et al had pubertal 
gon ado trop hi n levels which rose into the normal adult
range following lOOug LH-RH given intravenously.
A further difference  between the studies was the mode 
of de li ve ry  of LH-RH. Since subcutaneous therapy has been 
shown to be eff ective at doses less than 22 .4u g/pul se 
(Valk et al, 1980; Morris et al, 1984; Santoro et al, 
1986) we do not believe that this explains the lack of 
response of our patient.
Prior therapy with te stosterone esters in our patient
13b
with congenital adrenal hypoplasia may initially have 
inhibited the response to low dose pulsatile treatment 
with LH-RH (Sawin et al, 1978; Lipsett, 1979). However no 
such inhibitory effect was observed in patients 2 and 4 
with hyp og onadotr op hic hypogonadism.
The lack of LH and FSH response in our patient with 
congenital adrenal hypoplas ia  suggests either a 
diminis he d pituitary gon adotrop hi n reserve or decreased 
ability to secrete FSH and LH in response to LH-RH. Hence 
it is possible that patients with this condition have a 
pituitary defect.
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CHAPTER 10
EV ALUAI QN  OF HUMAN CHORIONIC  G O N A D O T R O P H I N  (HCG) 
THERAPY IN BOYS WITH DELAYED PUB ERTY
10. 1) INTRODUCTION
F o l l ow in g the initial investigations involving 
pu lsatile a d m i n is tr ation  of LH-RH all boys were 
re a s s e s s e d  at the endo crine clinic 6 weeks later. After 
full discuss ion with each boy and his parents a decision 
was taken either to pursue an expectant policy or to
induce puberty with a 6 month course of injections of
HCG.
Since Dorff (1940) first de scribed the growth 
p ro m o t i n g  effects of HCG, several authors have describe d 
its effect on the development of boys with 
c o n s t i t u t i o n a l l y  short stature and de layed puberty 
(Dorff, 1942; Reiss et al, 1965; Van den Bosch et al,
1982). However, little interest has been shown in the
factors which might influence response to such treatment, 
and the use of a control group to help identify and 
q u a n ti ta te the acc eler ation  of pubertal dev elopm en t and 
height veloci ty has never been reported. Futhermore, the 
effect of such therapy on the final height outcome of 
tr eated patients has never been ad equately assessed.
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In view of these short comings in the literature, it 
was deci ded to review retrospe ct ively all patients 
tre ate d over the previous 4 years with HCG and to study 
p r o s p e c t i v e 1y all patients referred for investigation of 
pubertal delay.
10.2) PATIENTS AND METH ODS
C as e-n ote s for all patients who had atten ded the 
Endoc rin e Clinic for investigation of short stature or 
d el ayed puberty between the years 1979 - 1987 were
reviewed. All patients who had had careful serial 
m easur em en ts at 3 monthly intervals, of height and sexual 
ma tu rati on  by one of two obser ver s (D.G. or H.N.C.) were 
selected. Attempts were made to recall all selected 
patients in order to de ter mine present height and bone 
a g e .
Fifty males who receiv ed  HCG therapy either in the 
previous 4 years or du ring the study period were 
reviewed. A further 30 patients who declined  treatment 
acted as a control group.
Bone ages were asses se d r e t r o s pecti ve ly by one person 
who had no knowledge of the p a t i e n t s ’ clinical status. 
The TW2 method of Tanner et al (1975b) was used for bone 
age estimat ion and final height esti ma tions were made by 
the method of Tanner et al (1975).
Chronological Height SDS Skeletal
age (yrs) for age age (yrs)
Treated
Group Median 15.2 -3.02 12.0
Range
n=50 13.3 - 17.8 -5.35 to +1.5 9.5-14.0
Control
Group Median 15.0 -3.42 12.5
n=28 12.4 - 17.5 -5.16 to +0.36 7.0-13.6
TABLE 18
Clinical characteristics of the treated and control
Genital stage 
G1 G2 G3 unknown
n=
20 22 4 4
n=
9 12 5 2
patient groups
Height SDS = Height standard deviation score. There are no significant 
differences in age, height SDS, or skeletal maturity between the groups.
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10.3) RESULTS
10.3.1) C h a ra cteri st ics of control and treated groups
Table 18 summari ses the main cha ra cteris ti cs of the 
two groups of patients. The chronological ages and the 
height standa rd dev iation scores (SDS) of the two groups 
were not sign if ic antly  diffe ren t (p>0.05). There was also 
no signific ant differe nc e in skeletal ages between the 
groups (p>0.05). However, skeletal age delay
(chronological age - skeletal age) was shorter in the 
control group r e f l ectin g the fact that this group
co n t a i n e d  more patients who had entered puberty at the 
start of the study. In order to take account of this 
difference, results were compared between patients at 
similar genital de ve lopment when this was conside re d 
appropri a t e .
10.3.2) Pubertal stag ing data
Accurate pubertal st aging data is avail able for 45 of 
50 patients who recei ved HCG therapy and for 25 of 28 
pa tie nts in the control group. Figure 35 shows the 
chan ges  in genital stagin g during 6 months of HCG therapy 
in the treated group and during the comp ar able time 
interval in the control group. Forty four of the 45
G5 n
G4
Genital
stage
G3 -
G2 -
 • Control
 •--------  Treated
Gl -J
Figure 35
Changes in genital staging of peri-puberta 1 
boys with short stature / delayed puberty 
during 6 months therapy with HCG and during 
the comparable time in the control group of 
untreated boys.
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patients in the tre ated group achieved either genital 
stage 3 or 4 by the end of the treatment period. The 
greatest advances in genital developome nt therefore 
oc cur r e d  in the patients who were pre-pubertal prior to 
the therapy; most patients in stage G1 advan ce d 2 or 3 
stages. On the other hand, of the 4 HCG treated patients 
at G3 development, genital staging remaine d unchanged in 
1 and advance d only one stage to G4 in the remainder.
The pattern of pubertal change in the control group 
durin g the compara ble 6 month period is quite different: 
Patient s either rem ai ned unchanged or progress ed only 1 
genital stage except for one patient who went from G3 to 
G5 development.
10.3.3) Testicu lar volumes
Testic ula r volumes, immediately before and after 
th erapy are known for 43 of the 50 treated patients and 
in 27 of 28 control patien ts for the eq uivalent time 
per i o d .
Te sticular  volumes increased in all but 2 patients 
with HCG therapy from a pre -treat me nt median volume of 
5.0 mis (range l-12mls) to 9.0mls (range 
4 - 1 5 m l s )immediately after HCG. During a comparable  period 
te sticular  volumes in the control group increased from a 
median volume of 6.0mls (range 2-10mls) to 9.5mls (range 
4-20mls). Two patients in the control group showed no
Mean
testicular
volume
(mis)
20 n 
1 8 -  
1 6 -  
14-
12 1 
10 -]
8 -
Ii
6 -  
4 -  
o _
0 J
i i
Control
Treated
F i g u r e  36
C h a n g e s  in t e s t i c u l a r  v o l u m e  of p e r i - p u b e r t a  1 
b o y s  w i t h  s h o r t  s t a t u r e  / d e l a y e d  p u b e r t y  
d u r i n g  6 m o n t h s  t h e r a p y  w i t h  H C G  a n d  d u r i n g  
the c o m p a r a b l e  t i m e  in t h e  c o n t r o l  g r o u p  of 
u n t r e a t e d  b o y s .
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change in testicular volume during this time.
Figure 36 illustrates the changes in testicular 
volumes during the study in the two groups. There is 
conside ra ble variation in testicular growth during the 
study period and because of the small numbers of patients 
at each initial testicular volume, it is difficult to 
d e m o ns tr ate an effect of HCG on testicular growth with 
this d a t a .
10.3.4) Height veloc it y data
Information on height velo citie s during HCG treatment 
and in the 3 month periods immediately before and 
following therapy was ava ilable on 40 boys. Similar 
information on growth veloc ities over co mp arable time 
intervals during the first year of study was obtained for 
the control group. Releva nt growth data were not 
av ail able for 2 control patients for the second study 
period and for 3 patien ts durin g period 3.
Five patients treated with HCG were growing at rates 
>7.0cms/yr during the initial 3 month period and may have 
al re ady been e st ab lished in a pubertal growth spurt prior 
to therapy. One of these patients showed decrease d growth 
veloc it y during the following 6 months, growth in one 
patient rem ained  unchanged, while 3 patients showed 
increased growth during HCG therapy. All patients growing 
initially at < 7.0cm/yr showed marked acceler ation in
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growth (pre-therapy median growth rate 3.9cm/yr [range 
0 - 6 . 6cra/yr] increasing to a median velocity of 12.7cm/yr 
[range 8.9-16.8  cm/yr ] ) (Fig 37), with subsequent 
deceler at ion of height velocity in the 3 month period 
immediately following therapy (median 6.0cm/yr [range 
0 - 1 2 c m / y r ]).
Four patients in the untreated group had initial 
growth velocities > 7.0cm/yr and all showed decreased 
growth during  the subsequent 6 months. Of the re mai nin g 
24 patients in this group gro wing at < 7.0cm/yr, 4 had
re du ced velocities in the following 6 months, in 2 growth 
remained esse nt ially unchanged, in 16 height velocity 
increased and data were not available on 2 (Fig 37).
The annual height ve lo cit ies during the first year of 
the study for the two groups of patients on which results 
are available are shown in table 19. The data is shown 
s e p a ra te ly for each genital stage since, clea rly the
annual growth velocity in the control group is dep endent 
upon the pubertal de velopment of the patients. The
results for the untreat ed  patients illustrate this; the
median height velocity for untreated patients who were 
pre-pubertal at the start of the year was 5. lcm/yr 
increasing to 7.5cm/yr at G2 development and 8.4 cm/yr 
for those patients in stage G3 puberty. In the treated 
group the annual height veloci ty appears to be 
independent of pubertal staging with median height 
velo ci ties for genital stages 1 to 3 of 8.6, 8.3 and
Annual Height Velocities (cm/yr)
Genital stage 
G1
Treated group
Median 8.6 
Range 6 - 12.1
Control group
Median 5.1 
Range 3.6 - 6.4
G2 Median 8.3 
Range 4.5 -  12
Median 7.5 
Range 4.5 -  10.8
G3 Median 8.3 
Range 5.7 - 13
Median 8.4 
Range 5.8 -  12
TABLE 19
Annual height velocities in the treated and control 
during the year of study
Signif icance
p < 0.001
p > 0.05 
p >0.05
groups
Each group is sub-divided according to genital stages of the patients at 
the startof the year. P values relate to comparisons between control and 
treated groups.
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8.3cm/yr respectively. Therefore pre-pubertal patients 
showed the greatest and most significant response to HCG 
th erapy in terms of increased growth rates.
The annual height velocit ies for the HCG treated 
grou p are con si de rably lower than the height velocities 
me asu re d during the treatment periods, r eflect in g the 
rapid accelera tion and deceleration  in growth which 
oc cu re d during and after treatment.
10.3.5) Effect of HCG treatment on skeletal age and 
final height outcome
Bone age es timations are available on 40 patients 
prior to and following HCG therapy. In 13 patients the 
e stima ti on s were made at the begin ning and end of the 
year du ri ng which treatment was given. In the remainder, 
the second bone age estimat ion was made 0.9-7.8years  
after the initial x-ray and 8 of these patients have 
ac hi ev ed bone ages of 18yrs or greater. Table 20 compares 
the actual final heights achieved by these 8 patients 
with the predi cte d heights from the initial bone ages. 
Only one of these 8 patients who reached adult height 
du rin g the follow up period, achieved a height greater 
than that predicted prior to therapy. Figure 38 shows the 
change in predi ct ed adult height including the 
information for the patients  in whom the final height is 
known, and compares this data against initial skeletal
Initial Height at first Estimated Actual
Patient Bone age 
(yrs)
bone age (cm) final height 
(cm)
f inal 
height
1 11.0 147 172 166
2 11.5 147 170 170
3 12.5 149 171 166.5
4 11.0 145 171 169
5 13.5 150 165 164.5
6 12.5 147 171 168
7 13.0 165 183 188
8 11.0 141 171 159
•TABLE 20
Comparison of actual and predicted final heights 
in 8 patients treated with HCG
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age. For patients with bone ages greater than 11.5 years 
there is no obvious differen ce between the predicted 
adult heights (PAH) and either the post-thera py  PAH or
final height outcome of the group. However, only one of
11 patients with initial skeletal ages less than 11.5 
years showed an improved height expecta ncy after therapy. 
The mean reduction in PAH in this group was considerable; 
-5.1cms. Figure 38 also illustrates the genital staging
of the patients in relation to their predicted height
outcome and clearly genital stage per se cannot predict 
the influence of HCG therapy on final height.
10.4) DISCU SSION
HCG is clearly e st ablish ed  as a potent stimulator of 
growth and sexual de velopment in pre -pubertal males 
(Dorff, 1940; Dorff, 1942; Reiss et al, 1965; Van den 
Bosch, et al, 1982). However the value of such therapy 
for influencing both height velocity and genital 
deve lo pment in a typical population of boys referred to 
an en docrine clinic, has never been fully assessed. The 
present study includes a control group of untreated 
patient s who were s e 1f - s e 1e c t e d . This control group, 
however contains a greater number of boys in the later 
stages of puberty and there fore there is a bias to treat 
patients in the earlier stages of puberty. In co mparing 
patients in the two groups care has been taken to match
+4 J ©
& Predicted 9 J  •
adult +“ ~ | © •  Pre-treatment
r eigh\  ° j  " 7 " * -------12 '*  I . 1 3 -------0-------T4 ^ ° " “ aSe(cms) - G o ® 9 k yrs)
-4
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Figure 38
Change in pr edict ed final height following HCG 
therapy as a function of initial bone age.
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patients for genital staging and bone aga or 
ch ron ologica l age where relevent and therefore it is 
hoped that any bias in the study has been eliminated.
We have shown that patients rec eiving HCG treatment 
achieve genital stage 3 or 4 by the end of the therapy 
period with pre-pubertal patients showing the greatest 
advances. Untreated patients, by contrast, ad vanced no 
more than one genital stage during a compar able time 
period. According to Marshall and Tanner (1970) over a 
six month period ap prox i m a t e l y  5% of boys will advance 
from genital stage 2 (G2) to G3, and a p pr oximat el y 20% 
will change from G3 to G4. In the present study, even in 
the control group, a greater than expecte d number of 
patients advanced from one genital stage to the next. 
This would suggest that many of the boys were about to 
enter the next stage of develo pment at the time of 
presentation. For the treatment group, even if all the 
patie nts  who were pre-pubertal at the start of the 
treat men t period were about to enter genital stage 2 
imminently, only 5% would be expected to achieve stage 3 
puberty in 6 months and none would be expe cted to advance 
to G 4 .
The information on testicu lar volumes is more 
dif fi cu lt to interpret due to the wide range of volumes 
in the patients studied and the rather poor overlap 
between the treated and control populations.
The rapid ac ce ler ation in growth velocit y during  HCG
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therapy is dem onst rated  by this work which confirms the 
early data of Dorff (1940, 1942) and Reiss et al (1965).
Host patients grew during the treatment periods at rates 
which are greater than a normal pubertal growth spurt 
(Tanner et al, 1966). However when the growth velocities 
for the whole year of study are computed the difference 
in height gain between the two groups of patients is much 
less obvious and the mean growth velocity for the HCG 
group of 8.7cm/yr is no longer greater than the normal 
pubertal growth spurt. This is mainly due to the rapid 
d ec el eratio n in growth which occurs on cessation of 
t r e a t m e n t .
Marshall (1971) has pointed out the difficult ie s in 
me as ur ing growth velociti es over periods of less than 1 
year when errors can arise because of inaccuracies in 
height measurement and because of variation in growth 
rates in normal children du ring the year. These errors, 
however would not explain the very obvious differenc es in 
growth patterns in the two groups of patients.
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C O N C L U S I O N S  A N D IM P  I C A T  I O N S  F O R  F U R T H E R  R E S E A R C H
T h i s  w o r k  h a s  d e m o n s t r a t e d  t h e  pf f e c t  s o f e x o g e n o u s  
p u l s a t i l e  L H - R H  a d m i n i s t r a t i o n  u p o n  t h e  e n d o g e n o u s  
s e c r e t i o n  of g o n a d o t r o p h i n s  t h r o u g h o u t  24 h o u r  p e r i o d s  in 
p u b e r t a l  boys. E x o g e n o u s  a d m i n i s t r a t i o n  of L H - R H  
s t i m u l a t e s  g o n a d o t r o p h i n  s e c r e t i o n  a b o v e  p r e - i n f u s i o n  
c o n c e n t r a t i o n s  o n l y  at t i m e s  of t h e  d a y  w h e n  e n d o g e n o u s  
s e c r e t i o n  is at a m i n i m u m .  D u r i n g  the n i g h t  w h e n  n a t u r a l  
L H - R H  s u r g e s  o c c u r ,  the e f f e c t  of e x o g e n o u s  L H - R H  is 
v a r i a b l e .  If e n d o g e n o u s  a n d  e x o g e n o u s  L H - - R H p u l s e s  
c o i n c i d e  t h e n  f u r t h e r  s t i m u l a t i o n  of the g o n a d o t r o p h  m a y  
be e x p e c t e d .  H o w e v e r ,  if e n d o g e n o u s  a n d  e x o g e n o u s  p u l s e s  
a r e  a s y n c r o n o u s  t h e n  th e  g o n a d o t r o p h  is e x p o s e d  to p u l s e s  
at an i n c r e a s e d  f r e q  u e n c y  and t h i s  m a y  r e s u l t  in 
d o w n - r e g u 1 a t i o n  of t h e  g o n a d o t r o p h .
D e s p i t e  the a l t e r a t i o n  in g o n a d o t r o p h i n  d i u r n a l
r h y t h m s  c a u s e d  by p u l s a t i l e  L H - R H  i n f u s i o n s ,  s e r u m  
t e s t o s t e r o n e  m a i n t a i n e d  s t i m u l a t e d  l e v e l s  t h r o u g h o u t  the 
2 4  h o u r  p e r i o d s  d u r i n g  L H - R H  a d m i n i s t r a t i o n .  T h i s  w o u l d  
s u g g e s t  t h a t  th e  l e n g t h  of t i m e  of e x p o s u r e  to 
c i r c u l a t i n g  LH as w e l l  as t h e  L H  c o n c e n t r a t i o n s  is
i m p o r t a n t  for s t i m u l a t i o n  of t e s t o s t e r o n e  s e c r e t i o n  by
t h e  L e y d  i g c e l l s .
It w o u l d  t h e r e f o r e  be of i n t e r e s t  to i n v e s t i g a t e  t h e  
e f f e c t s  of p u l s a t i l e  L H - R H  a d m i n i s t r a t i o n ,  g i v e n  o v e r  
s h o r t e r  p e r i o d s  d u r i n g  t h e  a f t e r n o o n  a n d  e a r l y  e v e n i n g ,
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upon serum tes tosterone levels throughout the 24 hour
period. It may well be that LH-RH infusions in the
afternoon would be sufficient to stimulate testosterone 
secretion throughout the day and night.
It would also be of interest to investigate the 
b io-ac ti vi ty of LH pulses during the day and night prior 
to and during pulsatile LH-RH infusions.
This work failed to show a rel atio nship between LH-RH 
pulse dosage and gonad ot rophin response after 6 days of 
therapy. The gonadotrophin  response to LH-RH infusion may 
be dependent upon the length of time of LH-RH 
ad mi ni strati on  and this requires further investigation.
It has been shown in the present thesis that mean 
gon ado tr ophin concent ra tions following pulsatile LH-RH 
infusions to hypogonadal males is dependent upon the 
pre -in fusi on  gonad otrophin concentrations. Patients with 
per manent hyp og on a d o t r o p h i c  hy pog onadi sm showed
q ua nt i t a t i v e l y  greater gonadotrophin  increments when 
co mpa re d with patients with const ituti onal delay of
pub ert y or short stature. The increased gonadotr ophin
release in patients with hy po tha lamic h yp og onadis m may be 
due to a lack of interference between endogenous and 
e xo genous LH-RH pulses in these patients. A further 
possible explanation could be reduced or delayed 
tes tic ular response to gonadot ro phins in the 
h yp og on a d o t r o p h i c  patients. However, no differences in 
te st os terone  response to pul satile LH-RH infusion was
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d e m o n s t r a t e d  b e t w e e n  t h e  g r o u p s  s t u d i e d .  O n e  a g o n a d a l  
p a t i e n t  w h o  w a s  s t u d i e d ,  a l s o  s h o w e d  i n c r e a s e d  
g o n a d o t r o p h i n  s e c r e t i o n  in r e s p o n s e  to p u l s a t i l e  L H - R H  
i n f u s i o n  w h e n  c o m p a r e d  to d e l a y e d  p u b e r t y  or s h o r t
s t a t u r e  p a t i e n t s .  H o w e v e r ,  in t h i s  p a t i e n t ,  F S H  r o s e
p r e d o m i n a n t l y  a n d  t h e  F S H  : L H  r a t i o  t h e r e f o r e  s i m u l a t e d
t h e  p i c t u r e  w h i c h  is o f t e n  f o u n d  in a d u l t  m a l e s  w i t h  
p r i m a r y  t e s t i c u l a r  f a i l u r e .
T h e  t e s t o s t e r o n e  r e s p o n s e  to p u l s a t i l e  L H - R H  
i n f u s i o n s  w a s  d e p e n d e n t  on b a s a l  t e s t o s t e r o n e  a n d  th e  
p a t i e n t ’s b o n e  age. M o s t  p a t i e n t s  w i t h  u n d e t e c t a b l e  b a s a l  
t e s t o s t e r o n e  c o n c e n t r a t i o n s  or b o n e  a g e s  l e s s  t h a n  12 
y e a r s  f a i l e d  to s h o w  s i g n i f i c a n t  r i s e s  in s e r u m  
t e s t o s t e r o n e  d u r i n g  t h e  i n f u s i o n  p e r i o d s .  M e a s u r e m e n t  of 
s e r u m  t e s t o s t e r o n e  c o n c e n t r a t i o n s  t h r o u g h  t h e  n i g h t  m i g h t  
h a v e  s h o w n  t e s t o s t e r o n e  r e s p o n s e s  in s o m e  of t h e s e  
p a t i e n t s  a n d  f u r t h e r  n o c t u r n a l  p r o f i l e s  in p a t i e n t s  in 
e a r l y  p u b e r t y  u n d e r g o i n g  p u l s a t i l e  t h e r a p y  w o u l d  be 
v a l u a b l e .
T h e  g r a d e d  t e s t o s t e r o n e  r e s p o n s e  to L H - R H  i n f u s i o n s
a g a i n  d e m o n s t r a t e s  t h a t  t h e  d e g r e e  of r e s p o n s e  of t h e  
p i t u i t a r y - g o n a d a l  a x i s  is d e p e n d e n t  u p o n  p r i o r  p r i m i n g  of 
t h e  a x i s  at all l e v e l s .
S t a n d a r d  b o l u s  L H - R H  t e s t s  ( l O O u g  i.v . )  f a i l e d  to 
d i f f e r e n t i a t e  t h e  g r o u p s  of h y p o g o n a d a l  m a l e s  b o t h  b e f o r e  
a n d  f o l l o w i n g  p u l s a t i l e  L H - R H  a d m i n i s t r a t i o n .  LH 
i n c r e m e n t s  to b o l u s  L H - R H  t e s t s  w e r e  u n a l t e r e d  by
149
p u l s a t i l e  L H - R H  i n f u s i o n s  in the 3 p a t i e n t  g r o u p s
s t u d i e d .  P e a k  F S H  c o n c e n t r a t i o n s  in b o l u s  L H - R H  t e s t s  
w e r e  r e d u c e d  f o l l o w i n g  p u l s a t i l e  L H - R H  i n f u s i o n s  in t h e  
d e l a y e d  p u b e r t y  a n d  s h o r t  s t a t u r e  g r o u p s .  In c o n t r a s t ,
p e a k  F S H  c o n c e n t r a t i o n s  in b o l u s  L H - R H  t e s t s  w e r e
i n c r e a s e d  in h y p o g o n a d o t r o p h i c  h y p o g o n a d a l  p a t i e n t s  
f o l l o w i n g  p u l s a t i l e  L H - R H  i n f u s i o n s .  H o w e v e r  t h e  v a l u e  of 
t h i s  f i n d i n g  is d i m i n i s h e d  by t h e  o v e r l a p  in F S H  v a l u e s  
b e t w e e n  t h e  g r o u p s .  T h e  m e a n  b a s a l  g o n a d o t r o p h i n  
c o n c e n t r a t i o n s  w e r e  b e t t e r  a b l e  to d i s c r i m i n a t e  b e t w e e n  
t h e  g r o u p s  t h a n  s t i m u l a t e d  g o n a d o t r o p h i n  l e v e l s  a f t e r
b o l u s  i n j e c t i o n s .  W h e t h e r  t h e  d i m i n i s h e d  F S H  r e s p o n s e s  to 
b o l u s  L H - R H  a f t e r  p u l s a t i l e  t h e r a p y  r e p r e s e n t s  m a t u r a t i o n  
of t h e  h y p o t h a l a m i c - p i t u i t a r y  a x i s  r e m a i n s  c o n j e c t u r e .
T h e  p r e s e n t  w o r k  h a s  c o n f i r m e d  t h a t  t h e  p r o l a c t i n  
r e s p o n s e  to i n t r a v e n o u s  T R H  ( 2 0 0 u g )  w a s  u n a b l e  to 
d i f f e r e n t i a t e  b e t w e e n  p a t i e n t s  w i t h  p u b e r t a l  d e l a y  or
p e r m a n e n t  h y p o g o n a d o t r o p h i c  h y p o g o n a d i s m .  T h e  f a i l u r e  of 
p u l s a t i l e  L H - R H  a d m i n i s t r a t i o n  to a l t e r  t h e  p r o l a c t i n
r e s p o n s e  to T R H  in e i t h e r  g r o u p  of p a t i e n t  s t u d i e d ,
s u g g e s t s  t h a t  t h e r e  is no s i g n i f i c a n t  r e l a t i o n s h i p  
b e t w e e n  e x o g e n o u s  L H - R H  a n d  t h e  m e c h a n i s m  by w h i c h  T R H  
s t i m u l a t e s  p r o l a c t i n  r e l e a s e .  T h i s  w o r k ,  h o w e v e r  d o e s  no t 
e x c l u d e  t h e  p o s s i b i l i t y  of an a s s o c i a t i o n  b e t w e e n  
e n d o g e n o u s  L H - R H  r e l e a s e  a n d  p r o l a c t i n  s e c r e t i o n .
P r o l o n g e d  p u l s a t i l e  i n f u s i o n s  of L H - R H  f o r  the 
i n d u c t i o n  of f e r t i l i t y  in p a t i e n t s  w i t h  h y p o g o n a d o t r o p h i c
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h y p o g o n a d i s m  p r o d u c e d  d i s a p p o i n t i n g  r e s u l t s .  W h i l e  th e  
b i o c h e m i c a l  c h a n g e s  of p u b e r t y  c o u l d  be i n d u c e d  in s o m e  
p a t i e n t s ,  i m p r o v e m e n t  in s p e r m  c o u n t  w a s  m o d e s t  or a b s e n t  
a n d  no p a t i e n t  b e c a m e  f e r t i l e  d u r i n g  t h i s  t h e r a p y .  T h e  
t r e a t m e n t  p r o v e d  i n t r u s i v e  a n d  i n t e r f e r e d  w i t h  th e  
a b i l i t y  of s e v e r a l  of t h e  p a t i e n t s  to c o n t i n u e  t h e i r  
n o r m a l  w o r k .  I m p a i r e d  t e s t i c u l a r  f u n c t i o n  or a c q u i r e d  
s e n s i t i v i t y  w e r e  f u r t h e r  p r o b l e m s  e n c o u n t e r e d .
L H - R H  a n d  H C G  s t i m u l a t i o n  t e s t s  p r i o r  to p u l s a t i l e
t r e a t m e n t  w e r e  u n r e l i a b l e  p r e d i c t o r s  of r e s p o n s e .  F u r t h e r  
s t u d i e s  u s i n g  L H - R H  i n f u s i o n s  to i n d u c e  f e r t i l i t y  a r e  
r e q u i r e d .  C l i n i c a l  d e t a i l s  s u c h  as a h i s t o r y  of 
c r y p t o r c h i d i s m ,  p a t i e n t ’s a g e  a n d  p r i o r  t h e r a p y  to i n d u c e  
p u b e r t y  a r e  n e c e s s a r y  b e f o r e  t h e  e f f i c a c y  of t h i s
t r e a t m e n t  c a n  be f u l l y  a s s e s s e d .  A c o m p a r i s o n  w i t h  t h e
c o n v e n t i o n a l  t r e a t m e n t  ( H C G  a n d  H M G  ) is a l s o  r e q u i r e d .
P r o l o n g e d  p u l s a t i l e  L H - R H  i n f u s i o n  f a i l e d  to s t i m u l a t e  
g o n a d o t r o p h i n  s e c r e t i o n  in o n e  p a t i e n t  w i t h  c o n g e n i t a l  
a d r e n a l  h y p o p l a s i a .  T h i s  r e s u l t  w o u l d  s u g g e s t  t h a t  t h e
h y p o g o n a d i s m  in t h i s  r a r e  c o n g e n i t a l  d i s o r d e r  is of 
p i t u i t a r y  o r i g i n .
H u m a n  c h o r i o n i c  g o n a d o t r o p h i n  h a s  b e e n  s h o w n  to
a c c e l e r a t e  p u b e r t a l  d e v e l o p m e n t  in b o y s  at g e n i t a l  s t a g e s  
1 a n d  2 w h e n  c o m p a r e d  w i t h  u n t r e a t e d  p a t i e n t s  of s i m i l a r  
s e x u a l  m a t u r a t i o n .  H e i g h t  v e l o c i t y  is i n c r e a s e d  d u r i n g  
t r e a t m e n t ,  p a r t i c u l a r l y  in p a t i e n t s  g r o w i n g  i n i t i a l l y  at 
l e s s  t h a n  7 c m / y r .  C l e a r l y ,  t h e r e f o r e ,  b o y s  w h o  a r e
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a l r e a d y  w e l l  e s t a b l i s h e d  i n t o  p u b e r t y  s h o w  l i t t l e  b e n e f i t  
f r o m  t r e a t m e n t .  F u r t h e r m o r e  c h i l d r e n  w i t h  b o n e  a g e s  of 
l e s s  t h a n  1 1.5 y e a r s  at t h e  s t a r t  of t h e r a p y  a p p e a r  to be 
at r i s k  of d i m i n i s h e d  f i n a l  h e i g h t  o u t c o m e .  T h e r e  a p p e a r s  
t h e r f o r e ,  to be a f a i r l y  n a r r o w  c l i n i c a l  s p e c t r u m  of
p a t i e n t s  w h o  s h o w  b e n e f i t  f r o m  t h i s  t r e a t m e n t  w i t h o u t  
p r e j u d i c i n g  t h e i r  u l t i m a t e  h e i g h t .  T h e s e  r e s u l t s  w i t h  H C G  
t r e a t m e n t  a r e  s i m i l a r  to m a n y  of t h e  f i n d i n g s  p r e v i o u s l y  
s h o w n  to o c c u r  w i t h  a n d r o g e n  t h e r a p y  for d e l a y e d  p u b e r t y  
in m a l e s .
P e r h a p s  m o n i t o r i n g  of s e r u m  t e s t o s t e r o n e
c o n c e n t r a t i o n s  d u r i n g  H C G  t r e a t m e n t  w o u l d  h e l p  to d e f i n e  
an o p t i m u m  d o s a g e  r e g i m e n .  It w o u l d  a l s o  be of i n t e r e s t  
to c o m p a r e  r e s p o n s e  to H C G  w i t h  t h e  u s e  of l e s s  f r e q u e n t  
i n j e c t i o n s  of s m a l l  d o s e s  of t e s t o s t e r o n e  i t s e l f .
L i t t l e  is k n o w n  a b o u t  t h e  n a t u r a l  m a t u r a t i o n  of t h e
h y p o t h a l a m i c - p i t u i t a r y - t e s t i c u l a r  a x i s  d u r i n g  H C G  
t h e r a p y .  W i t h  t h e  d e v e l o p m e n t  of a s s a y s  fo r  p l a s m a  L H - E H  
a n d  h i g h l y  s p e c i f i c  a s s a y s  for LH a n d  F S H  it m a y  be 
p o s s i b l e  to i n v e s t i g a t e  t h e  e f f e c t  of e x o g e n o u s
a n d r o g e n i c  s t e r o i d s  a n d  H C G  u p o n  t h i s  a x i s .
T h e  a s s e s s m e n t ,  m a n a g e m e n t  a n d  t r e a t m e n t  of d e l a y e d  
s e x u a l  d e v e l o p m e n t  in t h e  m a l e  r e m a i n s  a d i f f i c u l t  a r e a  
of p a e d i a t r i c  a n d  a d o l e s c e n t  e n d o c r i n o l o g y .  F u r t h e r  
s t u d i e s  a r e  r e q u i r e d  in o r d e r  to e s t a b l i s h  a s i m p l e  a n d
r a p i d  m e t h o d  for i n v e s t i g a t i n g  t h e s e  p a t i e n t s  a n d  for
i d e n t i f y i n g ,  w h e n  c o n s i d e r e d  a p p r o p r i a t e ,  t h e  m o s t
152
u i t a b l e  t  r  pa t  m en t r e g i m e  n
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